Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,A1BG,Alpha-1B-glycoprotein,24261,142,0.43 [0.18-1.04],0.06089366224406
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AAMDC,Mth938 domain-containing protein,23591,137,0.91 [0.67-1.24],0.5472620066853373
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AARSD1,Alanyl-tRNA editing protein Aarsd1,27657,152,1.03 [0.80-1.33],0.8069752012454219
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ABCA2,ATP-binding cassette sub-family A member 2,23445,136,0.80 [0.50-1.29],0.3579187606687721
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ABHD14B,Protein ABHD14B,27496,152,0.90 [0.70-1.15],0.4065179838269531
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ABL1,Tyrosine-protein kinase ABL1,27657,152,0.88 [0.71-1.10],0.2723855346422846
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ABO,Histo-blood group ABO system transferase,24226,140,1.04 [0.94-1.17],0.4390462954392606
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ABRAXAS2,BRISC complex subunit Abraxas 2,23445,136,0.91 [0.71-1.17],0.466143047150745
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",27127,147,0.91 [0.76-1.09],0.3028205053082348
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",23760,138,0.94 [0.73-1.20],0.5934378915645688
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",24214,140,0.89 [0.74-1.07],0.1973596057904186
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACAN,Aggrecan core protein,27535,151,0.66 [0.40-1.10],0.1097178552173786
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACE,Angiotensin-converting enzyme,24226,140,0.55 [0.30-0.99],0.0453106671871254
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACE2,Angiotensin-converting enzyme 2,27269,150,1.00 [0.75-1.34],0.9790273647245632
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACHE,Acetylcholinesterase,23702,141,0.66 [0.39-1.11],0.1199010033203893
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACOT13,Acyl-coenzyme A thioesterase 13,24088,141,0.93 [0.81-1.07],0.3338224856413632
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,27780,151,0.72 [0.53-0.98],0.0340242348920957
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACP1,Low molecular weight phosphotyrosine protein phosphatase,23526,136,1.00 [0.69-1.43],0.9800561669492728
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACP5,Tartrate-resistant acid phosphatase type 5,27906,155,0.95 [0.61-1.50],0.8350546639190173
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACP6,Lysophosphatidic acid phosphatase type 6,27963,153,1.17 [0.93-1.46],0.1862547490628753
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACRBP,Acrosin-binding protein,24077,140,0.87 [0.57-1.35],0.5391566017597477
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACRV1,Acrosomal protein SP-10,23526,136,0.62 [0.38-1.01],0.0530692247527731
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACSL1,Long-chain-fatty-acid--CoA ligase 1,23445,136,1.00 [0.65-1.54],0.9958101105287592
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACTA2,"Actin, aortic smooth muscle",27269,150,0.88 [0.62-1.25],0.4711669830191248
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACTN2,Alpha-actinin-2,23445,136,1.39 [1.07-1.79],0.0118707269100374
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACTN4,Alpha-actinin-4,27224,148,0.96 [0.61-1.53],0.8767121901120154
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACVRL1,Serine/threonine-protein kinase receptor R3,27544,152,1.00 [0.55-1.81],0.9895302184472262
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACY1,Aminoacylase-1,27780,151,0.91 [0.71-1.16],0.4445165141653224
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,23445,136,1.01 [0.75-1.35],0.9706406148042024
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACYP1,Acylphosphatase-1,23606,141,0.85 [0.66-1.09],0.1903909028630791
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADA,Adenosine deaminase,28067,151,1.01 [0.67-1.53],0.9452851275830052
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADA2,Adenosine deaminase 2,27601,155,1.17 [0.83-1.63],0.3714519524683701
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,23526,136,0.50 [0.29-0.87],0.0143145929920864
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,27269,150,0.99 [0.62-1.59],0.9670822483073392
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,27586,152,0.89 [0.59-1.35],0.5853378539454288
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,28067,151,1.29 [0.84-1.98],0.2404295517817826
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,27971,153,0.72 [0.44-1.17],0.1806556893974681
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,24088,141,0.97 [0.57-1.67],0.9252347213087662
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,23526,136,0.61 [0.35-1.09],0.0932063516438194
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,28118,155,1.20 [0.65-2.23],0.5559823414523495
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,27657,152,0.87 [0.64-1.17],0.3507107297320693
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,27269,150,1.24 [0.83-1.85],0.2868267683419151
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,23526,136,1.01 [0.64-1.61],0.9555888668877984
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,27877,155,0.78 [0.57-1.06],0.1124378338713951
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAMTSL2,ADAMTS-like protein 2,24212,142,1.23 [0.75-2.02],0.4062372442174462
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAMTSL4,ADAMTS-like protein 4,23591,137,0.73 [0.36-1.49],0.390655355661772
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAMTSL5,ADAMTS-like protein 5,24214,140,0.87 [0.57-1.32],0.5084229537638876
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,27127,147,0.94 [0.60-1.45],0.7671063717760245
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADD1,Alpha-adducin,23702,141,0.83 [0.66-1.04],0.1086085104916667
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADGRB3,Adhesion G protein-coupled receptor B3,27544,152,1.25 [0.82-1.91],0.3042175984234262
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADGRD1,Adhesion G-protein coupled receptor D1,23702,141,0.83 [0.53-1.30],0.4227156980581052
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADGRE1,Adhesion G protein-coupled receptor E1,24088,141,0.92 [0.69-1.24],0.5800014119126022
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADGRE2,Adhesion G protein-coupled receptor E2,27917,151,1.08 [0.65-1.81],0.759775988955405
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADGRE5,Adhesion G protein-coupled receptor E5,27981,154,0.83 [0.51-1.36],0.4634494691246367
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADGRF5,Adhesion G protein-coupled receptor F5,24214,140,0.51 [0.30-0.86],0.0112373845763686
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADGRG1,Adhesion G-protein coupled receptor G1,27657,152,1.05 [0.83-1.33],0.6791551657828832
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADGRG2,Adhesion G-protein coupled receptor G2,27780,151,0.61 [0.35-1.03],0.0655375092635478
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADGRV1,Adhesion G-protein coupled receptor V1,23430,140,0.87 [0.68-1.13],0.2976517739764189
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADH1B,All-trans-retinol dehydrogenase,23702,141,0.99 [0.79-1.23],0.9080967199520996
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,27269,150,1.00 [0.84-1.18],0.9714214576841668
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADIPOQ,Adiponectin,24261,142,0.86 [0.68-1.09],0.2169739168398145
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADM,Pro-adrenomedullin,28012,153,0.72 [0.43-1.22],0.2265141130227125
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADRA2A,Alpha-2A adrenergic receptor,23445,136,0.93 [0.73-1.19],0.574643638498443
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AFAP1,Actin filament-associated protein 1,23702,141,1.05 [0.87-1.26],0.6406972154667843
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AFM,Afamin,24261,142,0.45 [0.19-1.02],0.0569639825207887
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AFP,Alpha-fetoprotein,27504,151,1.08 [0.88-1.33],0.4637623050262319
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AGBL2,Cytosolic carboxypeptidase 2,23430,140,0.87 [0.74-1.03],0.097896570429918
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AGER,Advanced glycosylation end product-specific receptor,27732,151,1.01 [0.71-1.44],0.941726895340432
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AGR2,Anterior gradient protein 2 homolog,26861,146,0.96 [0.83-1.12],0.6282366488117781
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AGR3,Anterior gradient protein 3,27079,147,1.00 [0.78-1.28],0.989732891691494
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AGRN,Agrin,27917,151,0.73 [0.47-1.14],0.171701774809596
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AGRP,Agouti-related protein,28067,151,1.21 [0.92-1.60],0.1656129815569029
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AGT,Angiotensinogen,24226,140,1.02 [0.51-2.06],0.9515618134157936
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AGXT,Serine--pyruvate aminotransferase,27780,151,1.08 [0.90-1.29],0.4307249894868706
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AHCY,Adenosylhomocysteinase,27780,151,0.88 [0.71-1.09],0.2457478670279113
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AHNAK,Neuroblast differentiation-associated protein AHNAK,23591,137,0.55 [0.32-0.96],0.0354083096848215
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AHNAK2,Protein AHNAK2,23591,137,0.78 [0.43-1.43],0.4273861829926578
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,24077,140,0.84 [0.65-1.10],0.2140030374542725
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AHSG,Alpha-2-HS-glycoprotein,24226,140,0.68 [0.40-1.15],0.1532083164318698
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AHSP,Alpha-hemoglobin-stabilizing protein,27743,153,0.98 [0.83-1.15],0.8160731616424397
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AIDA,"Axin interactor, dorsalization-associated protein",23536,141,1.01 [0.84-1.22],0.8980843212884475
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AIF1,Allograft inflammatory factor 1,27127,147,0.81 [0.61-1.08],0.1478341901693808
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AIF1L,Allograft inflammatory factor 1-like,23591,137,0.90 [0.66-1.23],0.5135868997733268
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",27606,152,0.90 [0.79-1.04],0.1586260802067579
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AK1,Adenylate kinase isoenzyme 1,27780,151,0.94 [0.75-1.17],0.5818277965604787
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AK2,"Adenylate kinase 2, mitochondrial",24158,142,0.90 [0.77-1.04],0.1561759677752121
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AKAP12,A-kinase anchor protein 12,23702,141,0.53 [0.23-1.19],0.1220820782144578
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AKR1B1,Aldo-keto reductase family 1 member B1,27127,147,1.09 [0.90-1.32],0.3688169394196399
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AKR1B10,Aldo-keto reductase family 1 member B10,23536,141,0.77 [0.57-1.03],0.0766195072080915
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AKR1C4,Aldo-keto reductase family 1 member C4,27269,150,0.83 [0.61-1.12],0.2217321258926891
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AKR7L,Aflatoxin B1 aldehyde reductase member 4,23526,136,1.00 [0.79-1.26],0.9893811560970698
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AKT1S1,Proline-rich AKT1 substrate 1,27099,148,1.00 [0.80-1.24],0.995643925683352
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AKT2,RAC-beta serine/threonine-protein kinase,24175,141,0.90 [0.80-1.02],0.1143679647407867
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AKT3,RAC-gamma serine/threonine-protein kinase,26996,147,0.94 [0.73-1.22],0.6663419105904879
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ALCAM,CD166 antigen,28118,155,0.65 [0.31-1.37],0.2607579709751645
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ALDH1A1,Retinal dehydrogenase 1,27784,153,1.00 [0.77-1.30],0.9972232125198376
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ALDH2,"Aldehyde dehydrogenase, mitochondrial",24077,140,0.91 [0.66-1.27],0.5957553454168045
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",27692,152,1.10 [0.90-1.35],0.338258147021295
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",24175,141,0.93 [0.66-1.32],0.6842799419929009
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ALMS1,Alstrom syndrome protein 1,23760,138,0.84 [0.57-1.25],0.3855446344463767
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ALPI,Intestinal-type alkaline phosphatase,23526,136,0.94 [0.82-1.08],0.3620158200136513
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ALPP,"Alkaline phosphatase, placental type",27657,152,0.90 [0.79-1.04],0.1433331703651472
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMBN,Ameloblastin,27224,148,1.01 [0.61-1.69],0.9608304616352468
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMBP,Protein AMBP,27974,152,1.12 [0.55-2.29],0.7597823563747795
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,24212,142,0.56 [0.31-1.02],0.0586169423634543
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMFR,E3 ubiquitin-protein ligase AMFR,27099,148,0.91 [0.72-1.15],0.4353048524905495
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMIGO1,Amphoterin-induced protein 1,23536,141,0.78 [0.54-1.12],0.1787548887824273
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMIGO2,Amphoterin-induced protein 2,27657,152,0.96 [0.51-1.80],0.895946971959626
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMN,Protein amnionless,27224,148,0.87 [0.63-1.19],0.3736657796415968
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMOT,Angiomotin,23702,141,0.92 [0.62-1.37],0.6801436706894559
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMOTL2,Angiomotin-like protein 2,23996,140,1.07 [0.78-1.48],0.6577753224909235
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMPD3,AMP deaminase 3,24158,142,1.05 [0.85-1.31],0.6270509325103595
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,22670,125,1.11 [0.79-1.56],0.5618795457550039
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMY2A,Pancreatic alpha-amylase,26681,152,1.00 [0.73-1.36],0.9876215816340004
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMY2B,Alpha-amylase 2B,25880,147,1.03 [0.76-1.41],0.8386560220576087
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANG,Angiogenin,27689,155,0.80 [0.52-1.22],0.2908440326883678
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANGPT1,Angiopoietin-1,27682,151,0.90 [0.76-1.06],0.2199658043712337
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANGPT2,Angiopoietin-2,28012,153,0.83 [0.56-1.22],0.3338832854599652
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANGPTL1,Angiopoietin-related protein 1,27403,149,0.89 [0.54-1.46],0.6355103203193373
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANGPTL2,Angiopoietin-related protein 2,27831,150,0.98 [0.68-1.39],0.8914273998528139
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANGPTL3,Angiopoietin-related protein 3,27779,155,0.92 [0.63-1.36],0.6881671732360242
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANGPTL4,Angiopoietin-related protein 4,27869,151,0.79 [0.57-1.09],0.1479088503825053
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANGPTL7,Angiopoietin-related protein 7,28012,153,0.92 [0.62-1.36],0.6711423221599946
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANK2,Ankyrin-2,23445,136,1.17 [0.97-1.41],0.1080290318857341
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,23526,136,0.92 [0.74-1.13],0.4180419854435122
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANKRA2,Ankyrin repeat family A protein 2,23335,137,0.85 [0.62-1.16],0.3004918154710962
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANKRD54,Ankyrin repeat domain-containing protein 54,27127,147,0.87 [0.66-1.14],0.322214260681495
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,23591,137,1.06 [0.74-1.53],0.748300009911469
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANPEP,Aminopeptidase N,27825,155,1.06 [0.64-1.74],0.8243652128254643
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANXA1,Annexin A1,23557,139,0.97 [0.67-1.41],0.8779768009130979
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANXA10,Annexin A10,27099,148,0.94 [0.79-1.13],0.5356874120219066
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANXA11,Annexin A11,27696,152,0.93 [0.76-1.14],0.4849046053319603
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANXA2,Annexin A2,23228,136,0.82 [0.64-1.05],0.1207834790038762
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANXA3,Annexin A3,27971,153,0.95 [0.77-1.16],0.6064955268324546
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANXA4,Annexin A4,27639,151,0.92 [0.75-1.12],0.3990845846833366
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANXA5,Annexin A5,27017,145,1.21 [0.75-1.94],0.4383094397480017
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AOC1,Amiloride-sensitive amine oxidase [copper-containing],27224,148,1.00 [0.78-1.29],0.9994017005081508
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AOC3,Membrane primary amine oxidase,27874,155,1.03 [0.64-1.64],0.9070097947543876
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AP1G2,AP-1 complex subunit gamma-like 2,24077,140,0.86 [0.70-1.06],0.151435969784407
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AP2B1,AP-2 complex subunit beta,23536,141,0.81 [0.57-1.15],0.2386320505868005
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AP3B1,AP-3 complex subunit beta-1,24088,141,0.83 [0.67-1.03],0.0989223874546175
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AP3S2,AP-3 complex subunit sigma-2,24158,142,0.72 [0.50-1.04],0.0803577126932205
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,27657,152,0.76 [0.53-1.08],0.1255630354988548
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APCS,Serum amyloid P-component,24042,142,0.54 [0.35-0.84],0.0053922783609677
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,27915,153,0.85 [0.67-1.09],0.2062855868924918
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APLP1,Amyloid-like protein 1,27780,151,0.86 [0.65-1.14],0.2889560786902959
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOA1,Apolipoprotein A-I,24261,142,0.46 [0.23-0.90],0.0235691333249017
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOA2,Apolipoprotein A-II,24226,140,0.92 [0.66-1.28],0.6110127500520941
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOA4,Apolipoprotein A-IV,24261,142,0.60 [0.37-0.98],0.0423318172543029
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOB,Apolipoprotein B-100,24226,140,0.64 [0.33-1.26],0.1958561229021233
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOBR,Apolipoprotein B receptor,23591,137,1.04 [0.70-1.53],0.8540989903071539
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOC1,Apolipoprotein C-I,24209,142,0.71 [0.44-1.14],0.1579205288964767
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOD,Apolipoprotein D,23142,128,0.89 [0.58-1.38],0.605242236749524
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOE,Apolipoprotein E,24261,142,0.89 [0.69-1.15],0.3575780204322434
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOF,Apolipoprotein F,24226,140,1.16 [0.57-2.37],0.678854319462687
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOH,Beta-2-glycoprotein 1,27784,153,0.83 [0.55-1.26],0.3837864333801163
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOL1,Apolipoprotein L1,24226,140,0.80 [0.60-1.06],0.1154196055471872
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOM,Apolipoprotein M,27826,155,0.69 [0.41-1.17],0.1670743111930384
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APP,Amyloid-beta precursor protein,27743,153,0.79 [0.64-0.98],0.0323652720167883
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APPL2,DCC-interacting protein 13-beta,23702,141,0.94 [0.81-1.09],0.4064737931762149
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APRT,Adenine phosphoribosyltransferase,27547,151,1.11 [0.82-1.50],0.5062138107515552
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARAF,Serine/threonine-protein kinase A-Raf,23760,138,0.95 [0.75-1.22],0.7082352117655253
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AREG,Amphiregulin,27657,152,1.17 [0.87-1.56],0.2967239156219258
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARF6,ADP-ribosylation factor 6,24088,141,0.89 [0.76-1.03],0.106586904866354
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARFIP1,Arfaptin-1,24175,141,0.78 [0.61-0.98],0.0360594651823013
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARG1,Arginase-1,27631,151,1.01 [0.77-1.31],0.96072673307224
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARG2,"Arginase-2, mitochondrial",24077,140,0.99 [0.69-1.43],0.97102438422067
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARHGAP1,Rho GTPase-activating protein 1,27127,147,1.00 [0.73-1.38],0.9928370846930556
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARHGAP25,Rho GTPase-activating protein 25,27127,147,0.99 [0.77-1.27],0.9327999422573984
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARHGAP30,Rho GTPase-activating protein 30,23760,138,1.07 [0.71-1.60],0.7601127637688097
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARHGAP45,Rho GTPase-activating protein 45,23702,141,0.88 [0.72-1.08],0.2153485292149156
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARHGAP5,Rho GTPase-activating protein 5,23335,137,0.91 [0.73-1.15],0.4380233076341604
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARHGEF1,Rho guanine nucleotide exchange factor 1,24158,142,0.86 [0.72-1.02],0.0841988072596075
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARHGEF10,Rho guanine nucleotide exchange factor 10,24175,141,0.90 [0.76-1.08],0.2595095636620087
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARHGEF12,Rho guanine nucleotide exchange factor 12,27734,152,1.00 [0.87-1.14],0.9596096873719482
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARHGEF5,Rho guanine nucleotide exchange factor 5,23430,140,1.10 [0.89-1.35],0.3770861645498927
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARID3A,AT-rich interactive domain-containing protein 3A,23430,140,0.92 [0.61-1.40],0.7077666336918623
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARID4B,AT-rich interactive domain-containing protein 4B,27099,148,0.99 [0.70-1.39],0.9497721154202484
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARL13B,ADP-ribosylation factor-like protein 13B,23445,136,0.90 [0.70-1.15],0.3992780548318743
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,23445,136,0.78 [0.51-1.18],0.2351544464736959
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARMCX2,Armadillo repeat-containing X-linked protein 2,23430,140,0.83 [0.62-1.11],0.214839411532338
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARNT,Aryl hydrocarbon receptor nuclear translocator,27224,148,0.81 [0.53-1.24],0.3369200054842555
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,23445,136,1.16 [0.89-1.52],0.2683893182616574
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARSA,Arylsulfatase A,27784,153,0.79 [0.57-1.11],0.1757546214618681
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARSB,Arylsulfatase B,27657,152,0.83 [0.63-1.08],0.1670551434108869
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ART3,Ecto-ADP-ribosyltransferase 3,27874,155,0.50 [0.33-0.77],0.0017113136876447
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ART5,Ecto-ADP-ribosyltransferase 5,23430,140,1.09 [0.88-1.36],0.4301791228844551
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARTN,Artemin,27224,148,1.07 [0.79-1.45],0.6812975546564517
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ASAH1,Acid ceramidase,23983,142,0.54 [0.37-0.80],0.0020491718459797
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ASAH2,Neutral ceramidase,27586,152,1.09 [0.82-1.45],0.5427348437247682
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ASGR1,Asialoglycoprotein receptor 1,27586,152,0.96 [0.58-1.57],0.8631927954946139
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ASGR2,Asialoglycoprotein receptor 2,24226,140,0.83 [0.45-1.54],0.5502857758480808
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ASPN,Asporin,24214,140,1.01 [0.56-1.80],0.9855672945928444
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ASPSCR1,Tether containing UBX domain for GLUT4,24175,141,0.91 [0.72-1.16],0.4457943595428071
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ASRGL1,Isoaspartyl peptidase/L-asparaginase,23591,137,0.92 [0.78-1.08],0.3209782779944461
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ASS1,Argininosuccinate synthase,23445,136,0.98 [0.80-1.21],0.8763802274598922
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATF2,Cyclic AMP-dependent transcription factor ATF-2,27099,148,0.96 [0.77-1.20],0.7172938227403203
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATF4,Cyclic AMP-dependent transcription factor ATF-4,23335,137,0.64 [0.38-1.10],0.1040883106204649
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATG16L1,Autophagy-related protein 16-1,24088,141,0.91 [0.75-1.10],0.330792318965376
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATG4A,Cysteine protease ATG4A,27127,147,0.93 [0.73-1.19],0.5772252963046353
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATOX1,Copper transport protein ATOX1,27877,155,0.91 [0.75-1.11],0.363995996285561
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,23445,136,1.06 [0.78-1.45],0.7095401147968209
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,23445,136,0.77 [0.45-1.34],0.3592336991460781
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,23445,136,0.86 [0.55-1.34],0.4981817828173636
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP1B4,Protein ATP1B4,23335,137,0.95 [0.64-1.41],0.7871684498076075
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP2B4,Plasma membrane calcium-transporting ATPase 4,23445,136,1.06 [0.83-1.36],0.6171144401376332
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP5F1D,"ATP synthase subunit delta, mitochondrial",23445,136,0.99 [0.72-1.36],0.9361966919299286
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP5IF1,"ATPase inhibitor, mitochondrial",27917,151,0.89 [0.78-1.01],0.0727923490509723
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP5PO,"ATP synthase subunit O, mitochondrial",27099,148,1.17 [0.85-1.59],0.3357623878624517
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP6AP2,Renin receptor,27127,147,0.98 [0.68-1.41],0.915911999230451
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP6V1D,V-type proton ATPase subunit D,27657,152,0.82 [0.46-1.45],0.4917660786749416
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP6V1F,V-type proton ATPase subunit F,27047,148,0.83 [0.66-1.04],0.1123156792358994
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP6V1G1,V-type proton ATPase subunit G 1,23591,137,0.98 [0.78-1.23],0.8445021911949572
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP6V1G2,V-type proton ATPase subunit G 2,23445,136,0.88 [0.74-1.05],0.1638884633174048
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATRAID,All-trans retinoic acid-induced differentiation factor,24088,141,0.62 [0.33-1.17],0.1389237052957221
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATRN,"Attractin, Isoform 2",24261,142,0.51 [0.20-1.32],0.1632909414903808
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATXN10,Ataxin-10,27099,148,0.95 [0.78-1.17],0.6533472206995019
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATXN2,Ataxin-2,23430,140,0.92 [0.78-1.07],0.2860658665672664
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATXN2L,Ataxin-2-like protein,24175,141,0.93 [0.66-1.32],0.6940936672516133
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATXN3,Ataxin-3,24158,142,0.88 [0.68-1.14],0.3408120925904028
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AXIN1,Axin-1,27734,152,0.96 [0.83-1.12],0.6454195863986512
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AXL,Tyrosine-protein kinase receptor UFO,27874,155,1.04 [0.62-1.75],0.8698373555046549
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AZI2,5-azacytidine-induced protein 2,24175,141,0.96 [0.71-1.29],0.7759003400741956
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AZU1,Azurocidin,26890,148,1.08 [0.91-1.29],0.368585574232346
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,B2M,Beta-2-microglobulin,24261,142,0.75 [0.42-1.34],0.3330492187889591
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,23445,136,0.78 [0.34-1.81],0.5694112989969788
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",23591,137,1.27 [0.81-2.01],0.2972110601474602
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,B4GALT1,"Beta-1,4-galactosyltransferase 1",27917,151,1.05 [0.62-1.78],0.8464221371572422
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,B4GAT1,"Beta-1,4-glucuronyltransferase 1",27784,153,0.77 [0.42-1.39],0.385062250033115
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BABAM1,BRISC and BRCA1-A complex member 1,23526,136,0.74 [0.40-1.37],0.343493309958354
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BACH1,Transcription regulator protein BACH1,27734,152,0.94 [0.77-1.15],0.553638941383679
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BAG3,BAG family molecular chaperone regulator 3,27544,152,0.90 [0.63-1.27],0.5427726821608447
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BAG4,BAG family molecular chaperone regulator 4,23526,136,0.68 [0.47-0.99],0.0438845611976724
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BAG6,Large proline-rich protein BAG6,27269,150,0.83 [0.55-1.26],0.3790332303755623
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,27127,147,0.92 [0.73-1.17],0.4947116686856063
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BAMBI,BMP and activin membrane-bound inhibitor homolog,27127,147,1.21 [0.75-1.95],0.4336323950815662
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BANK1,B-cell scaffold protein with ankyrin repeats,27734,152,0.97 [0.85-1.11],0.6237223672154499
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BAP18,Chromatin complexes subunit BAP18,24158,142,0.80 [0.61-1.04],0.0923491098131424
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BATF,Basic leucine zipper transcriptional factor ATF-like,23536,141,0.97 [0.80-1.18],0.7880782055799361
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BAX,Apoptosis regulator BAX,27057,147,0.98 [0.83-1.16],0.7878053206217963
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCAM,Basal cell adhesion molecule,27784,153,1.46 [0.81-2.60],0.2050241516311869
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCAN,Brevican core protein,27586,152,0.71 [0.47-1.08],0.1129660406931106
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",24214,140,0.53 [0.29-0.95],0.0319519340856408
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",23430,140,1.20 [0.94-1.54],0.1424038825568647
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCHE,Cholinesterase,23779,136,1.46 [0.80-2.67],0.2136295046623494
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCL2,Apoptosis regulator Bcl-2,24088,141,0.90 [0.65-1.24],0.5036329328763836
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCL2L1,Bcl-2-like protein 1,24158,142,0.88 [0.75-1.04],0.1308293846313609
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",27734,152,0.99 [0.72-1.36],0.9391203125820228
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCL2L15,Bcl-2-like protein 15,23526,136,0.87 [0.64-1.18],0.3622269266284438
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCL7A,B-cell CLL/lymphoma 7 protein family member A,23335,137,0.91 [0.69-1.20],0.4984679519451248
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCL7B,B-cell CLL/lymphoma 7 protein family member B,24077,140,1.31 [0.98-1.75],0.0707246238133724
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCR,Breakpoint cluster region protein,27734,152,0.96 [0.82-1.12],0.5971787060136468
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BDNF,Brain-derived neurotrophic factor,24212,142,0.82 [0.68-0.99],0.035865800671057
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BECN1,Beclin-1,23591,137,0.97 [0.74-1.28],0.8535168596355633
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BEX3,Protein BEX3,23335,137,0.71 [0.47-1.07],0.1051490400479835
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BGLAP,Osteocalcin,24212,142,0.94 [0.79-1.11],0.4517320130930139
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BGN,Biglycan,27080,146,1.00 [0.89-1.13],0.9759198911387764
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BHLHE40,Class E basic helix-loop-helix protein 40,23430,140,1.11 [0.90-1.37],0.3151880340967679
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,23445,136,0.74 [0.39-1.41],0.3623706787712221
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BID,BH3-interacting domain death agonist,27734,152,0.81 [0.65-1.01],0.0666672317421832
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BIN2,Bridging integrator 2,27784,153,0.88 [0.75-1.03],0.1160791808488991
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BIRC2,Baculoviral IAP repeat-containing protein 2,27127,147,0.96 [0.76-1.21],0.7302381714801092
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BLMH,Bleomycin hydrolase,28118,155,0.66 [0.45-0.97],0.0355115196336713
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BLNK,B-cell linker protein,23526,136,0.64 [0.39-1.06],0.0817001254293525
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,23430,140,1.12 [0.93-1.36],0.238911087665239
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,24158,142,0.67 [0.43-1.04],0.0720481402327324
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BLVRB,Flavin reductase,27784,153,1.09 [0.89-1.33],0.4270441362453122
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BMP10,Bone morphogenetic protein 10,23702,141,0.65 [0.37-1.12],0.1208251674603656
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BMP4,Bone morphogenetic protein 4,27544,152,0.91 [0.65-1.26],0.5550141036248848
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BMP6,Bone morphogenetic protein 6,27225,150,0.67 [0.49-0.91],0.010003907400576
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BMPER,BMP-binding endothelial regulator protein,23702,141,0.93 [0.45-1.91],0.8391224465728571
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,24214,140,0.61 [0.37-1.02],0.057343696221237
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,23526,136,0.81 [0.55-1.20],0.2946305255353809
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BOC,Brother of CDO,27269,150,1.41 [0.76-2.61],0.2721291896339387
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BOLA1,BolA-like protein 1,23430,140,1.06 [0.80-1.41],0.6941577083412311
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BOLA2_BOLA2B,BolA-like protein 2,23591,137,0.95 [0.71-1.28],0.7466913028676352
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BPIFA2,BPI fold-containing family A member 2,22723,126,1.05 [0.90-1.23],0.5492082657520183
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BPIFB1,BPI fold-containing family B member 1,27707,153,0.82 [0.65-1.03],0.0905336587397036
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BPIFB2,BPI fold-containing family B member 2,24166,140,0.98 [0.78-1.24],0.8899815735986072
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BRAP,BRCA1-associated protein,23878,141,0.97 [0.83-1.12],0.6379458163464247
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BRD1,Bromodomain-containing protein 1,23760,138,1.68 [1.15-2.45],0.0074355217102449
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BRD2,Bromodomain-containing protein 2,23430,140,0.76 [0.45-1.28],0.3016689930616402
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BRD3,Bromodomain-containing protein 3,23445,136,1.01 [0.72-1.41],0.952475942873572
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BRDT,Bromodomain testis-specific protein,23445,136,0.71 [0.44-1.12],0.1409536292375173
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BRK1,Protein BRICK1,27099,148,0.68 [0.48-0.96],0.0260580179996718
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BRME1,Break repair meiotic recombinase recruitment factor 1,23430,140,1.02 [0.71-1.48],0.9006978213139122
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BRSK2,Serine/threonine-protein kinase BRSK2,24175,141,0.70 [0.45-1.09],0.1110969015352979
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BSG,Basigin,28021,150,0.65 [0.37-1.16],0.1433264857500727
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BSND,Barttin,23335,137,0.82 [0.49-1.38],0.4578063474928753
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,28018,153,1.08 [0.78-1.49],0.6466092316004584
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BST2,Bone marrow stromal antigen 2,28018,153,0.78 [0.58-1.06],0.1141460812611086
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BTC,Probetacellulin,27127,147,0.98 [0.80-1.19],0.8350267445044935
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BTD,Biotinidase,24261,142,0.79 [0.37-1.68],0.5468471315990038
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BTLA,B- and T-lymphocyte attenuator,23335,137,0.82 [0.64-1.04],0.0980983374528745
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BTN1A1,Butyrophilin subfamily 1 member A1,24031,139,0.68 [0.42-1.10],0.1156224379144539
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BTN2A1,Butyrophilin subfamily 2 member A1,27917,151,0.91 [0.52-1.59],0.7297103357738839
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BTN3A2,Butyrophilin subfamily 3 member A2,27734,152,0.90 [0.62-1.32],0.5928861446226878
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BTNL10,Butyrophilin-like protein 10,23335,137,0.67 [0.40-1.12],0.1238882361538396
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C19orf12,Protein C19orf12,27099,148,1.03 [0.82-1.29],0.796912391566609
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1GALT1C1,C1GALT1-specific chaperone 1,23445,136,0.89 [0.53-1.51],0.6735305863187793
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1QA,Complement C1q subcomponent subunit A,27924,150,1.33 [0.70-2.52],0.3852215309162431
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",24175,141,1.02 [0.82-1.27],0.8562943484509707
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1QL2,Complement C1q-like protein 2,23526,136,0.90 [0.61-1.32],0.5852096519915013
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,27874,155,0.82 [0.58-1.15],0.2447385258650525
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,23702,141,0.76 [0.51-1.14],0.1832566036065136
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,24175,141,0.89 [0.53-1.49],0.6549240731754548
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,23653,140,0.79 [0.58-1.09],0.1498854990165555
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1R,Complement C1r subcomponent,24261,142,0.38 [0.14-1.07],0.0666021215407627
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1RL,Complement C1r subcomponent-like protein,24223,142,0.81 [0.36-1.80],0.5990536460252749
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1S,Complement C1s subcomponent,24261,142,0.41 [0.20-0.84],0.0150944629621709
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C2,Complement C2,27826,155,0.64 [0.46-0.90],0.0101955182935801
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C2CD2L,Phospholipid transfer protein C2CD2L,27047,148,0.91 [0.64-1.28],0.5815801927615745
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C2orf69,UPF0565 protein C2orf69,23536,141,1.01 [0.76-1.32],0.9701068953960906
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C3,Complement C3,23008,135,0.48 [0.30-0.75],0.0015971474714297
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C4BPB,C4b-binding protein beta chain,27877,155,1.03 [0.73-1.45],0.8529043192819417
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C5,Complement C5,24261,142,0.47 [0.16-1.43],0.1833804606917604
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C7,Complement component C7,23680,135,0.98 [0.58-1.65],0.9312502716447136
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C7orf50,Uncharacterized protein C7orf50,24158,142,0.47 [0.18-1.18],0.1066843346795685
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C8B,Complement component C8 beta chain,24261,142,0.87 [0.52-1.47],0.6016388842095066
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C9,Complement component C9,24226,140,0.99 [0.71-1.37],0.9317712990383592
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C9orf40,Uncharacterized protein C9orf40,24088,141,1.06 [0.87-1.27],0.5747215941391377
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA1,Carbonic anhydrase 1,27138,150,1.02 [0.81-1.28],0.874587113348496
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA11,Carbonic anhydrase-related protein 11,27127,147,1.14 [0.77-1.67],0.5165581453179418
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA12,Carbonic anhydrase 12,27657,152,0.96 [0.61-1.51],0.8620411400430853
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA13,Carbonic anhydrase 13,27483,146,0.95 [0.83-1.09],0.4516155813052434
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA14,Carbonic anhydrase 14,28012,153,0.73 [0.49-1.11],0.1437434601470419
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA2,Carbonic anhydrase 2,27694,153,0.96 [0.79-1.17],0.6941647955553887
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA3,Carbonic anhydrase 3,28068,153,1.29 [1.04-1.60],0.0184399132026811
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA4,Carbonic anhydrase 4,28118,155,0.63 [0.35-1.15],0.1355849910471745
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA5A,"Carbonic anhydrase 5A, mitochondrial",27269,150,0.94 [0.80-1.11],0.4645025200591964
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA6,Carbonic anhydrase 6,27696,153,1.08 [0.86-1.36],0.5004255729685461
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA7,Carbonic anhydrase 7,23760,138,0.74 [0.44-1.24],0.251443387663339
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA8,Carbonic anhydrase-related protein,23526,136,0.70 [0.33-1.46],0.337015981939029
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA9,Carbonic anhydrase 9,28012,153,0.85 [0.62-1.17],0.3113525795546624
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CABP2,Calcium-binding protein 2,23536,141,0.84 [0.64-1.10],0.2004665042772778
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,23430,140,0.89 [0.54-1.49],0.6694505966181779
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,23445,136,1.16 [0.93-1.44],0.2008790478841973
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,23430,140,0.95 [0.72-1.25],0.7022143418944624
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,24175,141,0.86 [0.71-1.04],0.1084055261780587
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CACYBP,Calcyclin-binding protein,23654,141,0.90 [0.77-1.05],0.1689222434578879
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CADPS,Calcium-dependent secretion activator 1,23536,141,0.93 [0.64-1.36],0.7093498324256888
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CALB1,Calbindin,27657,152,1.25 [0.89-1.77],0.2053723227692552
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CALB2,Calretinin,27099,148,1.31 [0.92-1.85],0.1295922664116957
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CALCA,Calcitonin,27534,152,1.09 [0.85-1.40],0.5068444978265236
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CALCB,Calcitonin gene-related peptide 2,24158,142,1.27 [0.90-1.77],0.1685158097750457
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,27921,152,0.94 [0.82-1.08],0.411918171848323
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,23591,137,0.96 [0.78-1.19],0.719704417517502
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CALY,Neuron-specific vesicular protein calcyon,23445,136,0.87 [0.55-1.40],0.5752297652742765
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,27127,147,1.08 [0.78-1.49],0.6511191697569794
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,23536,141,0.94 [0.69-1.27],0.6930837887146943
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,24175,141,0.97 [0.83-1.13],0.6882606641098188
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CANT1,Soluble calcium-activated nucleotidase 1,27704,151,0.55 [0.27-1.12],0.0981090363884785
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CAPG,Macrophage-capping protein,27564,150,0.84 [0.65-1.08],0.1716577649089545
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CAPN3,Calpain-3,24077,140,1.25 [0.88-1.78],0.2215239012338715
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CAPS,Calcyphosin,24158,142,0.81 [0.65-1.03],0.0831058200274693
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CARHSP1,Calcium-regulated heat-stable protein 1,27099,148,1.15 [0.88-1.49],0.3082732884903195
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CASC3,Protein CASC3,23536,141,0.87 [0.58-1.30],0.4963838228035505
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CASP1,Caspase-1,27099,148,1.04 [0.85-1.28],0.7059566426956475
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CASP10,Caspase-10,27099,148,0.98 [0.80-1.21],0.8821689918847533
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CASP2,Caspase-2,27734,152,0.90 [0.73-1.12],0.3382806100605805
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CASP3,Caspase-3,28118,155,0.96 [0.82-1.12],0.5897904481894995
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CASP4,Caspase-4,23760,138,1.04 [0.95-1.14],0.3830727100331427
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CASP7,Caspase-7,24158,142,0.88 [0.72-1.07],0.1874412183226465
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CASP8,Caspase-8,27925,152,0.90 [0.71-1.13],0.3541341912165973
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CASP9,Caspase-9,23526,136,1.00 [0.77-1.31],0.9723179101040922
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CASQ2,Calsequestrin-2,23445,136,0.70 [0.46-1.07],0.1014746750679245
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CAT,Catalase,23856,139,1.02 [0.77-1.37],0.8700849239409362
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CBLIF,Cobalamin binding intrinsic factor,27735,151,1.00 [0.83-1.22],0.9634179355930368
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CBLN1,Cerebellin-1,23430,140,1.01 [0.85-1.19],0.9356385906108994
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CBLN4,Cerebellin-4,28012,153,1.07 [0.69-1.67],0.7587242926524844
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CBS,Cystathionine beta-synthase,23591,137,1.10 [0.81-1.49],0.5475460178160374
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CBX2,Chromobox protein homolog 2,23445,136,1.04 [0.71-1.53],0.8246616489606982
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,27586,152,0.90 [0.74-1.10],0.3102679130178927
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCAR2,Cell cycle and apoptosis regulator protein 2,24158,142,0.95 [0.70-1.28],0.734955555113421
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCDC134,Coiled-coil domain-containing protein 134,24077,140,0.81 [0.58-1.14],0.2337578315023979
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCDC28A,Coiled-coil domain-containing protein 28A,23536,141,1.18 [0.68-2.04],0.5558239515760558
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCDC50,Coiled-coil domain-containing protein 50,24175,141,1.11 [0.92-1.34],0.2653442167009248
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCDC80,Coiled-coil domain-containing protein 80,27780,151,0.82 [0.54-1.24],0.346090245859897
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,23591,137,1.30 [1.02-1.67],0.0354419971105964
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL11,Eotaxin,28067,151,0.90 [0.61-1.31],0.5712505694582073
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL13,C-C motif chemokine 13,28016,151,1.00 [0.81-1.23],0.9997005206895528
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL14,C-C motif chemokine 14,27689,155,0.99 [0.69-1.42],0.9390651537860016
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL15,C-C motif chemokine 15,28118,155,1.01 [0.73-1.39],0.9590006711096208
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL16,C-C motif chemokine 16,28118,155,0.93 [0.72-1.22],0.6130464148166006
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL17,C-C motif chemokine 17,27741,151,0.92 [0.78-1.08],0.3002911248865211
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL18,C-C motif chemokine 18,27376,153,0.99 [0.80-1.21],0.8962494757003777
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL19,C-C motif chemokine 19,28018,153,1.05 [0.95-1.16],0.303866835971387
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL2,C-C motif chemokine 2,27544,152,1.13 [0.87-1.47],0.3629564391369936
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL20,C-C motif chemokine 20,28067,151,0.94 [0.79-1.11],0.4366831646249645
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL21,C-C motif chemokine 21,27917,151,0.85 [0.60-1.21],0.3746056662128424
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL22,C-C motif chemokine 22,27521,150,0.84 [0.63-1.12],0.2438156873868401
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL23,C-C motif chemokine 23,27917,151,0.93 [0.66-1.32],0.696634197347858
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL24,C-C motif chemokine 24,27869,151,0.96 [0.81-1.14],0.615950322912229
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL25,C-C motif chemokine 25,28067,151,0.86 [0.64-1.16],0.3167552624682319
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL26,C-C motif chemokine 26,27734,152,1.00 [0.86-1.17],0.9857962360529028
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL27,C-C motif chemokine 27,27780,151,0.91 [0.71-1.16],0.4230369876478105
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL28,C-C motif chemokine 28,27646,152,0.76 [0.59-0.99],0.044197279821091
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL3,C-C motif chemokine 3,27734,152,1.07 [0.86-1.34],0.5352430416442562
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL4,C-C motif chemokine 4,27827,151,1.10 [0.91-1.32],0.3267829158598769
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL5,C-C motif chemokine 5,27874,155,0.89 [0.77-1.02],0.0900624750126713
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL7,C-C motif chemokine 7,27734,152,0.94 [0.73-1.21],0.6322542449101648
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL8,C-C motif chemokine 8,27974,152,1.07 [0.85-1.36],0.5640901230792305
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCN1,CCN family member 1,27609,151,0.87 [0.73-1.05],0.153176681273828
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCN2,CCN family member 2,27779,151,0.85 [0.66-1.09],0.1908498554728794
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCN3,CCN family member 3,28078,155,1.21 [0.81-1.82],0.3476868058239251
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCN4,CCN family member 4,28012,153,0.79 [0.55-1.13],0.2000237721396213
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCN5,CCN family member 5,27784,153,0.96 [0.67-1.39],0.8314096808664903
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCND2,G1/S-specific cyclin-D2,23760,138,0.66 [0.46-0.94],0.0207410218673216
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCNE1,G1/S-specific cyclin-E1,23526,136,0.86 [0.69-1.08],0.2050530120598698
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCS,Copper chaperone for superoxide dismutase,27586,152,0.94 [0.70-1.26],0.6788661309337924
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCT5,T-complex protein 1 subunit epsilon,27127,147,0.91 [0.65-1.28],0.587445936064282
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD101,Immunoglobulin superfamily member 2,24088,141,0.81 [0.56-1.16],0.2489995502654289
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD109,CD109 antigen,27784,153,0.97 [0.63-1.50],0.8991327445509882
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD14,Monocyte differentiation antigen CD14,27179,154,0.90 [0.64-1.29],0.5758894508936092
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD160,CD160 antigen,28067,151,1.03 [0.76-1.40],0.8544933829795811
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD163,Scavenger receptor cysteine-rich type 1 protein M130,27874,155,1.08 [0.78-1.50],0.641915739443087
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD164,Sialomucin core protein 24,27784,153,0.84 [0.47-1.50],0.5638869760636585
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD164L2,CD164 sialomucin-like 2 protein,23536,141,0.73 [0.46-1.15],0.1757595012121933
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD177,CD177 antigen,27741,153,0.97 [0.87-1.08],0.5839474710450817
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD1C,T-cell surface glycoprotein CD1c,27877,155,0.99 [0.55-1.77],0.9598963889233256
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD2,T-cell surface antigen CD2,23445,136,0.76 [0.46-1.24],0.2685620240875899
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD200,OX-2 membrane glycoprotein,27734,152,0.89 [0.51-1.55],0.6876959990055098
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD200R1,Cell surface glycoprotein CD200 receptor 1,27645,152,0.95 [0.63-1.45],0.8237485605029214
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD207,C-type lectin domain family 4 member K,27193,148,1.14 [0.78-1.67],0.4886969365162846
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD209,CD209 antigen,27847,151,0.88 [0.61-1.27],0.486942940940086
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD22,B-cell receptor CD22,28067,151,1.06 [0.75-1.49],0.7597937877489046
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD226,CD226 antigen,23526,136,0.47 [0.31-0.70],0.0002490491028694
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD244,Natural killer cell receptor 2B4,28067,151,0.70 [0.41-1.20],0.195176953547279
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD248,Endosialin,24212,142,0.48 [0.32-0.72],0.0003834053256872
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD27,CD27 antigen,27877,155,0.73 [0.51-1.04],0.0846628144951259
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD274,Programmed cell death 1 ligand 1,27586,152,0.71 [0.45-1.10],0.1266183421382748
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD276,CD276 antigen,27782,151,1.56 [1.04-2.34],0.0315802742196001
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD28,T-cell-specific surface glycoprotein CD28,27127,147,0.85 [0.56-1.28],0.4409818359095472
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD2AP,CD2-associated protein,27780,151,0.83 [0.66-1.04],0.1122409392215612
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD300A,CMRF35-like molecule 8,23702,141,0.77 [0.45-1.33],0.3498095543901617
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD300C,CMRF35-like molecule 6,28018,153,0.92 [0.60-1.39],0.6868280554351343
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD300E,CMRF35-like molecule 2,27909,153,0.68 [0.47-0.99],0.0438939965074948
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD300LF,CMRF35-like molecule 1,28012,153,1.00 [0.79-1.27],0.971773995910273
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD300LG,CMRF35-like molecule 9,27784,153,0.86 [0.59-1.26],0.4512920131636222
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD302,CD302 antigen,27657,152,0.85 [0.52-1.38],0.4998539547345294
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD33,Myeloid cell surface antigen CD33,27877,155,0.99 [0.83-1.18],0.9135201136224086
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD34,Hematopoietic progenitor cell antigen CD34,27926,152,0.84 [0.46-1.52],0.5551425010082793
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD36,Platelet glycoprotein 4,23526,136,0.48 [0.32-0.72],0.0004045916037863
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,27657,152,0.64 [0.40-1.01],0.0564048566719286
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD3D,T-cell surface glycoprotein CD3 delta chain,23430,140,0.99 [0.61-1.59],0.9615165339403484
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD3E,T-cell surface glycoprotein CD3 epsilon chain,23760,138,0.87 [0.53-1.42],0.5722435728704719
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD3G,T-cell surface glycoprotein CD3 gamma chain,23526,136,1.01 [0.85-1.21],0.8868191436726208
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD4,T-cell surface glycoprotein CD4,27688,152,0.82 [0.50-1.36],0.4512936019206839
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD40,Tumor necrosis factor receptor superfamily member 5,27779,151,0.66 [0.48-0.90],0.0096560839322318
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD40LG,CD40 ligand,28067,151,0.93 [0.77-1.12],0.4331041430296913
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD46,Membrane cofactor protein,27593,155,0.81 [0.48-1.36],0.4311449112823655
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD48,CD48 antigen,27869,151,0.71 [0.43-1.15],0.1646596829261405
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD5,T-cell surface glycoprotein CD5,27974,152,0.87 [0.56-1.34],0.5239767692240169
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD55,Complement decay-accelerating factor,26795,152,0.74 [0.41-1.33],0.3143995067013575
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD58,Lymphocyte function-associated antigen 3,27743,151,0.95 [0.42-2.13],0.8952377228981651
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD59,CD59 glycoprotein,26750,147,0.57 [0.28-1.16],0.1231386181226681
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD5L,CD5 antigen-like,24118,142,1.08 [0.77-1.52],0.6620204088201822
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD6,T-cell differentiation antigen CD6,28021,150,0.89 [0.68-1.16],0.3886436948771163
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD63,CD63 antigen,27544,152,0.75 [0.57-0.99],0.0409955062634893
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD69,Early activation antigen CD69,27648,151,0.87 [0.74-1.02],0.0969504787658785
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD7,T-cell antigen CD7,23476,136,1.05 [0.72-1.53],0.8021196836125466
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD70,CD70 antigen,27734,152,0.82 [0.58-1.15],0.2439241465451454
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD72,B-cell differentiation antigen CD72,23702,141,1.11 [0.76-1.63],0.5784178519243259
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD74,HLA class II histocompatibility antigen gamma chain,28018,153,1.18 [0.79-1.77],0.4199098920708385
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD79B,B-cell antigen receptor complex-associated protein beta chain,28067,151,0.93 [0.67-1.30],0.6831170425822353
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD80,T-lymphocyte activation antigen CD80,24214,140,1.02 [0.64-1.65],0.92557519135418
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD82,CD82 antigen,23760,138,1.11 [0.78-1.58],0.5521476239037297
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD83,CD83 antigen,27734,152,0.92 [0.60-1.41],0.6971422129375604
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD84,SLAM family member 5,27734,152,0.87 [0.55-1.38],0.544403127513431
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD86,T-lymphocyte activation antigen CD86,24088,141,0.69 [0.41-1.16],0.1627722508198851
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD8A,T-cell surface glycoprotein CD8 alpha chain,28018,153,0.99 [0.74-1.32],0.9552085071533176
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD93,Complement component C1q receptor,26713,149,0.90 [0.56-1.45],0.67459829684002
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD99,CD99 antigen,27784,153,0.80 [0.38-1.68],0.5521953336245564
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD99L2,CD99 antigen-like protein 2,27784,153,0.71 [0.39-1.31],0.2703423927920882
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDA,Cytidine deaminase,24165,140,0.96 [0.69-1.35],0.8330022994247717
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDAN1,Codanin-1,24158,142,1.21 [0.66-2.23],0.5348849612807467
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDC123,Cell division cycle protein 123 homolog,23335,137,0.82 [0.62-1.10],0.1931089058761392
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDC25A,M-phase inducer phosphatase 1,23335,137,0.62 [0.39-0.99],0.0444535816735119
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDC26,Anaphase-promoting complex subunit CDC26,24047,141,0.85 [0.67-1.08],0.1732810399867904
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDC27,Cell division cycle protein 27 homolog,27127,147,1.00 [0.79-1.28],0.9778804834009978
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDC37,Hsp90 co-chaperone Cdc37,27877,155,0.89 [0.75-1.06],0.19292369719251
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDC42BPB,Serine/threonine-protein kinase MRCK beta,24088,141,0.91 [0.77-1.06],0.2321345909828724
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDCP1,CUB domain-containing protein 1,27586,152,0.85 [0.63-1.15],0.2907172961017178
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDH1,Cadherin-1,26839,151,1.01 [0.70-1.46],0.9422991346703612
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDH15,Cadherin-15,27966,153,0.97 [0.71-1.33],0.8590351369662016
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDH17,Cadherin-17,27780,151,1.01 [0.82-1.25],0.9036513759765116
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDH2,Cadherin-2,27780,151,1.11 [0.74-1.67],0.621806547038851
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDH22,Cadherin-22,23760,138,0.88 [0.50-1.57],0.6727170142973611
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDH23,Cadherin-23,24158,142,0.71 [0.38-1.33],0.2855637405261955
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDH3,Cadherin-3,28018,153,1.07 [0.72-1.60],0.7284037014913674
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDH4,Cadherin-4,23430,140,0.92 [0.65-1.31],0.641641132829958
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDH5,Cadherin-5,28118,155,0.82 [0.51-1.33],0.4235078359938579
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDH6,Cadherin-6,27780,151,1.22 [0.84-1.78],0.292080138695198
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDHR1,Cadherin-related family member 1,27099,148,1.12 [0.82-1.54],0.4700041137553742
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDHR2,Cadherin-related family member 2,27657,152,0.94 [0.78-1.14],0.5545440025504076
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDHR5,Cadherin-related family member 5,27780,151,0.91 [0.63-1.32],0.6234334857009609
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDK1,Cyclin-dependent kinase 1,23335,137,0.68 [0.44-1.06],0.0856829526416712
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,24175,141,0.79 [0.59-1.07],0.1273531630347033
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDKL5,Cyclin-dependent kinase-like 5,23430,140,0.86 [0.62-1.19],0.3607948033841524
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDKN1A,Cyclin-dependent kinase inhibitor 1,27657,152,0.96 [0.84-1.11],0.6050291884850322
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,27657,152,0.95 [0.82-1.10],0.5046760590309923
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDNF,Cerebral dopamine neurotrophic factor,27657,152,0.58 [0.36-0.92],0.019690320051251
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,27831,151,0.56 [0.33-0.95],0.0300722086459704
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDSN,Corneodesmosin,27974,151,1.07 [0.77-1.49],0.6721866015543232
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,27832,155,0.71 [0.39-1.28],0.2515081767442371
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,24088,141,1.03 [0.84-1.26],0.7897228016357831
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,23760,138,0.91 [0.70-1.18],0.473514879999596
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,24088,141,0.88 [0.58-1.32],0.5247857212777723
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,23760,138,1.12 [0.80-1.58],0.514119919753997
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,27734,152,0.93 [0.78-1.10],0.4051719348331203
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,27127,147,0.93 [0.68-1.27],0.6459648191014871
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,26769,147,0.85 [0.68-1.08],0.1799484243994593
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,24212,142,0.83 [0.54-1.27],0.3882025661148087
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,27269,150,0.93 [0.69-1.24],0.611069250636249
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEBPA,CCAAT/enhancer-binding protein alpha,23526,136,0.60 [0.33-1.10],0.1000440920126484
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEBPB,CCAAT/enhancer-binding protein beta,27269,150,1.04 [0.71-1.52],0.831403527484301
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CELA2A,Chymotrypsin-like elastase family member 2A,24212,142,0.87 [0.67-1.13],0.2966547665397524
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CELA3A,Chymotrypsin-like elastase family member 3A,28070,155,0.73 [0.57-0.93],0.0126526604214413
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,23702,141,0.58 [0.33-1.02],0.0590714321486237
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEMIP2,Cell surface hyaluronidase,23526,136,0.70 [0.39-1.25],0.2279571144816383
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEND1,Cell cycle exit and neuronal differentiation protein 1,23430,140,0.87 [0.64-1.20],0.40124728343832
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CENPF,Centromere protein F,23760,138,0.97 [0.72-1.30],0.8456763232008554
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CENPJ,Centromere protein J,23760,138,0.97 [0.76-1.22],0.7667915901222939
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEP112,Centrosomal protein of 112 kDa,23445,136,1.06 [0.75-1.51],0.7409733127974819
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEP152,Centrosomal protein of 152 kDa,23335,137,0.61 [0.39-0.95],0.0293954938747615
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEP164,Centrosomal protein of 164 kDa,27224,148,1.02 [0.82-1.27],0.8590943893363718
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEP170,Centrosomal protein of 170 kDa,23591,137,0.95 [0.76-1.18],0.6189086484395463
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEP20,Centrosomal protein 20,27127,147,0.89 [0.73-1.09],0.2500610740292818
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEP290,Centrosomal protein of 290 kDa,23760,138,0.96 [0.70-1.31],0.7769115146861557
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEP350,Centrosome-associated protein 350,23335,137,0.72 [0.45-1.14],0.1573600924673584
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEP43,Centrosomal protein 43,27050,148,0.95 [0.77-1.18],0.6567471388587883
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEP85,Centrosomal protein of 85 kDa,27127,147,0.91 [0.71-1.15],0.4194937267674591
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CERT,Ceramide transfer protein,27099,148,0.98 [0.77-1.25],0.8795044061602287
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CES1,Liver carboxylesterase 1,27840,152,1.07 [0.90-1.28],0.443138924283867
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CES2,Cocaine esterase,27657,152,0.94 [0.72-1.22],0.6308105607631824
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CES3,Carboxylesterase 3,27657,152,0.91 [0.73-1.13],0.3986262859003657
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CETN2,Centrin-2,27099,148,0.96 [0.77-1.20],0.7334150462958798
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CETN3,Centrin-3,24088,141,0.87 [0.70-1.07],0.1869398514696997
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CFB,Complement factor B,23798,141,0.68 [0.41-1.12],0.1274060568990787
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CFC1,Cryptic protein,27127,147,0.82 [0.58-1.16],0.2612787444275454
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CFD,Complement factor D,24261,142,0.46 [0.20-1.07],0.0719972011666759
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CFH,Complement factor H,22820,135,0.50 [0.24-1.02],0.0581180398041029
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CFHR2,Complement factor H-related protein 2,24075,142,0.99 [0.75-1.31],0.9644033545893832
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CFHR4,Complement factor H-related protein 4,24218,141,0.97 [0.78-1.20],0.7828112308746565
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CFHR5,Complement factor H-related protein 5,23900,138,0.84 [0.58-1.23],0.3685177074563167
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CFI,Complement factor I,24261,142,0.46 [0.21-1.01],0.0531451147495018
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CFP,Properdin,24261,142,0.55 [0.25-1.21],0.1363735627927869
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CGA,Glycoprotein hormones alpha chain,27784,153,1.05 [0.88-1.25],0.5963710181592163
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,24226,140,1.13 [0.81-1.58],0.4779242224652071
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CGN,Cingulin,23536,141,1.18 [0.84-1.64],0.3404382093611915
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CGREF1,Cell growth regulator with EF hand domain protein 1,27780,151,0.81 [0.57-1.15],0.2362928025771015
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,27127,147,0.98 [0.77-1.24],0.8491931064737912
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHAD,Chondroadherin,23702,141,0.87 [0.65-1.17],0.3475119152889314
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",24158,142,1.00 [0.66-1.51],0.9969727365632692
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHCHD6,MICOS complex subunit MIC25,24077,140,0.64 [0.34-1.24],0.1867932639999618
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHEK2,Serine/threonine-protein kinase Chk2,27269,150,1.46 [1.00-2.13],0.0525486182057709
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHGA,Chromogranin-A,24212,142,0.91 [0.76-1.09],0.3282619310063291
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHGB,Secretogranin-1,27914,153,0.92 [0.64-1.32],0.6494421132669873
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHI3L1,Chitinase-3-like protein 1,27145,154,0.92 [0.76-1.12],0.4252235065223957
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHIT1,Chitotriosidase-1,27888,153,1.00 [0.91-1.10],0.9675161469934648
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHL1,Neural cell adhesion molecule L1-like protein,27831,155,0.74 [0.46-1.18],0.2065800085930205
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHM,Rab proteins geranylgeranyltransferase component A 1,23536,141,0.89 [0.68-1.16],0.3877474867506312
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHMP1A,Charged multivesicular body protein 1a,27586,152,0.97 [0.81-1.17],0.7655305412627125
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHMP6,Charged multivesicular body protein 6,24214,140,0.81 [0.60-1.08],0.1505186304217628
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHP1,Calcineurin B homologous protein 1,23430,140,0.92 [0.72-1.16],0.4719841011829169
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHRDL1,Chordin-like protein 1,27869,151,0.76 [0.47-1.22],0.2586572224254011
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHRDL2,Chordin-like protein 2,27780,151,0.96 [0.74-1.25],0.7815237855137844
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHRM1,Muscarinic acetylcholine receptor M1,23536,141,0.84 [0.52-1.34],0.4584885376393262
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CIAPIN1,Anamorsin,27877,155,0.87 [0.69-1.08],0.2068185384023942
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CILP,Cartilage intermediate layer protein 1,24212,142,1.02 [0.75-1.37],0.9190185824134536
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CINP,Cyclin-dependent kinase 2-interacting protein,23760,138,0.82 [0.55-1.24],0.3476434463141118
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CIRBP,Cold-inducible RNA-binding protein,24088,141,0.89 [0.76-1.06],0.1914246236386888
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CIT,Citron Rho-interacting kinase,23536,141,0.80 [0.55-1.16],0.2354163226542385
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CKAP4,Cytoskeleton-associated protein 4,27932,150,0.91 [0.52-1.58],0.7404100868887921
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CKB,Creatine kinase B-type,24212,142,1.08 [0.83-1.41],0.5509883762184142
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",27691,151,0.81 [0.70-0.95],0.0091018837293649
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLASP1,CLIP-associating protein 1,23335,137,0.90 [0.70-1.15],0.3992767743947594
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLC,Galectin-10,27739,151,0.97 [0.78-1.21],0.7889287897356052
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC10A,C-type lectin domain family 10 member A,27586,152,0.82 [0.55-1.23],0.3369116000337087
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC11A,C-type lectin domain family 11 member A,27732,153,0.81 [0.60-1.08],0.1475352303529727
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC12A,C-type lectin domain family 12 member A,23526,136,0.80 [0.35-1.82],0.5967487208011184
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC14A,C-type lectin domain family 14 member A,27784,153,0.80 [0.51-1.27],0.3481130737961735
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC1A,C-type lectin domain family 1 member A,27269,150,0.60 [0.38-0.95],0.027981428583225
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC1B,C-type lectin domain family 1 member B,28018,153,0.86 [0.74-1.00],0.0484186484079178
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC2L,C-type lectin domain family 2 member L,23536,141,1.05 [0.78-1.42],0.7308851591459483
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC3B,Tetranectin,23674,139,0.44 [0.20-0.96],0.0380277422124438
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC4A,C-type lectin domain family 4 member A,27734,152,0.69 [0.46-1.02],0.0654615570359182
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC4C,C-type lectin domain family 4 member C,27734,152,1.05 [0.77-1.42],0.7727970383700762
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC4D,C-type lectin domain family 4 member D,27734,152,0.97 [0.77-1.22],0.7796950057888512
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC4G,C-type lectin domain family 4 member G,27734,152,1.25 [0.81-1.93],0.3150400224183505
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC4M,C-type lectin domain family 4 member M,24165,142,0.91 [0.66-1.27],0.5923393054194288
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC5A,C-type lectin domain family 5 member A,27691,151,0.76 [0.45-1.26],0.286999933373295
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC6A,C-type lectin domain family 6 member A,27127,147,1.15 [0.85-1.57],0.3639952807869707
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC7A,C-type lectin domain family 7 member A,28067,151,0.90 [0.72-1.11],0.313850315263047
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLGN,Calmegin,23536,141,0.71 [0.48-1.05],0.0843467856348911
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLIC5,Chloride intracellular channel protein 5,23536,141,0.64 [0.36-1.15],0.136895918508357
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLINT1,Clathrin interactor 1,23335,137,0.88 [0.59-1.30],0.5108649808509003
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLIP2,CAP-Gly domain-containing linker protein 2,27734,152,0.96 [0.84-1.09],0.4917631953897031
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLMP,CXADR-like membrane protein,28012,153,0.73 [0.36-1.49],0.3918483812481819
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLNS1A,Methylosome subunit pICln,23536,141,1.27 [0.81-1.99],0.2943281351090389
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",27534,152,0.90 [0.78-1.05],0.188208486935677
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLPS,Colipase,27743,153,0.92 [0.75-1.13],0.4423451817480062
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLSPN,Claspin,27047,148,1.06 [0.70-1.60],0.79898319798597
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLSTN1,Calsyntenin-1,27099,148,1.27 [1.02-1.59],0.0315568105062341
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLSTN2,Calsyntenin-2,28067,151,1.04 [0.72-1.50],0.8420099069347844
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLSTN3,Calsyntenin-3,24158,142,0.72 [0.42-1.23],0.2253185146835357
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLTA,Clathrin light chain A,27269,150,0.88 [0.64-1.21],0.4366466188117801
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLU,Clusterin,24261,142,0.86 [0.48-1.56],0.6274943800953867
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLUL1,Clusterin-like protein 1,27739,151,0.64 [0.47-0.89],0.0070581860532252
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CMC1,COX assembly mitochondrial protein homolog,24214,140,0.88 [0.73-1.05],0.1564019936132353
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CMIP,C-Maf-inducing protein,24077,140,0.88 [0.72-1.07],0.205400096134145
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNDP1,Beta-Ala-His dipeptidase,27874,155,0.87 [0.64-1.17],0.3595542936307885
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNGB3,Cyclic nucleotide-gated cation channel beta-3,23430,140,1.02 [0.77-1.37],0.8679767608417855
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",23545,137,0.88 [0.71-1.08],0.2189117579999367
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNPY2,Protein canopy homolog 2,27269,150,1.05 [0.84-1.31],0.6729829520988242
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNPY4,Protein canopy homolog 4,27657,152,0.93 [0.77-1.13],0.4613227112518271
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNST,Consortin,27780,151,0.89 [0.78-1.02],0.0949029698036366
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNTF,Ciliary neurotrophic factor,23430,140,0.96 [0.59-1.55],0.86753953500432
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNTN1,Contactin-1,28118,155,1.12 [0.67-1.87],0.6557039273255436
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNTN2,Contactin-2,28012,153,0.85 [0.61-1.17],0.3069956671217902
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNTN3,Contactin-3,27784,153,0.98 [0.65-1.48],0.9329364180858248
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNTN4,Contactin-4,27784,153,1.12 [0.62-2.02],0.7071270970216887
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNTN5,Contactin-5,27842,152,0.97 [0.66-1.42],0.878543640214847
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNTNAP2,Contactin-associated protein-like 2,27734,152,0.96 [0.67-1.37],0.820400297169184
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNTNAP4,Contactin-associated protein-like 4,23536,141,0.99 [0.84-1.16],0.9000552212544093
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COCH,Cochlin,24214,140,0.65 [0.45-0.93],0.0192555483925501
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL15A1,Collagen alpha-1(XV) chain,24212,142,0.80 [0.43-1.47],0.468216484500335
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL18A1,Collagen alpha-1(XVIII) chain,27894,153,0.75 [0.41-1.40],0.3695809384430015
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL1A1,Collagen alpha-1(I) chain,28118,155,0.59 [0.35-1.02],0.0567552931138159
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL24A1,Collagen alpha-1(XXIV) chain,24088,141,0.89 [0.67-1.18],0.4133753330357815
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL28A1,Collagen alpha-1(XXVIII) chain,23536,141,0.84 [0.67-1.06],0.1428026384964315
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL2A1,Collagen alpha-1(II) chain,23591,137,0.86 [0.70-1.06],0.151268557673363
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL3A1,Collagen alpha-1(III) chain,24212,142,0.49 [0.24-0.97],0.0398559316941905
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL4A1,Collagen alpha-1(IV) chain,27780,151,1.09 [0.76-1.56],0.635144750050564
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL4A4,Collagen alpha-4(IV) chain,23720,138,0.89 [0.66-1.19],0.4296294981478606
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL5A1,Collagen alpha-1(V) chain,23702,141,1.12 [0.75-1.67],0.5743492622376388
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL6A3,Collagen alpha-3(VI) chain,28118,155,1.00 [0.66-1.51],0.9908353547674744
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL9A1,Collagen alpha-1(IX) chain,27734,152,0.88 [0.65-1.19],0.4201008671765203
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL9A2,Collagen alpha-2(IX) chain,23760,138,1.13 [0.82-1.55],0.4527427577843199
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COLEC12,Collectin-12,27782,151,0.80 [0.45-1.41],0.4373969636108407
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COMMD1,COMM domain-containing protein 1,23591,137,0.87 [0.66-1.14],0.3224862260753853
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COMMD9,COMM domain-containing protein 9,24077,140,0.86 [0.56-1.32],0.4838167834524812
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COMP,Cartilage oligomeric matrix protein,27467,154,1.02 [0.67-1.56],0.9233530798822398
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COMT,Catechol O-methyltransferase,26981,149,0.94 [0.79-1.12],0.501490379626502
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COPB2,Coatomer subunit beta',23445,136,0.92 [0.62-1.36],0.6610102213644842
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COPE,Coatomer subunit epsilon,27099,148,1.05 [0.78-1.41],0.7545500027940653
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",23591,137,0.95 [0.66-1.38],0.7931240803571731
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CORO1A,Coronin-1A,27192,149,0.84 [0.71-1.00],0.0553400436277838
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CORO6,Coronin-6,23430,140,1.18 [0.78-1.77],0.4341654072820939
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",27657,152,1.00 [0.82-1.23],0.980293922446914
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COX6B1,Cytochrome c oxidase subunit 6B1,24214,140,0.86 [0.52-1.42],0.5481182826621585
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPA1,Carboxypeptidase A1,28118,155,0.69 [0.54-0.88],0.0025558313576665
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPA2,Carboxypeptidase A2,27917,152,0.85 [0.68-1.07],0.1668576661360011
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPA4,Carboxypeptidase A4,23218,138,0.80 [0.55-1.15],0.2282465520270659
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPB1,Carboxypeptidase B,28118,155,0.75 [0.58-0.96],0.0252263060724072
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPB2,Carboxypeptidase B2,24209,142,0.45 [0.22-0.91],0.0256134134666507
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPE,Carboxypeptidase E,27806,152,0.76 [0.54-1.07],0.1141752207617574
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPLX2,Complexin-2,23335,137,0.76 [0.43-1.35],0.3493203578917493
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPM,Carboxypeptidase M,27885,153,0.94 [0.62-1.43],0.7861092251040585
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",23526,136,0.56 [0.30-1.06],0.0760789309798411
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPPED1,Serine/threonine-protein phosphatase CPPED1,28018,153,0.99 [0.80-1.23],0.9328015652637124
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPQ,Carboxypeptidase Q,24164,142,0.81 [0.52-1.25],0.3365745906441609
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPTP,Ceramide-1-phosphate transfer protein,23445,136,0.84 [0.54-1.30],0.4370614035910154
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPVL,Probable serine carboxypeptidase CPVL,27975,152,1.28 [0.89-1.83],0.1802833651513288
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPXM1,Probable carboxypeptidase X1,27877,155,0.85 [0.69-1.04],0.1160019114049286
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPXM2,Inactive carboxypeptidase-like protein X2,24214,140,0.68 [0.35-1.31],0.246958902243882
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CR1,Complement receptor type 1,24132,139,0.78 [0.50-1.22],0.2783210130753808
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CR2,Complement receptor type 2,27874,155,1.05 [0.78-1.42],0.749352883932431
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,27127,147,0.96 [0.81-1.15],0.672267483341586
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRADD,Death domain-containing protein CRADD,27534,152,0.90 [0.75-1.09],0.2769710728937887
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CREB3,Cyclic AMP-responsive element-binding protein 3,23335,137,0.91 [0.67-1.24],0.5624742113975073
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CREBZF,CREB/ATF bZIP transcription factor,23335,137,0.46 [0.23-0.90],0.0233652895300874
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CREG1,Protein CREG1,27429,155,0.77 [0.51-1.15],0.1945803170752922
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRELD1,Protein disulfide isomerase CRELD1,23702,141,0.93 [0.61-1.43],0.7551594345238998
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRELD2,Protein disulfide isomerase CRELD2,27869,151,0.83 [0.63-1.10],0.1878641988774479
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRH,Corticoliberin,27080,146,1.05 [0.89-1.25],0.5430237362318229
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRHBP,Corticotropin-releasing factor-binding protein,27782,151,0.90 [0.54-1.49],0.6749167691820973
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRHR1,Corticotropin-releasing factor receptor 1,27269,150,1.09 [0.88-1.35],0.4478756609403685
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRIM1,Cysteine-rich motor neuron 1 protein,27917,151,0.85 [0.42-1.75],0.6625284894153909
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRIP2,Cysteine-rich protein 2,27586,152,0.86 [0.58-1.29],0.471362766423922
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRISP2,Cysteine-rich secretory protein 2,28012,153,0.91 [0.72-1.13],0.3826549462238261
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRISP3,Cysteine-rich secretory protein 3,24001,138,1.04 [0.57-1.90],0.8980180773978848
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRKL,Crk-like protein,27830,151,0.96 [0.84-1.09],0.5008989452818168
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRLF1,Cytokine receptor-like factor 1,27917,151,1.19 [0.68-2.08],0.551582923413103
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRNN,Cornulin,26974,149,1.14 [0.92-1.42],0.2244435499773077
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRTAC1,Cartilage acidic protein 1,28118,155,0.72 [0.45-1.15],0.1679620354893237
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRTAM,Cytotoxic and regulatory T-cell molecule,27586,152,0.96 [0.72-1.28],0.7971298046930254
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRTAP,Cartilage-associated protein,23536,141,0.94 [0.67-1.32],0.7310504508947901
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRX,Cone-rod homeobox protein,27269,150,1.18 [1.06-1.30],0.0017088002550272
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRYBB1,Beta-crystallin B1,24214,140,0.87 [0.67-1.12],0.263596701058296
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRYBB2,Beta-crystallin B2,24158,142,0.96 [0.76-1.22],0.7492643019682401
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRYGD,Gamma-crystallin D,24158,142,0.92 [0.78-1.08],0.304062857540524
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRYM,Ketimine reductase mu-crystallin,23430,140,0.97 [0.78-1.21],0.7941222713482108
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRYZL1,Quinone oxidoreductase-like protein 1,23591,137,0.94 [0.79-1.13],0.521998759450309
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSDE1,Cold shock domain-containing protein E1,23445,136,0.90 [0.77-1.05],0.1934188947159398
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSF1,Macrophage colony-stimulating factor 1,27917,151,0.96 [0.57-1.64],0.8943846095382226
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSF1R,Macrophage colony-stimulating factor 1 receptor,24226,140,0.81 [0.54-1.22],0.3177439580877391
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSF2,Granulocyte-macrophage colony-stimulating factor,23445,136,0.62 [0.38-1.02],0.0590840613084565
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,27586,152,1.01 [0.80-1.27],0.9653977913618652
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSF2RB,Cytokine receptor common subunit beta,23526,136,0.80 [0.55-1.16],0.2413927087817328
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSF3,Granulocyte colony-stimulating factor,27224,148,0.87 [0.64-1.18],0.3591612673363619
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSF3R,Granulocyte colony-stimulating factor receptor,23526,136,0.74 [0.42-1.30],0.2908811703520778
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSH1,Chorionic somatomammotropin hormone 1,24226,140,0.66 [0.38-1.16],0.1529715043749224
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSNK1D,Casein kinase I isoform delta,23526,136,0.85 [0.65-1.13],0.2624751556647324
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSNK2A1,Casein kinase II subunit alpha,24175,141,0.81 [0.57-1.16],0.2489612113789189
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSPG4,Chondroitin sulfate proteoglycan 4,24212,142,0.62 [0.38-1.01],0.0549252573716417
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSPG5,Chondroitin sulfate proteoglycan 5,23430,140,1.02 [0.74-1.40],0.910923269638584
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSRP3,Cysteine and glycine-rich protein 3,23445,136,1.27 [1.11-1.45],0.0004070134756489
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CST1,Cystatin-SN,20997,121,1.02 [0.85-1.21],0.8378538752412884
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CST3,Cystatin-C,27833,154,0.90 [0.54-1.50],0.6749670394268237
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CST5,Cystatin-D,27308,151,0.85 [0.65-1.10],0.2154033701181176
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CST6,Cystatin-M,27041,152,1.26 [0.93-1.71],0.1299851237443292
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CST7,Cystatin-F,27827,151,0.98 [0.84-1.15],0.8023617436610979
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSTB,Cystatin-B,27392,152,1.09 [0.78-1.54],0.6029962392729723
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTAG1A_CTAG1B,Cancer/testis antigen 1,23713,138,0.97 [0.70-1.34],0.8397036679899688
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTBS,Di-N-acetylchitobiase,23865,139,1.14 [0.61-2.11],0.6787400604222047
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTF1,Cardiotrophin-1,27269,150,0.85 [0.71-1.01],0.0681366760020542
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTHRC1,Collagen triple helix repeat-containing protein 1,24212,142,0.74 [0.41-1.32],0.3032379514664954
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTLA4,Cytotoxic T-lymphocyte protein 4,24212,142,0.78 [0.45-1.35],0.368840648580743
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTNNA1,Catenin alpha-1,23430,140,1.28 [0.91-1.82],0.1595675450420572
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTRB1,Chymotrypsinogen B,27784,153,0.88 [0.68-1.15],0.3515574585810321
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTRC,Chymotrypsin-C,27785,151,0.75 [0.60-0.94],0.011742255285044
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTRL,Chymotrypsin-like protease CTRL-1,24158,142,0.88 [0.70-1.12],0.3035513213477664
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSB,Cathepsin B,27808,153,1.04 [0.80-1.35],0.7677099527484151
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSC,Dipeptidyl peptidase 1,27747,150,0.97 [0.69-1.36],0.8480994507566517
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSD,Cathepsin D,25936,147,1.08 [0.75-1.55],0.6904431155670099
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSE,Cathepsin E,23702,141,1.06 [0.77-1.44],0.7335617564961461
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSF,Cathepsin F,27877,155,0.77 [0.54-1.10],0.1470003798036814
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSH,Pro-cathepsin H,27189,149,0.89 [0.73-1.08],0.2295985527266872
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSL,Cathepsin L1,27780,151,1.11 [0.62-2.01],0.7203684792884315
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSO,Cathepsin O,28067,151,0.81 [0.50-1.30],0.378775853498248
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSS,Cathepsin S,21800,114,1.34 [0.64-2.83],0.4383282906751178
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSV,Cathepsin L2,27932,152,1.01 [0.72-1.41],0.95515677373052
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSZ,Cathepsin Z,27780,155,0.89 [0.57-1.41],0.6236904249957516
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CUZD1,CUB and zona pellucida-like domain-containing protein 1,23536,141,1.06 [0.69-1.63],0.7767818635225613
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CWC15,Spliceosome-associated protein CWC15 homolog,23950,141,1.00 [0.77-1.30],0.9841387848833866
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CX3CL1,Fractalkine,27586,152,0.94 [0.61-1.44],0.7668444978054412
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXADR,Coxsackievirus and adenovirus receptor,27734,152,0.78 [0.59-1.04],0.095432633573217
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL1,Growth-regulated alpha protein,27738,150,0.92 [0.79-1.07],0.2745375792105037
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL10,C-X-C motif chemokine 10,27917,151,0.94 [0.75-1.17],0.5656732239541742
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL11,C-X-C motif chemokine 11,28018,153,0.87 [0.72-1.05],0.1583064852032552
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL12,Stromal cell-derived factor 1,27224,148,0.98 [0.68-1.40],0.9043960077702824
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL13,C-X-C motif chemokine 13,28018,153,1.00 [0.79-1.25],0.9779769070077956
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL14,C-X-C motif chemokine 14,27224,148,1.00 [0.79-1.27],0.9704866665355496
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL16,C-X-C motif chemokine 16,28071,155,0.46 [0.25-0.85],0.0128917244420152
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL17,C-X-C motif chemokine 17,28067,151,0.89 [0.63-1.26],0.5079153850388185
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL3,C-X-C motif chemokine 3,27779,151,0.90 [0.77-1.04],0.1634074127761896
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL5,C-X-C motif chemokine 5,27691,150,0.96 [0.85-1.09],0.5543809474087383
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL6,C-X-C motif chemokine 6,28067,151,1.00 [0.84-1.21],0.9679821117648773
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL8,Interleukin-8,27549,151,0.89 [0.71-1.11],0.2834810104380038
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL9,C-X-C motif chemokine 9,27917,151,0.98 [0.79-1.21],0.832838225035359
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CYB5A,Cytochrome b5,23335,137,0.99 [0.79-1.24],0.9046085718430138
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CYB5R2,NADH-cytochrome b5 reductase 2,23801,140,0.87 [0.64-1.16],0.3404861124661129
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",23445,136,0.94 [0.77-1.15],0.5565620531863888
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CYTH3,Cytohesin-3,23335,137,0.71 [0.54-0.93],0.0129508701139558
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CYTL1,Cytokine-like protein 1,24212,142,0.75 [0.38-1.48],0.4019828070263087
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DAAM1,Disheveled-associated activator of morphogenesis 1,23702,141,0.83 [0.68-1.01],0.0622471702270375
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DAB2,Disabled homolog 2,28012,153,0.96 [0.85-1.09],0.5447426998629499
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DAG1,Dystroglycan,27917,151,0.82 [0.60-1.11],0.1921042555440273
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DAND5,DAN domain family member 5,23526,136,1.03 [0.77-1.39],0.8412992492212259
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DAPK2,Death-associated protein kinase 2,23526,136,0.71 [0.50-1.00],0.0501156802928266
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,27734,152,0.99 [0.88-1.11],0.8605176879783021
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DARS1,"Aspartate--tRNA ligase, cytoplasmic",27534,152,0.97 [0.80-1.17],0.7345478554226919
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DBH,Dopamine beta-hydroxylase,24177,140,1.11 [0.93-1.31],0.2432262622779665
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DBI,Acyl-CoA-binding protein,27652,153,0.95 [0.79-1.14],0.5846756631976906
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DBN1,Drebrin,23526,136,0.73 [0.52-1.03],0.0758788386291572
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DBNL,Drebrin-like protein,27917,151,0.92 [0.79-1.07],0.2689206684010744
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",27877,155,0.74 [0.50-1.11],0.1417342128761446
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCC,Netrin receptor DCC,23536,141,0.83 [0.38-1.77],0.621798971156688
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCDC2C,Doublecortin domain-containing protein 2C,23335,137,0.97 [0.75-1.26],0.832445582630186
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCLRE1C,Protein artemis,23335,137,0.66 [0.38-1.14],0.1353313977874699
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCN,Decorin,27269,150,0.79 [0.42-1.50],0.4735988550778365
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCTD,Deoxycytidylate deaminase,23702,141,0.91 [0.77-1.08],0.2815003487497657
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCTN1,Dynactin subunit 1,28012,153,0.94 [0.76-1.17],0.5871132374189452
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCTN2,Dynactin subunit 2,27657,152,0.96 [0.83-1.12],0.6341350116176427
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCTN6,Dynactin subunit 6,27099,148,0.89 [0.72-1.11],0.31596383892123
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCTPP1,dCTP pyrophosphatase 1,27780,151,0.56 [0.36-0.87],0.0109273859296765
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCUN1D1,DCN1-like protein 1,23430,140,1.02 [0.83-1.25],0.8608724727595136
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCUN1D2,DCN1-like protein 2,23335,137,1.06 [0.88-1.28],0.5493718214991408
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCXR,L-xylulose reductase,27877,155,0.99 [0.76-1.30],0.9464841877519318
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDA1,DET1- and DDB1-associated protein 1,23445,136,0.98 [0.65-1.47],0.9130660668896632
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",27657,152,0.90 [0.65-1.25],0.5467617867762846
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDC,Aromatic-L-amino-acid decarboxylase,27735,151,0.91 [0.67-1.22],0.5107516216050959
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDHD2,Phospholipase DDHD2,24175,141,0.85 [0.67-1.09],0.2087830576956837
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDI2,Protein DDI1 homolog 2,23702,141,0.94 [0.77-1.15],0.5739819416167649
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDR1,Epithelial discoidin domain-containing receptor 1,28018,153,1.38 [0.75-2.54],0.3068258995570106
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDT,D-dopachrome decarboxylase,24212,142,0.76 [0.51-1.15],0.1933068536805441
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDX1,ATP-dependent RNA helicase DDX1,24088,141,0.98 [0.71-1.34],0.8891969756193957
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDX25,ATP-dependent RNA helicase DDX25,23536,141,0.93 [0.60-1.42],0.7209815012382748
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDX39A,ATP-dependent RNA helicase DDX39A,23526,136,1.25 [0.62-2.51],0.5373097195900101
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDX4,Probable ATP-dependent RNA helicase DDX4,23526,136,0.98 [0.72-1.34],0.9031826146123496
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDX53,Probable ATP-dependent RNA helicase DDX53,23536,141,1.28 [0.83-1.97],0.2693247578328364
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDX58,Antiviral innate immune response receptor RIG-I,27127,147,0.82 [0.62-1.09],0.1749211979690023
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",27734,152,0.95 [0.82-1.11],0.5406914370668576
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DEFA1_DEFA1B,Neutrophil defensin 1,27204,154,0.98 [0.75-1.29],0.9041389587815272
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DEFB103A_DEFB103B,Beta-defensin 103,23345,135,0.91 [0.60-1.40],0.674071051448329
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DEFB104A_DEFB104B,Beta-defensin 104,23430,140,1.27 [1.00-1.60],0.0485625820000816
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DEFB116,Beta-defensin 116,23430,140,1.14 [0.96-1.36],0.1377412806662542
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DEFB118,Beta-defensin 118,23430,140,0.92 [0.68-1.25],0.59547564264341
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DEFB4A_DEFB4B,Beta-defensin 4A,27403,151,0.95 [0.86-1.05],0.2847235403044958
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DENND2B,DENN domain-containing protein 2B,23445,136,1.00 [0.73-1.38],0.9805745675975436
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DENR,Density-regulated protein,23526,136,0.74 [0.54-1.02],0.0663270807495455
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DFFA,DNA fragmentation factor subunit alpha,28067,151,0.92 [0.74-1.14],0.4420909521523724
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DGCR6,Protein DGCR6,23430,140,0.76 [0.49-1.16],0.1992209911182841
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DGKA,Diacylglycerol kinase alpha,23526,136,0.79 [0.58-1.09],0.1510523193658
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DGKZ,Diacylglycerol kinase zeta,27224,148,0.84 [0.55-1.29],0.433726670396276
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DHODH,Dihydroorotate dehydrogenase,23445,136,1.05 [0.76-1.45],0.7662212316649097
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DHPS,Deoxyhypusine synthase,24077,140,0.84 [0.55-1.28],0.4104210907326642
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,24158,142,0.77 [0.53-1.12],0.1720569961152442
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DIABLO,"Diablo homolog, mitochondrial",27691,151,0.89 [0.78-1.01],0.0710059356698352
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DIPK1C,Divergent protein kinase domain 1C,23536,141,0.62 [0.40-0.97],0.0381390439845135
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DIPK2B,Divergent protein kinase domain 2B,23702,141,0.50 [0.27-0.92],0.0266503775644795
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DKK1,Dickkopf-related protein 1,28018,153,0.77 [0.61-0.97],0.0287767055755307
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DKK3,Dickkopf-related protein 3,28118,155,0.66 [0.41-1.06],0.0875924232117678
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DKK4,Dickkopf-related protein 4,27545,152,0.85 [0.61-1.17],0.3195742602612504
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DKKL1,Dickkopf-like protein 1,27657,152,1.18 [0.99-1.41],0.0704402696435415
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DLG4,Disks large homolog 4,24158,142,0.83 [0.65-1.05],0.123938025692972
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DLGAP5,Disks large-associated protein 5,24175,141,0.99 [0.73-1.34],0.9366977138595868
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DLK1,Protein delta homolog 1,28118,155,0.84 [0.64-1.09],0.1876922485270625
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DLL1,Delta-like protein 1,27877,155,1.28 [0.79-2.06],0.3113313708271112
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DLL4,Delta-like protein 4,23591,137,0.88 [0.68-1.14],0.3386699325743776
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DMD,Dystrophin,23591,137,1.05 [0.77-1.44],0.750094673523773
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DMP1,Dentin matrix acidic phosphoprotein 1,23591,137,0.84 [0.66-1.06],0.1333775140910443
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJA1,DnaJ homolog subfamily A member 1,23335,137,0.59 [0.38-0.91],0.0166816004062014
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJA2,DnaJ homolog subfamily A member 2,27978,151,0.92 [0.78-1.10],0.3624012116583043
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJA4,DnaJ homolog subfamily A member 4,24158,142,1.09 [0.88-1.35],0.4235266013748853
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJB1,DnaJ homolog subfamily B member 1,27657,152,0.93 [0.79-1.10],0.3940487633613725
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJB14,DnaJ homolog subfamily B member 14,24088,141,0.78 [0.60-1.01],0.0637455140195272
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJB2,DnaJ homolog subfamily B member 2,23702,141,0.92 [0.68-1.24],0.5840073189915971
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJB6,DnaJ homolog subfamily B member 6,23475,139,0.91 [0.75-1.10],0.3220623254680055
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJB8,DnaJ homolog subfamily B member 8,27269,150,1.02 [0.80-1.30],0.885876132825818
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJC21,DnaJ homolog subfamily C member 21,24158,142,0.91 [0.59-1.39],0.6532674667820373
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJC6,Putative tyrosine-protein phosphatase auxilin,23591,137,0.96 [0.79-1.17],0.6883376842373325
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJC9,DnaJ homolog subfamily C member 9,24088,141,0.90 [0.73-1.11],0.3304399864476306
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNER,Delta and Notch-like epidermal growth factor-related receptor,27737,151,0.83 [0.46-1.48],0.524732598487078
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNLZ,DNL-type zinc finger protein,23430,140,0.95 [0.79-1.14],0.5956103383025722
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNM1,Dynamin-1,24088,141,0.96 [0.83-1.10],0.5696809392145694
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNM3,Dynamin-3,24175,141,0.95 [0.71-1.28],0.7427196869031656
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNMBP,Dynamin-binding protein,27586,152,0.83 [0.65-1.06],0.1432660983449461
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNPEP,Aspartyl aminopeptidase,24158,142,0.77 [0.60-0.99],0.0432917512068012
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,27878,151,0.91 [0.69-1.19],0.4789354281807834
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DOC2B,Double C2-like domain-containing protein beta,23536,141,0.80 [0.48-1.33],0.3846595499026024
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DOCK9,Dedicator of cytokinesis protein 9,23430,140,1.02 [0.90-1.16],0.7597437805116486
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DOK1,Docking protein 1,24158,142,0.96 [0.85-1.07],0.4578472327905851
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DOK2,Docking protein 2,27780,151,0.93 [0.82-1.05],0.223057106141199
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DPEP1,Dipeptidase 1,27534,152,1.09 [0.82-1.45],0.5349301301312159
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DPEP2,Dipeptidase 2,27657,152,0.84 [0.51-1.40],0.5043469135032199
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DPP10,Inactive dipeptidyl peptidase 10,27734,152,0.97 [0.64-1.47],0.8809544957166008
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DPP4,Dipeptidyl peptidase 4,27249,154,0.81 [0.50-1.31],0.3920663820931289
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DPP6,Dipeptidyl aminopeptidase-like protein 6,27657,152,0.95 [0.62-1.46],0.8173728570370421
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DPP7,Dipeptidyl peptidase 2,27545,150,0.74 [0.58-0.94],0.0155193617352421
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DPT,Dermatopontin,28118,155,0.69 [0.41-1.16],0.1596454727621338
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DPY30,Protein dpy-30 homolog,27915,153,0.80 [0.62-1.04],0.0918435923617578
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DRAXIN,Draxin,27586,152,1.00 [0.72-1.40],0.9765490451566244
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DRG2,Developmentally-regulated GTP-binding protein 2,27657,152,0.90 [0.70-1.17],0.4386984521309505
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DSC2,Desmocollin-2,27493,152,1.01 [0.66-1.55],0.9674567042435078
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DSCAM,Down syndrome cell adhesion molecule,24175,141,1.85 [1.20-2.85],0.0056165829318967
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DSG2,Desmoglein-2,27784,153,1.07 [0.63-1.82],0.7944000402258512
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DSG3,Desmoglein-3,27922,152,1.04 [0.68-1.59],0.865247922724242
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DSG4,Desmoglein-4,27570,150,0.84 [0.64-1.11],0.2288795412942679
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DTD1,D-aminoacyl-tRNA deacylase 1,23702,141,0.90 [0.74-1.08],0.2497413049695451
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DTNB,Dystrobrevin beta,24036,140,1.17 [0.80-1.70],0.4215651731141622
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DTX2,Probable E3 ubiquitin-protein ligase DTX2,23536,141,1.09 [0.87-1.37],0.4741228054506158
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DTX3,Probable E3 ubiquitin-protein ligase DTX3,27657,152,0.93 [0.51-1.69],0.8010408960783475
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DTYMK,Thymidylate kinase,24214,140,0.83 [0.66-1.05],0.1150255216135965
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DUOX2,Dual oxidase 2,27269,150,0.93 [0.75-1.15],0.4952155504608416
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DUSP13,Dual specificity protein phosphatase 13 isoform A,24077,140,0.71 [0.46-1.09],0.1140628068259041
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DUSP29,Dual specificity phosphatase 29,23536,141,1.07 [0.85-1.34],0.5790722723876736
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DUSP3,Dual specificity protein phosphatase 3,27099,148,0.79 [0.65-0.97],0.0225174847997031
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",24088,141,0.91 [0.78-1.06],0.2297361269516876
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DXO,Decapping and exoribonuclease protein,24158,142,0.77 [0.54-1.10],0.1519726870917823
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,24077,140,0.47 [0.29-0.75],0.00147227731843
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DYNLT1,Dynein light chain Tctex-type 1,23536,141,0.84 [0.68-1.04],0.109433584540666
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DYNLT3,Dynein light chain Tctex-type 3,24077,140,0.67 [0.46-0.99],0.0452997696953116
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,27586,152,0.96 [0.83-1.12],0.6343927732970456
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EBI3_IL27,Interleukin-27,27963,153,1.75 [1.14-2.67],0.0103490014867301
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ECE1,Endothelin-converting enzyme 1,27099,148,0.85 [0.56-1.29],0.4387685336598501
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",24214,140,0.93 [0.74-1.16],0.4979773467768223
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ECHS1,"Enoyl-CoA hydratase, mitochondrial",23591,137,0.91 [0.77-1.08],0.2977025551006295
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ECI2,Enoyl-CoA delta isomerase 2,23445,136,0.92 [0.70-1.21],0.5642650750075597
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ECM1,Extracellular matrix protein 1,23568,137,1.00 [0.64-1.55],0.9843216785916546
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ECSCR,Endothelial cell-specific chemotaxis regulator,23430,140,1.07 [0.80-1.43],0.6438147608568904
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EDA2R,Tumor necrosis factor receptor superfamily member 27,28012,153,1.39 [0.95-2.04],0.0911959759657903
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EDAR,Tumor necrosis factor receptor superfamily member EDAR,27734,152,0.94 [0.80-1.10],0.4201139411357756
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EDDM3B,Epididymal secretory protein E3-beta,24077,140,0.60 [0.40-0.91],0.0157696698346768
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,23445,136,1.20 [0.81-1.78],0.3543980734256329
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EDF1,Endothelial differentiation-related factor 1,24175,141,0.80 [0.61-1.04],0.0933743433865351
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,27269,150,0.76 [0.50-1.18],0.2201766351796246
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EDN1,Endothelin-1,23591,137,1.27 [0.72-2.22],0.4076514336039494
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EDNRB,Endothelin receptor type B,23526,136,0.80 [0.52-1.22],0.2943406451364211
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EEF1D,Elongation factor 1-delta,24214,140,0.86 [0.72-1.03],0.1108161219801468
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EFCAB14,EF-hand calcium-binding domain-containing protein 14,24088,141,0.72 [0.38-1.35],0.3021103228830586
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EFCAB2,Dynein regulatory complex protein 8,23760,138,0.82 [0.51-1.33],0.4263231952746552
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,27827,155,0.78 [0.49-1.24],0.2907615914042785
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EFHD1,EF-hand domain-containing protein D1,24175,141,1.32 [0.87-1.99],0.1917922776100736
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EFNA1,Ephrin-A1,27742,153,1.53 [0.92-2.52],0.0990230771650696
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EFNA4,Ephrin-A4,27544,152,0.81 [0.49-1.34],0.4046609719010234
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EFNB2,Ephrin-B2,23536,141,1.01 [0.77-1.33],0.9149076147826202
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EGF,Pro-epidermal growth factor,27738,151,0.94 [0.82-1.08],0.3798725045707333
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EGFL7,Epidermal growth factor-like protein 7,27127,147,0.92 [0.64-1.33],0.657140810631158
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EGFLAM,Pikachurin,24088,141,0.31 [0.17-0.55],6.113815233301767e-05
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EGFR,Epidermal growth factor receptor,28118,155,0.47 [0.20-1.12],0.0873072953836493
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EGLN1,Egl nine homolog 1,27734,152,0.97 [0.75-1.26],0.8243798113058839
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EHBP1,EH domain-binding protein 1,24214,140,0.87 [0.70-1.09],0.2310579906772784
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EHD3,EH domain-containing protein 3,23591,137,0.93 [0.81-1.07],0.324771283782988
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",24158,142,0.81 [0.58-1.12],0.2041707757605714
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",24000,141,0.94 [0.81-1.09],0.4252691910028217
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,23445,136,0.93 [0.72-1.21],0.6092521004001661
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,23591,137,1.11 [0.76-1.62],0.5803293656586456
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF4B,Eukaryotic translation initiation factor 4B,27586,152,0.88 [0.69-1.12],0.2963567092864486
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF4E,Eukaryotic translation initiation factor 4E,23526,136,0.83 [0.69-1.00],0.054090876127138
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,27780,151,0.93 [0.74-1.16],0.4934586592846851
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,28067,151,0.95 [0.82-1.10],0.4836185122635862
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,24175,141,0.82 [0.64-1.07],0.1404159028876796
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF5,Eukaryotic translation initiation factor 5,23445,136,1.10 [0.78-1.57],0.5800831418528436
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF5A,Eukaryotic translation initiation factor 5A-1,27224,148,1.33 [0.84-2.08],0.2227460940167799
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ELAC1,Zinc phosphodiesterase ELAC protein 1,24175,141,0.91 [0.76-1.10],0.325902945604092
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ELAVL4,ELAV-like protein 4,23430,140,1.03 [0.86-1.24],0.7311344833652385
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ELN,Elastin,24214,140,1.08 [0.69-1.69],0.7448895927849335
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ELOA,Elongin-A,27657,152,0.79 [0.58-1.08],0.1365457961686123
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ELOB,Elongin-B,23445,136,0.92 [0.59-1.42],0.6987342595078057
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENAH,Protein enabled homolog,27224,148,0.72 [0.52-1.00],0.0520503557033839
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENDOU,Poly(U)-specific endoribonuclease,22362,133,1.43 [1.05-1.94],0.021597093287227
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENG,Endoglin,28118,155,0.56 [0.24-1.30],0.1764776370172248
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENO1,Alpha-enolase,27732,152,0.97 [0.81-1.16],0.7563913537000049
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENO2,Gamma-enolase,28018,153,0.85 [0.69-1.06],0.1557477877674061
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENO3,Beta-enolase,23591,137,1.07 [0.81-1.43],0.6213481743288278
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENOPH1,Enolase-phosphatase E1,24077,140,0.98 [0.73-1.32],0.9109476654029188
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,23445,136,0.71 [0.38-1.34],0.2959196477647253
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENPEP,Glutamyl aminopeptidase,23445,136,0.86 [0.57-1.30],0.477488715695356
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,28118,155,0.61 [0.37-1.01],0.0526881002183025
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,27917,151,1.00 [0.70-1.42],0.9983352553801184
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,23591,137,1.06 [0.68-1.66],0.7985384360976746
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,26912,147,0.95 [0.81-1.13],0.5822929224842633
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENSA,Alpha-endosulfine,24077,140,0.84 [0.60-1.16],0.2847334235073837
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,27127,147,0.97 [0.69-1.35],0.8491803959393605
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,27269,150,0.81 [0.41-1.62],0.5524015802449658
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,27269,150,1.07 [0.63-1.84],0.7950068963593713
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENTR1,Endosome-associated-trafficking regulator 1,23591,137,0.94 [0.70-1.27],0.6970036841203775
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EP300,Histone acetyltransferase p300,23526,136,0.57 [0.32-1.01],0.0531624284508176
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPB41L5,Band 4.1-like protein 5,23536,141,0.85 [0.64-1.13],0.2598168112591807
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPCAM,Epithelial cell adhesion molecule,27787,151,0.88 [0.76-1.01],0.0718943830486993
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPGN,Epigen,24077,140,1.20 [0.91-1.58],0.2023833388973165
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPHA1,Ephrin type-A receptor 1,27878,151,0.73 [0.48-1.11],0.1441059214129276
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPHA10,Ephrin type-A receptor 10,27099,148,1.11 [0.92-1.36],0.2810064006849803
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPHA2,Ephrin type-A receptor 2,26797,150,0.83 [0.51-1.35],0.4551417699647645
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPHA4,Ephrin type-A receptor 4,23702,141,0.71 [0.40-1.25],0.2324860778268104
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPHB4,Ephrin type-B receptor 4,28118,155,0.77 [0.43-1.39],0.3858383221450667
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPHB6,Ephrin type-B receptor 6,27534,152,0.77 [0.49-1.23],0.2741378890034384
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPHX2,Bifunctional epoxide hydrolase 2,27269,150,1.14 [0.93-1.40],0.2008955372253995
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPN1,Epsin-1,23760,138,0.86 [0.57-1.29],0.4573840771826789
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPO,Erythropoietin,27734,152,0.93 [0.76-1.13],0.4552105199157632
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPPK1,Epiplakin,23591,137,0.95 [0.76-1.19],0.6614574786425961
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,27964,153,0.58 [0.35-0.95],0.0307730333164467
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERBB2,Receptor tyrosine-protein kinase erbB-2,27877,155,0.74 [0.42-1.32],0.3148536315585283
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERBB3,Receptor tyrosine-protein kinase erbB-3,27702,151,0.63 [0.29-1.36],0.2382503518298455
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERBB4,Receptor tyrosine-protein kinase erbB-4,27877,155,0.95 [0.53-1.70],0.8530737497021659
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERBIN,Erbin,27657,152,0.95 [0.83-1.09],0.4730306739778409
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERC2,ERC protein 2,23536,141,1.06 [0.87-1.29],0.5734540910521033
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERCC1,DNA excision repair protein ERCC-1,23335,137,0.53 [0.30-0.94],0.0307497951622615
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EREG,Proepiregulin,27534,152,0.98 [0.82-1.17],0.8364171863622263
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERI1,3'-5' exoribonuclease 1,23760,138,1.16 [0.74-1.83],0.514802998673111
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERMAP,Erythroid membrane-associated protein,23526,136,0.86 [0.59-1.24],0.4123151013624906
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,24077,140,0.58 [0.37-0.91],0.0176705734770591
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERP29,Endoplasmic reticulum resident protein 29,23702,141,0.91 [0.79-1.04],0.156103214851641
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERP44,Endoplasmic reticulum resident protein 44,27609,151,0.80 [0.45-1.40],0.4264424671100877
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,23445,136,1.03 [0.72-1.45],0.8865651285687614
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ESAM,Endothelial cell-selective adhesion molecule,28118,155,0.68 [0.43-1.07],0.0984728830096823
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ESM1,Endothelial cell-specific molecule 1,27782,151,0.87 [0.57-1.33],0.5187765133844142
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ESPL1,Separin,23335,137,0.94 [0.70-1.27],0.6942441255045395
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ESR1,Estrogen receptor,23526,136,0.89 [0.65-1.22],0.4724908784391338
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ESYT2,Extended synaptotagmin-2,24158,142,0.88 [0.72-1.08],0.2158035595340766
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EVI2B,Protein EVI2B,23335,137,0.66 [0.40-1.10],0.1108674708435794
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EVI5,Ecotropic viral integration site 5 protein homolog,23526,136,0.90 [0.74-1.08],0.2442948376427719
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EVPL,Envoplakin,23760,138,1.11 [0.71-1.75],0.6476771097270848
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EXOSC10,Exosome component 10,23445,136,0.97 [0.74-1.28],0.8283416470279423
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EXTL1,Exostosin-like 1,23445,136,0.88 [0.61-1.28],0.5058586542293381
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EZR,Ezrin,28018,153,0.74 [0.40-1.36],0.3331744991181511
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,F10,Coagulation factor X,24226,140,0.49 [0.28-0.86],0.012888409253877
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,F11,Coagulation factor XI,23906,139,0.62 [0.34-1.12],0.1145826719793203
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,F11R,Junctional adhesion molecule A,27784,153,0.80 [0.62-1.04],0.0910266180059867
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,F12,Coagulation factor XII,24261,142,0.95 [0.65-1.39],0.7992812743173281
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,F13B,Coagulation factor XIII B chain,24118,142,0.56 [0.31-1.03],0.0617283997020864
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,F2,Prothrombin,24261,142,0.44 [0.16-1.27],0.1298800104027912
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,F2R,Proteinase-activated receptor 1,27869,151,0.87 [0.67-1.11],0.2615820730805925
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,F3,Tissue factor,27848,151,0.61 [0.36-1.04],0.067351861035428
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,F7,Coagulation factor VII,27831,155,0.85 [0.53-1.37],0.515542924865693
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,F9,Coagulation factor IX,27826,155,0.91 [0.41-2.01],0.810098545354646
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FABP1,"Fatty acid-binding protein, liver",27782,151,0.86 [0.74-1.01],0.0725919200240968
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FABP2,"Fatty acid-binding protein, intestinal",27780,151,0.92 [0.76-1.11],0.3640003643078742
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FABP3,"Fatty acid-binding protein, heart",24214,140,1.29 [0.94-1.76],0.1093522812626527
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FABP4,"Fatty acid-binding protein, adipocyte",28118,155,0.82 [0.61-1.10],0.1949737597054601
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FABP5,Fatty acid-binding protein 5,27929,152,0.97 [0.78-1.19],0.7389834205752273
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FABP6,Gastrotropin,27224,149,0.99 [0.76-1.28],0.918293149291886
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FABP9,Fatty acid-binding protein 9,27734,152,1.01 [0.78-1.31],0.919677636852688
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FADD,FAS-associated death domain protein,27780,151,0.94 [0.78-1.14],0.5332811874407803
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FAM13A,Protein FAM13A,24088,141,0.91 [0.72-1.17],0.4769987245623807
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FAM171A2,Protein FAM171A2,24175,141,1.01 [0.92-1.11],0.8327441470569303
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FAM171B,Protein FAM171B,24077,140,1.08 [0.62-1.89],0.776385605630999
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FAM172A,Cotranscriptional regulator FAM172A,23591,137,0.86 [0.65-1.12],0.2580217291989444
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FAM20A,Pseudokinase FAM20A,24214,140,0.73 [0.41-1.31],0.2986455288485689
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FAM3B,Protein FAM3B,27657,152,0.76 [0.51-1.13],0.1718041760084067
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FAM3C,Protein FAM3C,27735,151,0.59 [0.36-0.97],0.037628068784362
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FAM3D,Protein FAM3D,24088,141,1.00 [0.82-1.21],0.9655582924668448
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FAP,Prolyl endopeptidase FAP,28118,155,1.07 [0.64-1.81],0.7897775907897872
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FARSA,Phenylalanine--tRNA ligase alpha subunit,23536,141,0.97 [0.76-1.23],0.8040942132158598
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FAS,Tumor necrosis factor receptor superfamily member 6,28028,155,0.85 [0.53-1.38],0.5099150436750719
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FASLG,Tumor necrosis factor ligand superfamily member 6,28067,151,0.78 [0.53-1.15],0.2083847381139926
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FBLN2,Fibulin-2,24212,142,0.63 [0.37-1.07],0.0858422277512362
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FBN2,Fibrillin-2,23536,141,1.20 [0.93-1.56],0.1632329674775735
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FBP1,"Fructose-1,6-bisphosphatase 1",27780,151,0.84 [0.69-1.03],0.0978066418785053
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,24214,140,0.98 [0.78-1.22],0.8460421877215908
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCAR,Immunoglobulin alpha Fc receptor,27734,152,0.62 [0.46-0.85],0.0026972881895091
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,24175,141,1.07 [0.55-2.09],0.8420397316072357
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCER2,Low affinity immunoglobulin epsilon Fc receptor,27784,153,1.03 [0.77-1.38],0.8575297511435644
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,27649,155,0.93 [0.75-1.16],0.5317554796602075
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,27127,147,0.96 [0.75-1.25],0.7861026464917441
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,27785,155,0.87 [0.66-1.15],0.3426692748347305
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCN1,Ficolin-1,24177,140,0.74 [0.60-0.93],0.0093811145004026
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCN2,Ficolin-2,27650,154,1.18 [0.82-1.69],0.3782273384763115
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCRL1,Fc receptor-like protein 1,27780,151,1.04 [0.76-1.44],0.7905180337444827
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCRL2,Fc receptor-like protein 2,27934,150,0.90 [0.67-1.21],0.4826376346675151
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCRL3,Fc receptor-like protein 3,27224,148,0.77 [0.59-1.00],0.0487779686107935
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCRL5,Fc receptor-like protein 5,27784,153,0.67 [0.52-0.87],0.0021458288799481
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCRL6,Fc receptor-like protein 6,27734,152,1.00 [0.81-1.23],0.9944294171030488
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCRLB,Fc receptor-like B,27127,147,0.92 [0.71-1.19],0.5460889303053165
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FDX1,"Adrenodoxin, mitochondrial",23445,136,0.87 [0.65-1.16],0.3327169094296961
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FDX2,"Ferredoxin-2, mitochondrial",23445,136,0.87 [0.64-1.19],0.376371501684784
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FEN1,Flap endonuclease 1,27127,147,0.99 [0.79-1.24],0.9526329354786456
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FES,Tyrosine-protein kinase Fes/Fps,27127,147,0.80 [0.58-1.12],0.1972681709932686
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FETUB,Fetuin-B,27826,155,0.96 [0.63-1.45],0.8361254129289175
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGA,Fibrinogen alpha chain,23671,139,1.07 [0.63-1.82],0.8043988533026849
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",24175,141,0.82 [0.67-1.01],0.0637571313251582
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF12,Fibroblast growth factor 12,23526,136,0.91 [0.62-1.35],0.6509001994152817
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF16,Fibroblast growth factor 16,23526,136,0.92 [0.65-1.32],0.6628687493004721
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF19,Fibroblast growth factor 19,27917,151,1.02 [0.85-1.23],0.8129768252451725
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF2,Fibroblast growth factor 2,27734,152,0.98 [0.79-1.21],0.8264099604563148
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF20,Fibroblast growth factor 20,23526,136,1.01 [0.71-1.46],0.9384645869595396
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF21,Fibroblast growth factor 21,27963,153,0.99 [0.88-1.12],0.8819194333240493
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF23,Fibroblast growth factor 23,27968,153,1.15 [0.92-1.43],0.21028803817887
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF3,Fibroblast growth factor 3,23526,136,1.24 [0.78-1.97],0.3668968167206002
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF5,Fibroblast growth factor 5,27224,148,0.86 [0.54-1.35],0.5062975308439804
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF6,Fibroblast growth factor 6,23526,136,1.01 [0.70-1.47],0.9542436414317226
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF7,Fibroblast growth factor 7,23335,137,0.96 [0.77-1.19],0.6942908322398541
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF9,Fibroblast growth factor 9,23293,137,0.83 [0.56-1.23],0.3505303738166068
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGFBP1,Fibroblast growth factor-binding protein 1,27877,155,0.79 [0.51-1.23],0.2906896106017899
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGFBP2,Fibroblast growth factor-binding protein 2,24212,142,0.86 [0.62-1.19],0.370650813238745
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGFBP3,Fibroblast growth factor-binding protein 3,24158,142,0.50 [0.32-0.77],0.0018694632407266
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGFR2,Fibroblast growth factor receptor 2,27877,155,0.94 [0.49-1.82],0.8523424936109553
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGFR4,Fibroblast growth factor receptor 4,23702,141,0.78 [0.57-1.05],0.1057248640443872
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGL1,Fibrinogen-like protein 1,24226,140,0.98 [0.76-1.26],0.8536935001319248
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGR,Tyrosine-protein kinase Fgr,27099,148,1.06 [0.84-1.33],0.6436158233522989
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FH,"Fumarate hydratase, mitochondrial",23430,140,0.98 [0.81-1.19],0.8179307285902234
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FHIP2A,FHF complex subunit HOOK interacting protein 2A,23445,136,0.88 [0.61-1.26],0.4855813279376825
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FHIT,Bis(5'-adenosyl)-triphosphatase,27099,148,0.93 [0.77-1.13],0.4850010289662314
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FIS1,Mitochondrial fission 1 protein,27788,151,0.86 [0.71-1.04],0.1265707829738621
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,24175,141,0.89 [0.76-1.04],0.1488529879046247
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,27844,149,0.92 [0.81-1.05],0.2180060199987438
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,27586,152,0.89 [0.65-1.23],0.4923418192441794
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,27586,152,1.01 [0.87-1.17],0.9028767172506053
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,27047,148,0.99 [0.73-1.35],0.970232676369994
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FKBPL,FK506-binding protein-like,24088,141,0.86 [0.65-1.13],0.28447930682968
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FLI1,Friend leukemia integration 1 transcription factor,27127,147,0.92 [0.80-1.05],0.2056462800403778
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,27586,152,1.08 [0.65-1.80],0.7638712402966688
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FLT1,Vascular endothelial growth factor receptor 1,27613,152,1.06 [0.56-2.03],0.850211410217911
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FLT3,Receptor-type tyrosine-protein kinase FLT3,27127,147,0.84 [0.51-1.38],0.4995982982973216
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FLT3LG,Fms-related tyrosine kinase 3 ligand,28067,151,0.86 [0.56-1.34],0.5086460019305461
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FLT4,Vascular endothelial growth factor receptor 3,27877,155,0.58 [0.39-0.87],0.0084714073979164
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FMNL1,Formin-like protein 1,27099,148,1.05 [0.85-1.29],0.6705085907629156
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FMR1,Synaptic functional regulator FMR1,27127,147,1.02 [0.67-1.56],0.9101047460397946
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FN1,Fibronectin,24261,142,0.56 [0.30-1.03],0.0614803409180228
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FNDC1,Fibronectin type III domain-containing protein 1,24158,142,0.74 [0.53-1.05],0.0900009594391982
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,24077,140,0.79 [0.48-1.28],0.3326684498363393
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FOLH1,Glutamate carboxypeptidase 2,23526,136,0.95 [0.80-1.12],0.528498555388567
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FOLR1,Folate receptor alpha,27740,154,1.09 [0.66-1.80],0.7416918399849894
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FOLR2,Folate receptor beta,28018,153,1.54 [0.96-2.48],0.0731960146835963
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FOLR3,Folate receptor gamma,27788,154,1.04 [0.97-1.12],0.2399997723586311
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FOS,Proto-oncogene c-Fos,23293,137,0.63 [0.40-1.00],0.0506953841403657
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FOSB,Protein fosB,27099,148,0.92 [0.62-1.36],0.6745936767311695
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FOXJ3,Forkhead box protein J3,23526,136,0.69 [0.45-1.04],0.0794711397298788
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FOXO1,Forkhead box protein O1,27734,152,0.95 [0.80-1.12],0.5261774049510599
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FOXO3,Forkhead box protein O3,27127,147,0.88 [0.74-1.03],0.1068770258142221
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FRMD4B,FERM domain-containing protein 4B,23445,136,0.93 [0.73-1.18],0.5457324671771107
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FRMD7,FERM domain-containing protein 7,23536,141,0.97 [0.59-1.58],0.901318492678801
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FRZB,Secreted frizzled-related protein 3,27490,152,1.45 [0.82-2.54],0.2012885773277269
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FSHB,Follitropin subunit beta,23591,137,1.18 [0.93-1.51],0.1702019813083096
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FST,Follistatin,27869,151,0.94 [0.71-1.25],0.6831460174179239
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FSTL1,Follistatin-related protein 1,23591,137,0.81 [0.39-1.68],0.5680045512746588
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FSTL3,Follistatin-related protein 3,27735,151,0.67 [0.41-1.08],0.0993046013133251
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FTCD,Formimidoyltransferase-cyclodeaminase,24117,142,0.92 [0.76-1.12],0.4094520024091099
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FUCA1,Tissue alpha-L-fucosidase,27956,155,0.98 [0.83-1.17],0.8513638357248259
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FUOM,Fucose mutarotase,23702,141,0.90 [0.70-1.17],0.431242670727621
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FURIN,Furin,27877,155,0.86 [0.56-1.31],0.4826995024011666
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FUS,RNA-binding protein FUS,27084,147,0.88 [0.60-1.29],0.5119710927183531
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",23710,138,1.03 [0.80-1.32],0.832262865546903
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,28018,153,1.01 [0.74-1.38],0.9315724657954614
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FUT8,"Alpha-(1,6)-fucosyltransferase",27586,152,0.96 [0.75-1.23],0.7318133958339699
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FXN,"Frataxin, mitochondrial",28012,153,0.90 [0.74-1.09],0.2662121130032971
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FXYD5,FXYD domain-containing ion transport regulator 5,27224,148,0.89 [0.71-1.12],0.3323238163727526
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FYB1,FYN-binding protein 1,27743,153,0.88 [0.75-1.03],0.1059318873717283
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FZD10,Frizzled-10,23536,141,1.17 [0.94-1.45],0.1660672331332793
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FZD8,Frizzled-8,23430,140,1.08 [0.76-1.54],0.650741250336389
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GABARAP,Gamma-aminobutyric acid receptor-associated protein,24077,140,1.13 [0.84-1.52],0.4225581370989977
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,23760,138,1.15 [0.93-1.42],0.195831344297429
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,23430,140,1.25 [1.03-1.52],0.0274135543342734
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GAD1,Glutamate decarboxylase 1,23335,137,0.59 [0.31-1.12],0.1059906094924322
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GAD2,Glutamate decarboxylase 2,23526,136,0.85 [0.57-1.26],0.409555884999028
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,23760,138,0.92 [0.65-1.32],0.6592946815088201
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,23591,137,0.97 [0.71-1.33],0.864351136670504
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GAGE2A,G antigen 2A,23335,137,0.94 [0.71-1.23],0.6351833208624882
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GAL,Galanin peptides,27917,151,1.31 [1.05-1.65],0.0178805391871116
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,27657,152,0.86 [0.51-1.43],0.5531028743234339
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,28012,153,0.72 [0.41-1.24],0.2342186110865532
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,27224,148,0.98 [0.69-1.39],0.928007266589913
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,24214,140,1.32 [0.74-2.35],0.3458585210196309
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GALNT7,N-acetylgalactosaminyltransferase 7,27657,152,0.66 [0.34-1.30],0.230942921016812
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GAMT,Guanidinoacetate N-methyltransferase,23445,136,0.96 [0.62-1.48],0.8379821447927714
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,23184,137,0.96 [0.60-1.55],0.8813340193903497
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GART,Trifunctional purine biosynthetic protein adenosine-3,24175,141,0.69 [0.35-1.34],0.2716728364585138
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GAS2,Growth arrest-specific protein 2,23760,138,0.88 [0.62-1.24],0.4583911238472167
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GAS6,Growth arrest-specific protein 6,27929,154,0.64 [0.37-1.12],0.1174323099090511
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GASK1A,Golgi-associated kinase 1A,23445,136,0.89 [0.61-1.30],0.5498993547475195
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GAST,Gastrin,24158,142,0.88 [0.77-1.01],0.0697276465452294
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,23335,137,0.52 [0.28-0.97],0.0395137924816632
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",23591,137,0.82 [0.66-1.03],0.0830507154327783
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GBA,Lysosomal acid glucosylceramidase,23536,141,0.82 [0.60-1.11],0.1957427765488058
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GBP1,Guanylate-binding protein 1,24116,142,0.78 [0.62-0.98],0.0340537206107574
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GBP2,Guanylate-binding protein 2,27224,148,1.20 [0.96-1.51],0.1149820617886999
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GBP4,Guanylate-binding protein 4,27099,148,0.89 [0.65-1.22],0.4664375575290198
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GBP6,Guanylate-binding protein 6,23445,136,1.11 [0.80-1.53],0.5301792518357922
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GC,Vitamin D-binding protein,24261,142,1.57 [0.86-2.85],0.1417870568711322
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GCC1,GRIP and coiled-coil domain-containing protein 1,24158,142,0.90 [0.77-1.04],0.1419055318986075
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GCG,Pro-glucagon,27127,147,1.03 [0.92-1.16],0.6003050416988074
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,23133,135,0.85 [0.60-1.21],0.370996173224261
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GCLM,Glutamate--cysteine ligase regulatory subunit,23445,136,1.16 [0.86-1.58],0.3345110943415928
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",27657,152,1.20 [0.80-1.80],0.3837436635592328
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GDF15,Growth/differentiation factor 15,28118,155,1.03 [0.74-1.44],0.8646368196209562
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GDF2,Growth/differentiation factor 2,27780,151,0.78 [0.52-1.16],0.2215194873456665
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GDNF,Glial cell line-derived neurotrophic factor,27099,148,0.97 [0.66-1.42],0.8687285497110069
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GET3,ATPase GET3,24214,140,0.94 [0.70-1.27],0.6974505264014076
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GFAP,Glial fibrillary acidic protein,27084,147,0.85 [0.62-1.17],0.3159035545792215
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GFER,FAD-linked sulfhydryl oxidase ALR,27127,147,0.90 [0.71-1.14],0.3922812239610918
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,27127,147,1.07 [0.97-1.19],0.1683548515245385
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GFRA1,GDNF family receptor alpha-1,27963,153,1.25 [0.75-2.06],0.3906940520740355
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GFRA2,GDNF family receptor alpha-2,27657,152,1.46 [0.75-2.85],0.2677550805904274
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GFRA3,GDNF family receptor alpha-3,27500,151,0.67 [0.40-1.12],0.1248902420447014
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GFRAL,GDNF family receptor alpha-like,23422,138,0.91 [0.69-1.19],0.4717962758052582
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GGA1,ADP-ribosylation factor-binding protein GGA1,27099,148,1.02 [0.83-1.26],0.8447045713848705
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GGACT,Gamma-glutamylaminecyclotransferase,24214,140,0.91 [0.72-1.14],0.4111164575467475
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GGCT,Gamma-glutamylcyclotransferase,24165,140,0.69 [0.49-0.98],0.0381812144792178
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GGH,Gamma-glutamyl hydrolase,27296,154,1.14 [0.76-1.71],0.5329561973733381
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GGT1,Glutathione hydrolase 1 proenzyme,27742,153,0.94 [0.69-1.26],0.659677020211958
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GGT5,Glutathione hydrolase 5 proenzyme,27586,152,1.02 [0.54-1.91],0.9544141305301864
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GH1,Somatotropin,27735,151,0.98 [0.90-1.07],0.6644867885524348
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GH2,Growth hormone variant,27127,147,0.99 [0.91-1.08],0.8899854658689355
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GHR,Growth hormone receptor,23702,141,0.71 [0.41-1.25],0.2386687082828658
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GHRHR,Growth hormone-releasing hormone receptor,27099,148,0.89 [0.67-1.18],0.4180939454045054
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GHRL,Appetite-regulating hormone,27780,151,0.86 [0.72-1.02],0.0829022948010097
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GID8,Glucose-induced degradation protein 8 homolog,24175,141,0.84 [0.49-1.43],0.5126929559920259
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GIGYF2,GRB10-interacting GYF protein 2,24175,141,0.92 [0.74-1.14],0.4210822341252886
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GIMAP7,GTPase IMAP family member 7,23702,141,0.59 [0.34-1.03],0.0621299204483166
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GIMAP8,GTPase IMAP family member 8,23335,137,0.87 [0.62-1.22],0.4206794409137259
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GIP,Gastric inhibitory polypeptide,23591,137,0.98 [0.72-1.31],0.8703421613438583
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GIPC2,PDZ domain-containing protein GIPC2,24158,142,0.82 [0.47-1.43],0.486744627897285
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GIPC3,PDZ domain-containing protein GIPC3,24088,141,0.86 [0.74-1.01],0.0724454544658292
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GIPR,Gastric inhibitory polypeptide receptor,23526,136,0.84 [0.57-1.23],0.3689516057057953
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GIT1,ARF GTPase-activating protein GIT1,23526,136,0.95 [0.80-1.12],0.5271193992446979
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GJA8,Gap junction alpha-8 protein,23335,137,0.81 [0.60-1.10],0.1791891961955499
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GKN1,Gastrokine-1,26563,143,1.08 [0.63-1.86],0.7708443010301658
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GLA,Alpha-galactosidase A,23654,141,0.81 [0.51-1.28],0.3725476033673073
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GLB1,Beta-galactosidase,27586,152,0.78 [0.54-1.12],0.1827979244154075
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GLI2,Zinc finger protein GLI2,23526,136,0.63 [0.36-1.13],0.1222116258550245
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GLO1,Lactoylglutathione lyase,27269,150,1.12 [0.88-1.43],0.3409199058714725
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GLOD4,Glyoxalase domain-containing protein 4,27740,151,0.82 [0.55-1.21],0.3076276589482158
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GLP1R,Glucagon-like peptide 1 receptor,23430,140,1.15 [0.79-1.69],0.4683736732803567
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GLRX,Glutaredoxin-1,27600,150,0.88 [0.68-1.13],0.3242754640960711
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",23702,141,0.89 [0.74-1.08],0.2370115748926861
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,27099,148,1.04 [0.77-1.39],0.8090781717694775
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GLYR1,Putative oxidoreductase GLYR1,24077,140,0.81 [0.60-1.11],0.1902172927649427
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GM2A,Ganglioside GM2 activator,23624,138,0.83 [0.52-1.31],0.419628100402459
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GMFG,Glia maturation factor gamma,24214,140,0.83 [0.67-1.04],0.1084666169424717
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GMPR,GMP reductase 1,28067,151,0.87 [0.66-1.14],0.3084772507334289
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GMPR2,GMP reductase 2,23702,141,0.85 [0.66-1.08],0.1710410735433808
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GNAS,Neuroendocrine secretory protein 55,24175,141,0.88 [0.72-1.08],0.2311881103748949
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,27127,147,0.98 [0.78-1.23],0.860650378533127
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,23536,141,1.14 [0.88-1.48],0.3285296878524171
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GNLY,Granulysin,27784,153,0.81 [0.61-1.07],0.1395943060405839
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GNPDA1,Glucosamine-6-phosphate isomerase 1,23591,137,0.98 [0.59-1.61],0.9292237642688792
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GNPDA2,Glucosamine-6-phosphate isomerase 2,23702,141,0.73 [0.46-1.14],0.1661495803465133
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GOLGA3,Golgin subfamily A member 3,24175,141,0.97 [0.78-1.19],0.7429336713892303
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GOLM2,Protein GOLM2,28018,153,0.91 [0.48-1.72],0.7637423387756055
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,27734,152,0.98 [0.85-1.13],0.7838037576758139
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GORASP2,Golgi reassembly-stacking protein 2,24088,141,0.81 [0.57-1.15],0.2336458795398153
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GOT1,"Aspartate aminotransferase, cytoplasmic",24212,142,0.72 [0.48-1.09],0.1208555218331286
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GP1BA,Platelet glycoprotein Ib alpha chain,27647,155,0.78 [0.50-1.22],0.2716624775321694
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GP1BB,Platelet glycoprotein Ib beta chain,23445,136,0.82 [0.64-1.04],0.1045173921560814
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,26922,148,1.01 [0.85-1.19],0.9393929281288712
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GP5,Platelet glycoprotein V,23702,141,0.73 [0.47-1.12],0.1484156854527691
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GP6,Platelet glycoprotein VI,27743,153,0.94 [0.80-1.10],0.4285948263029945
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPA33,Cell surface A33 antigen,27657,152,0.89 [0.80-0.99],0.0264044242125018
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPC1,Glypican-1,28012,153,1.13 [0.69-1.83],0.6338750535279833
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPC5,Glypican-5,27586,152,0.93 [0.72-1.20],0.59185122038347
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPD1,Glycerol-3-phosphate dehydrogenase,24077,140,0.81 [0.58-1.12],0.203419463726598
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPHA2,Glycoprotein hormone alpha-2,24088,141,1.17 [0.88-1.55],0.2867767681145972
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPI,Glucose-6-phosphate isomerase,24226,140,0.77 [0.54-1.10],0.1469378571176354
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,24088,141,0.85 [0.69-1.05],0.1337345022883614
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPKOW,G-patch domain and KOW motifs-containing protein,27099,148,0.84 [0.49-1.45],0.5405538182440207
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPNMB,Transmembrane glycoprotein NMB,27025,149,0.72 [0.43-1.20],0.2100020743139988
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPR101,Probable G-protein coupled receptor 101,23430,140,0.97 [0.75-1.27],0.8459263098852039
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPR158,Probable G-protein coupled receptor 158,24175,141,0.96 [0.62-1.50],0.8655466757195601
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPR15L,Protein GPR15L,24088,141,1.00 [0.77-1.30],0.9912919819272806
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPR37,Prosaposin receptor GPR37,27269,150,0.99 [0.79-1.22],0.8977868051220375
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPRC5C,G-protein coupled receptor family C group 5 member C,24077,140,0.73 [0.53-1.02],0.0682203579074896
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GRAP2,GRB2-related adapter protein 2,27780,151,0.96 [0.86-1.08],0.5165390087212969
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,24214,140,0.87 [0.68-1.11],0.2653690579637995
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GRIK2,"Glutamate receptor ionotropic, kainate 2",24175,141,1.01 [0.70-1.47],0.9435971158640576
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",23430,140,0.74 [0.52-1.06],0.105142041543613
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GRK5,G protein-coupled receptor kinase 5,27269,150,0.96 [0.72-1.29],0.7832740312900529
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GRN,Progranulin,27658,153,0.86 [0.47-1.57],0.6220005155837176
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GRP,Gastrin-releasing peptide,23591,137,1.00 [0.74-1.35],0.985839745533792
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GRPEL1,"GrpE protein homolog 1, mitochondrial",27657,152,0.95 [0.75-1.22],0.7067558611098668
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GRSF1,G-rich sequence factor 1,23211,137,0.94 [0.76-1.16],0.5680453481408155
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GSAP,Gamma-secretase-activating protein,27127,147,0.99 [0.83-1.17],0.9022140775918404
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GSN,Gelsolin,24143,139,0.75 [0.35-1.63],0.4707294400582155
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GSR,"Glutathione reductase, mitochondrial",24083,139,0.56 [0.31-0.99],0.0457268601466262
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GSTA1,Glutathione S-transferase A1,27739,151,0.96 [0.80-1.14],0.6170337455370138
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GSTA3,Glutathione S-transferase A3,27127,147,1.03 [0.85-1.25],0.7528449977965025
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GSTM4,Glutathione S-transferase Mu 4,23445,136,1.14 [0.93-1.39],0.1958734613220705
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GSTP1,Glutathione S-transferase P,26930,146,0.93 [0.75-1.16],0.515180838910066
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GSTT2B,Glutathione S-transferase theta-2B,24158,142,0.97 [0.90-1.03],0.3199334966713754
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,23760,138,0.98 [0.78-1.23],0.87428594346179
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GTPBP2,GTP-binding protein 2,23536,141,0.90 [0.74-1.11],0.3395963833668316
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GUCA2A,Guanylin,27656,153,0.87 [0.57-1.34],0.5399807707763151
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GUCY2C,Heat-stable enterotoxin receptor,23760,138,0.96 [0.78-1.17],0.6604478545881847
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GUK1,Guanylate kinase,23445,136,1.27 [0.91-1.76],0.1595584949713147
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GUSB,Beta-glucuronidase,27906,155,0.79 [0.62-1.01],0.0588901786257692
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GYS1,"Glycogen [starch] synthase, muscle",27269,150,0.91 [0.77-1.06],0.2248665769411634
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GZMA,Granzyme A,28067,151,0.84 [0.56-1.26],0.4009567294193566
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GZMB,Granzyme B,27734,152,0.97 [0.77-1.22],0.7676941299128177
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GZMH,Granzyme H,27269,150,0.90 [0.73-1.11],0.3143815649934629
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,H2AP,Huntingtin-interacting protein M,23335,137,0.91 [0.64-1.31],0.6183684363776902
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",23445,136,1.13 [0.93-1.39],0.2244933278731222
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",27925,152,0.96 [0.79-1.16],0.6763688463257355
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HAO1,Hydroxyacid oxidase 1,28012,153,1.01 [0.91-1.13],0.8034293575277546
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HARS1,"Histidine--tRNA ligase, cytoplasmic",27784,153,0.89 [0.74-1.07],0.2326959492310204
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HAVCR1,Hepatitis A virus cellular receptor 1,27974,152,0.97 [0.77-1.23],0.8143821869909835
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HAVCR2,Hepatitis A virus cellular receptor 2,27784,153,0.93 [0.62-1.41],0.7495139643333144
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HBEGF,Proheparin-binding EGF-like growth factor,27925,152,0.90 [0.74-1.09],0.272016880943168
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HBQ1,Hemoglobin subunit theta-1,28012,153,0.92 [0.73-1.17],0.5078676143541079
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HBZ,Hemoglobin subunit zeta,24214,140,1.10 [0.95-1.28],0.2052738170415066
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HCG22,Protein PBMUCL2,23445,136,0.95 [0.69-1.33],0.7797077003321493
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HCLS1,Hematopoietic lineage cell-specific protein,28067,151,0.99 [0.77-1.28],0.93605654717899
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HDAC8,Histone deacetylase 8,23526,136,1.04 [0.81-1.34],0.7408093857950944
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HDAC9,Histone deacetylase 9,23430,140,0.99 [0.77-1.28],0.9638044687812676
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HDDC2,5'-deoxynucleotidase HDDC2,24088,141,1.01 [0.70-1.45],0.957804769402361
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HDGF,Hepatoma-derived growth factor,27977,153,0.94 [0.81-1.09],0.3857542424350612
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HDGFL2,Hepatoma-derived growth factor-related protein 2,24158,142,0.81 [0.62-1.06],0.1239397413561041
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HEBP1,Heme-binding protein 1,27269,150,0.97 [0.75-1.26],0.838371842430634
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HEG1,Protein HEG homolog 1,23702,141,0.44 [0.24-0.81],0.0081937674917378
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HEPACAM2,HEPACAM family member 2,24158,142,0.80 [0.54-1.19],0.275008428997106
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HEPH,Hephaestin,24214,140,0.92 [0.48-1.75],0.7967330859527963
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HEXIM1,Protein HEXIM1,27734,152,0.92 [0.77-1.10],0.3714063228990716
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HGF,Hepatocyte growth factor,28067,151,1.05 [0.69-1.60],0.8121045874451125
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HGFAC,Hepatocyte growth factor activator,23987,138,0.76 [0.48-1.21],0.2453306042691197
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,27127,147,0.95 [0.79-1.15],0.6289067801879322
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HHEX,Hematopoietically-expressed homeobox protein HHEX,24158,142,0.92 [0.74-1.14],0.433485051241557
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HIF1A,Hypoxia-inducible factor 1-alpha,23526,136,0.73 [0.53-1.01],0.0610803450581137
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HIP1,Huntingtin-interacting protein 1,23445,136,0.67 [0.38-1.18],0.1629562619727741
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HIP1R,Huntingtin-interacting protein 1-related protein,24115,142,0.80 [0.53-1.21],0.2917302306845766
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HJV,Hemojuvelin,24175,141,0.72 [0.48-1.07],0.1075436579744708
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HK2,Hexokinase-2,27269,150,1.19 [0.72-1.96],0.498340391189765
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",24175,141,0.89 [0.55-1.46],0.6555677299208109
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",27654,152,0.90 [0.60-1.33],0.5877903523631822
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",27734,152,0.78 [0.47-1.30],0.345139158131194
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HMBS,Porphobilinogen deaminase,28012,153,1.07 [0.79-1.46],0.6501280249954233
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HMCN2,Hemicentin-2,23659,140,0.85 [0.64-1.13],0.2601782346123288
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",23591,137,0.80 [0.57-1.14],0.2160408080606962
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",23445,136,1.30 [0.95-1.77],0.1012420750306479
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HMMR,Hyaluronan mediated motility receptor,23295,137,0.99 [0.71-1.39],0.967481340571935
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HMOX1,Heme oxygenase 1,27461,151,0.80 [0.58-1.10],0.173219316602523
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HMOX2,Heme oxygenase 2,27099,148,0.81 [0.57-1.14],0.2264593147535593
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HNF1A,Hepatocyte nuclear factor 1-alpha,23536,141,0.96 [0.76-1.22],0.742600658680812
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HNMT,Histamine N-methyltransferase,27450,152,0.85 [0.63-1.15],0.2966959900722357
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,27187,150,0.88 [0.73-1.07],0.2078801910264059
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,24175,141,0.74 [0.51-1.07],0.1057281785653618
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HPCAL1,Hippocalcin-like protein 1,28067,151,0.96 [0.79-1.16],0.6418833917023172
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HPGDS,Hematopoietic prostaglandin D synthase,27127,147,0.91 [0.62-1.36],0.6592709545512365
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HPSE,Heparanase,23878,140,0.83 [0.70-0.98],0.030773418235318
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HRAS,GTPase Hras,23714,138,0.91 [0.76-1.10],0.3318508802022271
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,23591,137,0.95 [0.60-1.51],0.842909149566993
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HRG,Histidine-rich glycoprotein,24118,142,1.10 [0.66-1.84],0.7079649541239592
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HS1BP3,HCLS1-binding protein 3,23591,137,0.93 [0.77-1.12],0.4320973968435907
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,27657,152,0.87 [0.59-1.26],0.4534735017997187
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,28012,153,0.87 [0.58-1.33],0.5263427447182389
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,23526,136,1.42 [0.85-2.37],0.1827303027550263
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSBP1,Heat shock factor-binding protein 1,23591,137,1.06 [0.89-1.26],0.5012386388341432
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,27734,152,0.90 [0.63-1.29],0.5624841584446381
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,24158,142,1.13 [0.88-1.45],0.3384523455066975
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSD17B3,Testosterone 17-beta-dehydrogenase 3,23445,136,0.93 [0.65-1.32],0.6777474947290496
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,23591,137,0.84 [0.59-1.20],0.3395963654588296
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSP90B1,Endoplasmin,26963,147,1.12 [0.93-1.34],0.2468217606022806
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSPA1A,Heat shock 70 kDa protein 1A,27878,151,0.86 [0.70-1.05],0.1407376676980166
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSPA2,Heat shock-related 70 kDa protein 2,24077,140,1.39 [0.91-2.11],0.1277807126622374
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSPB1,Heat shock protein beta-1,27327,151,1.01 [0.82-1.25],0.9153311495981272
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSPB6,Heat shock protein beta-6,28012,153,1.65 [1.15-2.35],0.006369350762094
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,27553,154,0.85 [0.48-1.52],0.5882164629835684
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HTR1A,5-hydroxytryptamine receptor 1A,23430,140,0.86 [0.67-1.09],0.2035831923402654
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HTR1B,5-hydroxytryptamine receptor 1B,23430,140,0.79 [0.52-1.20],0.2743977434667732
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HTRA2,"Serine protease HTRA2, mitochondrial",27877,155,0.79 [0.62-1.00],0.049165019879007
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HYAL1,Hyaluronidase-1,27597,155,0.73 [0.39-1.36],0.3157817992363595
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HYOU1,Hypoxia up-regulated protein 1,28118,155,0.57 [0.30-1.09],0.0895948632446806
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ICA1,Islet cell autoantigen 1,27224,148,0.95 [0.78-1.14],0.5619203235742048
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ICAM1,Intercellular adhesion molecule 1,27650,155,1.04 [0.64-1.71],0.8676062553954262
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ICAM2,Intercellular adhesion molecule 2,28118,155,0.77 [0.49-1.19],0.2368085158197629
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ICAM3,Intercellular adhesion molecule 3,28118,155,0.41 [0.23-0.73],0.0023833202787494
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ICAM4,Intercellular adhesion molecule 4,27734,152,0.86 [0.66-1.12],0.262736451816936
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ICAM5,Intercellular adhesion molecule 5,27780,151,0.79 [0.57-1.09],0.150824784106157
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ICOSLG,ICOS ligand,27657,152,0.99 [0.47-2.09],0.9796587171593972
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ID4,DNA-binding protein inhibitor ID-4,23760,138,1.11 [0.80-1.55],0.543396713135136
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IDI2,Isopentenyl-diphosphate delta-isomerase 2,27099,148,1.16 [0.87-1.55],0.3110366897568169
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IDO1,"Indoleamine 2,3-dioxygenase 1",23591,137,0.87 [0.66-1.13],0.2855153387009105
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IDS,Iduronate 2-sulfatase,28067,151,0.42 [0.13-1.31],0.1355218446982145
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IDUA,Alpha-L-iduronidase,28012,153,1.10 [0.81-1.51],0.538253786152257
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,23498,139,0.80 [0.52-1.24],0.3168418937590667
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,23760,138,1.06 [0.79-1.43],0.6962079167024057
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,23760,138,0.87 [0.55-1.36],0.5340459077485676
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFNAR1,Interferon alpha/beta receptor 1,24088,141,1.11 [0.61-2.00],0.7294195246441115
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFNG,Interferon gamma,27224,148,1.01 [0.89-1.15],0.827209270808029
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFNGR1,Interferon gamma receptor 1,27917,151,0.68 [0.33-1.39],0.2895403076030215
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFNGR2,Interferon gamma receptor 2,27586,152,0.81 [0.60-1.08],0.1492707503543049
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFNL1,Interferon lambda-1,27099,148,0.95 [0.69-1.32],0.7715179723990231
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFNL2,Interferon lambda-2,23430,140,1.01 [0.79-1.30],0.9070649374051228
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFNLR1,Interferon lambda receptor 1,27734,152,0.60 [0.38-0.92],0.0206339598293822
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFNW1,Interferon omega-1,23445,136,1.09 [0.72-1.65],0.6914416832133603
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFT20,Intraflagellar transport protein 20 homolog,23536,141,0.76 [0.51-1.13],0.1720852770031227
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGBP1,Immunoglobulin-binding protein 1,24175,141,0.88 [0.68-1.15],0.3592707129771918
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,23430,140,0.80 [0.54-1.19],0.268830066116482
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,24212,142,0.83 [0.45-1.54],0.557684363333746
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGF1R,Insulin-like growth factor 1 receptor,27657,152,0.71 [0.35-1.42],0.3313494050659657
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,23445,136,0.81 [0.54-1.21],0.3028284179545988
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGF2R,Cation-independent mannose-6-phosphate receptor,27784,153,0.56 [0.30-1.05],0.0694924372207596
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGFBP1,Insulin-like growth factor-binding protein 1,28068,153,0.95 [0.84-1.07],0.4138899569889298
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGFBP2,Insulin-like growth factor-binding protein 2,28071,154,1.05 [0.84-1.32],0.6566009661580845
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGFBP3,Insulin-like growth factor-binding protein 3,27874,155,0.92 [0.56-1.53],0.7567021390338993
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGFBP4,Insulin-like growth factor-binding protein 4,27409,151,0.88 [0.61-1.25],0.4633867206241522
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGFBP6,Insulin-like growth factor-binding protein 6,27646,154,0.95 [0.57-1.56],0.8282629296536029
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGFBP7,Insulin-like growth factor-binding protein 7,28118,155,0.91 [0.56-1.47],0.6888954827994171
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGFBPL1,Insulin-like growth factor-binding protein-like 1,27780,151,0.96 [0.63-1.47],0.8636295103936522
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGFL4,Insulin growth factor-like family member 4,23526,136,1.24 [1.07-1.44],0.0053092067595273
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGHMBP2,DNA-binding protein SMUBP-2,23445,136,0.76 [0.55-1.06],0.1083979745758276
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGLC2,Immunoglobulin lambda constant 2,24210,141,0.43 [0.18-1.05],0.0640149810812092
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGLON5,IgLON family member 5,23335,137,0.76 [0.59-0.97],0.0306907666687988
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGSF21,Immunoglobulin superfamily member 21,23591,137,1.09 [0.73-1.63],0.6597185219293183
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGSF3,Immunoglobulin superfamily member 3,27657,152,0.82 [0.53-1.28],0.3798145477628393
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGSF8,Immunoglobulin superfamily member 8,27780,151,0.51 [0.31-0.84],0.0084468232191726
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGSF9,Protein turtle homolog A,24214,140,0.81 [0.66-1.00],0.0457881998365713
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IKBKG,NF-kappa-B essential modulator,27734,152,0.97 [0.83-1.14],0.7215575874866316
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IKZF2,Zinc finger protein Helios,27127,147,1.01 [0.87-1.19],0.8686824983275583
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL10,Interleukin-10,27224,148,1.01 [0.85-1.19],0.9108828612421518
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL10RA,Interleukin-10 receptor subunit alpha,27224,148,0.98 [0.76-1.26],0.8714263165064686
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL10RB,Interleukin-10 receptor subunit beta,27917,151,0.91 [0.55-1.52],0.7297305412708643
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL11,Interleukin-11,27224,148,1.04 [0.83-1.29],0.75503221399289
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL12A_IL12B,Interleukin-12,27657,152,1.08 [0.91-1.29],0.3826310804042643
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL12B,Interleukin-12 subunit beta,28067,151,1.11 [0.85-1.44],0.4358715961014262
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL12RB1,Interleukin-12 receptor subunit beta-1,27224,148,1.20 [0.82-1.74],0.3493198126069732
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL12RB2,Interleukin-12 receptor subunit beta-2,23526,136,0.86 [0.57-1.29],0.4631013300455454
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL13,Interleukin-13,27224,148,0.98 [0.72-1.33],0.8899078215216758
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL13RA1,Interleukin-13 receptor subunit alpha-1,27441,153,0.97 [0.49-1.94],0.9323369086016496
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL13RA2,Interleukin-13 receptor subunit alpha-2,23430,140,0.53 [0.31-0.93],0.0273198086300376
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL15,Interleukin-15,27734,152,0.76 [0.49-1.19],0.2354284502415592
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL15RA,Interleukin-15 receptor subunit alpha,27224,148,0.89 [0.59-1.34],0.5690665115401565
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL16,Pro-interleukin-16,28067,151,0.74 [0.52-1.07],0.1110296823494134
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL17A,Interleukin-17A,27194,148,1.21 [0.90-1.62],0.2182484019804788
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL17C,Interleukin-17C,27224,148,1.07 [0.87-1.30],0.5286876741446989
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL17D,Interleukin-17D,27224,148,0.86 [0.53-1.39],0.5381446761945173
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL17F,Interleukin-17F,27224,148,0.99 [0.83-1.20],0.9487975937216492
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL17RA,Interleukin-17 receptor A,27784,153,0.92 [0.67-1.27],0.6203383481147879
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL17RB,Interleukin-17 receptor B,27381,150,1.12 [0.85-1.47],0.4111724219366253
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL18,Interleukin-18,27694,150,0.90 [0.66-1.22],0.486120269173982
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL18BP,Interleukin-18-binding protein,27874,155,1.21 [0.77-1.91],0.4026711608763689
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL18R1,Interleukin-18 receptor 1,28067,151,0.82 [0.53-1.27],0.3677630127312637
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL18RAP,Interleukin-18 receptor accessory protein,27412,152,0.99 [0.92-1.08],0.886523264118537
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL19,Interleukin-19,27087,144,0.97 [0.78-1.21],0.788541346910915
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL1A,Interleukin-1 alpha,27224,148,0.96 [0.73-1.26],0.7572965287360852
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL1B,Interleukin-1 beta,27092,145,0.80 [0.61-1.07],0.1296467210038551
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL1R1,Interleukin-1 receptor type 1,27742,153,1.07 [0.57-2.02],0.8356516837921834
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL1R2,Interleukin-1 receptor type 2,27739,151,0.91 [0.44-1.89],0.7985563676394429
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL1RAP,Interleukin-1 receptor accessory protein,27784,153,1.19 [0.86-1.64],0.2883714993979122
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL1RL1,Interleukin-1 receptor-like 1,28028,155,0.86 [0.63-1.17],0.3437115311135236
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL1RL2,Interleukin-1 receptor-like 2,27224,148,1.05 [0.72-1.52],0.8006883619879022
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL1RN,Interleukin-1 receptor antagonist protein,27740,151,0.96 [0.74-1.24],0.744393849336615
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL2,Interleukin-2,27224,148,0.98 [0.61-1.56],0.9218119703736508
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL20,Interleukin-20,27224,148,0.93 [0.68-1.25],0.6146120983970289
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL20RA,Interleukin-20 receptor subunit alpha,27224,148,1.19 [0.91-1.55],0.214414936987045
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL20RB,Interleukin-20 receptor subunit beta,23526,136,0.87 [0.59-1.31],0.5134247370489922
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL21R,Interleukin-21 receptor,23526,136,1.00 [0.74-1.34],0.9899248725118932
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL22,Interleukin-22,24077,140,0.97 [0.76-1.24],0.808390909155454
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL22RA1,Interleukin-22 receptor subunit alpha-1,27224,148,0.97 [0.68-1.36],0.840033794580952
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL24,Interleukin-24,27224,148,1.05 [0.79-1.40],0.7325374645506353
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL25,Interleukin-25,23256,137,0.64 [0.40-1.02],0.06031172879852
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL2RA,Interleukin-2 receptor subunit alpha,27564,152,0.89 [0.62-1.28],0.5448832127592722
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL2RB,Interleukin-2 receptor subunit beta,27224,148,1.06 [0.75-1.51],0.7266570943381186
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL2RG,Cytokine receptor common subunit gamma,24077,140,0.80 [0.50-1.29],0.3628105553924787
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL3,Interleukin-3,23335,137,1.39 [1.03-1.88],0.0288265199628622
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL31,Interleukin-31,23526,136,0.98 [0.73-1.31],0.8967455658118632
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL31RA,Interleukin-31 receptor subunit alpha,23429,136,0.71 [0.47-1.07],0.1007848257018804
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL32,Interleukin-32,27734,152,0.99 [0.71-1.39],0.9680880763645456
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL33,Interleukin-33,27224,148,0.83 [0.57-1.20],0.324952913447878
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL34,Interleukin-34,27057,147,1.41 [0.93-2.14],0.1077328838348949
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL36A,Interleukin-36 alpha,23526,136,1.06 [0.81-1.39],0.6563027668250065
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL36G,Interleukin-36 gamma,23426,136,1.06 [0.84-1.34],0.6123644832606385
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL3RA,Interleukin-3 receptor subunit alpha,27224,148,0.73 [0.46-1.17],0.1905634056835875
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL4,Interleukin-4,27224,148,0.96 [0.83-1.12],0.6122776178094131
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL4R,Interleukin-4 receptor subunit alpha,27734,152,1.03 [0.69-1.54],0.8862054163695198
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL5,Interleukin-5,27224,148,1.05 [0.95-1.15],0.345095844652474
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL5RA,Interleukin-5 receptor subunit alpha,27734,152,1.00 [0.77-1.30],0.9743156842978756
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL6,Interleukin-6,27657,152,1.05 [0.87-1.26],0.6388119114549689
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL6R,Interleukin-6 receptor subunit alpha,27599,155,1.02 [0.67-1.55],0.913992493235582
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL6ST,Interleukin-6 receptor subunit beta,27780,151,1.04 [0.46-2.37],0.9278357457117946
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL7,Interleukin-7,27734,152,0.84 [0.67-1.05],0.1326050734332011
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL7R,Interleukin-7 receptor subunit alpha,27784,153,1.01 [0.77-1.32],0.9415082714239608
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL9,Interleukin-9,23760,138,0.93 [0.69-1.26],0.6442821780476303
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,27061,147,0.90 [0.69-1.17],0.4123821338315807
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IMMT,MICOS complex subunit MIC60,24077,140,0.95 [0.66-1.39],0.804311640752702
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IMPA1,Inositol monophosphatase 1,27586,152,0.90 [0.71-1.15],0.4032947192004625
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IMPACT,Protein IMPACT,24158,142,0.82 [0.62-1.09],0.1716316398108683
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IMPG1,Interphotoreceptor matrix proteoglycan 1,23430,140,1.43 [0.94-2.18],0.0966397937106425
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ING1,Inhibitor of growth protein 1,27047,148,0.69 [0.48-0.99],0.0449390915807163
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,INHBB,Inhibin beta B chain,23702,141,0.89 [0.65-1.22],0.4598659173315846
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,INHBC,Inhibin beta C chain,27784,153,1.02 [0.73-1.43],0.9066490308152924
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,INPP1,Inositol polyphosphate 1-phosphatase,27657,152,0.80 [0.61-1.04],0.100141200530549
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",23591,137,1.01 [0.76-1.34],0.9581377984039308
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",24175,141,1.41 [1.08-1.85],0.01125340660794
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",27657,152,0.95 [0.82-1.10],0.4571478600751132
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,INSL3,Insulin-like 3,24158,142,0.75 [0.60-0.95],0.0152618745752915
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,INSL4,Early placenta insulin-like peptide,24077,140,0.81 [0.56-1.17],0.2557073543044387
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,INSL5,Insulin-like peptide INSL5,24088,141,0.96 [0.81-1.15],0.6809320683003037
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,INSR,Insulin receptor,23526,136,0.30 [0.11-0.82],0.0193992217932938
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IPCEF1,Interactor protein for cytohesin exchange factors 1,27544,152,0.97 [0.82-1.13],0.6681758969355016
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IQGAP2,Ras GTPase-activating-like protein IQGAP2,27657,152,0.92 [0.70-1.20],0.5387140966025172
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",27269,150,0.88 [0.74-1.05],0.1417670311152984
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IRAK1,Interleukin-1 receptor-associated kinase 1,27224,148,0.93 [0.75-1.15],0.5096795200378417
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IRAK4,Interleukin-1 receptor-associated kinase 4,27734,152,0.95 [0.83-1.09],0.4833545108852953
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,26716,145,0.78 [0.52-1.17],0.2315421196875717
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ISM1,Isthmin-1,27734,152,0.89 [0.61-1.29],0.5315840458526515
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ISM2,Isthmin-2,24212,142,0.71 [0.48-1.06],0.096602931304296
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IST1,IST1 homolog,23919,141,0.91 [0.77-1.06],0.2232378648971826
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGA11,Integrin alpha-11,27734,152,0.69 [0.46-1.05],0.0832212784233416
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGA2,Integrin alpha-2,23702,141,0.43 [0.27-0.68],0.0003615936007106
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGA5,Integrin alpha-5,27784,153,0.47 [0.26-0.84],0.0106448556349647
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGA6,Integrin alpha-6,27734,152,0.78 [0.58-1.04],0.08978502553269
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGAL,Integrin alpha-L,23526,136,0.65 [0.47-0.90],0.008503250310554
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGAM,Integrin alpha-M,27784,153,0.64 [0.40-1.01],0.0535509938750163
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGAV,Integrin alpha-V,28012,153,0.59 [0.33-1.06],0.0778811783600535
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGAX,Integrin alpha-X,23760,138,1.09 [0.82-1.45],0.5405782259581553
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGB1,Integrin beta-1,27736,155,0.59 [0.30-1.17],0.1304211093053462
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGB1BP1,Integrin beta-1-binding protein 1,27127,147,1.03 [0.72-1.46],0.8805462256548595
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGB1BP2,Integrin beta-1-binding protein 2,27269,150,0.98 [0.86-1.11],0.7238384546293306
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGB2,Integrin beta-2,27602,152,0.60 [0.36-1.00],0.049530858682734
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGB5,Integrin beta-5,27877,155,0.40 [0.27-0.59],7.047190942187301e-06
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGB6,Integrin beta-6,27224,148,0.52 [0.32-0.84],0.0077898334970677
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGB7,Integrin beta-7,28012,153,0.86 [0.63-1.19],0.3730073715531068
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGBL1,Integrin beta-like protein 1,24212,142,1.01 [0.64-1.59],0.96870676080344
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,24261,142,0.36 [0.15-0.84],0.0174944703210842
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,27874,155,1.04 [0.72-1.52],0.8223651758183276
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,24261,142,0.72 [0.38-1.34],0.2970963778007807
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,24077,140,0.66 [0.44-1.00],0.0483553744461279
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITM2A,Integral membrane protein 2A,27734,152,1.09 [0.85-1.38],0.5046688151366698
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITPA,Inosine triphosphate pyrophosphatase,23445,136,0.99 [0.77-1.26],0.9097828703550748
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",23591,137,0.85 [0.66-1.10],0.2072213710249695
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",23430,140,0.81 [0.54-1.20],0.2902993835475934
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",27099,148,1.01 [0.75-1.36],0.9483661461924378
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IZUMO1,Izumo sperm-egg fusion protein 1,23335,137,0.60 [0.38-0.95],0.0303715319307652
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,JAM2,Junctional adhesion molecule B,28018,153,0.87 [0.50-1.52],0.62742762026734
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,JAM3,Junctional adhesion molecule C,23702,141,0.59 [0.41-0.85],0.0043322920205494
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,JCHAIN,Immunoglobulin J chain,27224,148,0.92 [0.73-1.17],0.4949360611358648
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,23335,137,0.93 [0.69-1.26],0.6486109839547288
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,JPT2,Jupiter microtubule associated homolog 2,24088,141,0.88 [0.73-1.05],0.1538905007527551
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,JUN,Transcription factor AP-1,27224,148,0.82 [0.59-1.15],0.2475465832056593
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,27657,152,1.34 [0.96-1.87],0.0869945724262053
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KAZN,Kazrin,24088,141,0.95 [0.82-1.11],0.5386612829081145
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KCNC4,Potassium voltage-gated channel subfamily C member 4,23430,140,1.29 [1.04-1.60],0.0228126664135448
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KCNH2,Potassium voltage-gated channel subfamily H member 2,23536,141,0.95 [0.76-1.19],0.6687598940515682
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KCNIP4,Kv channel-interacting protein 4,27099,148,0.69 [0.48-1.00],0.0510752632912978
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KCTD5,BTB/POZ domain-containing protein KCTD5,23708,140,0.66 [0.44-0.99],0.046359993379213
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KDM3A,Lysine-specific demethylase 3A,23526,136,0.99 [0.83-1.19],0.9551097945654616
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KDR,Vascular endothelial growth factor receptor 2,27877,155,0.63 [0.37-1.08],0.0929060102756044
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KEL,Kell blood group glycoprotein,27099,148,0.68 [0.46-1.03],0.0664364987487512
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KHDC3L,KH domain-containing protein 3,23335,137,0.92 [0.71-1.20],0.5472820774197557
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KHK,Ketohexokinase,23591,137,0.94 [0.73-1.22],0.6459780908046489
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIAA0319,Dyslexia-associated protein KIAA0319,24158,142,0.65 [0.38-1.14],0.1313944831151566
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIAA1549,UPF0606 protein KIAA1549,23760,138,0.96 [0.77-1.21],0.7426538790446748
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIAA1549L,UPF0606 protein KIAA1549L,23760,138,0.98 [0.56-1.72],0.9510045415086812
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIAA2013,Uncharacterized protein KIAA2013,24077,140,1.06 [0.82-1.38],0.644608782775838
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIF1C,Kinesin-like protein KIF1C,23445,136,0.83 [0.50-1.37],0.4639029832255779
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIF20B,Kinesin-like protein KIF20B,23430,140,1.16 [0.97-1.39],0.0999497923077435
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIF22,Kinesin-like protein KIF22,23445,136,1.01 [0.88-1.15],0.9020865013293504
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIFBP,KIF-binding protein,27657,152,0.97 [0.82-1.15],0.7128021514581397
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,24077,140,1.00 [0.83-1.20],0.97965248094074
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,27127,147,1.12 [0.93-1.35],0.2288352186538431
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,24088,141,0.97 [0.89-1.07],0.5530716081643252
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,27127,147,1.06 [0.94-1.19],0.3415370240490842
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,23335,137,0.86 [0.69-1.09],0.2185954015007244
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIRREL1,Kin of IRRE-like protein 1,23430,140,1.16 [0.93-1.45],0.1767486451893483
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIRREL2,Kin of IRRE-like protein 2,27099,148,0.85 [0.59-1.24],0.4074354189295881
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIT,Mast/stem cell growth factor receptor Kit,27826,155,0.88 [0.55-1.41],0.5895626992259192
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KITLG,Kit ligand,27780,151,0.95 [0.64-1.41],0.8150984143370961
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLB,Beta-klotho,27099,148,1.07 [0.88-1.30],0.4988895029277587
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLF4,Krueppel-like factor 4,23430,140,0.99 [0.66-1.50],0.9654899288377762
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLHL41,Kelch-like protein 41,24175,141,1.03 [0.74-1.44],0.8508413806630717
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK1,Kallikrein-1,27501,153,0.96 [0.86-1.08],0.5164717409143509
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK10,Kallikrein-10,27784,155,0.79 [0.55-1.13],0.1997799952948021
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK11,Kallikrein-11,27612,154,0.70 [0.43-1.15],0.1597463196342743
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK12,Kallikrein-12,27127,147,0.99 [0.90-1.10],0.8905949180215116
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK13,Kallikrein-13,27175,147,0.96 [0.69-1.33],0.7967508884267293
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK14,Kallikrein-14,28012,153,0.82 [0.60-1.11],0.1995755403214431
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK15,Kallikrein-15,24038,140,0.95 [0.69-1.29],0.7308586178015276
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK3,Prostate-specific antigen,24212,142,0.69 [0.52-0.90],0.006787112806049
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK4,Kallikrein-4,28012,153,0.96 [0.76-1.22],0.7518164504798373
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK6,Kallikrein-6,27837,154,0.88 [0.55-1.40],0.5908047818119734
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK7,Kallikrein-7,23068,135,1.09 [0.71-1.67],0.6948566126029804
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK8,Kallikrein-8,26861,152,0.98 [0.65-1.47],0.9132827174262844
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLKB1,Plasma kallikrein,23771,139,0.50 [0.26-0.94],0.0315850249390034
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLRB1,Killer cell lectin-like receptor subfamily B member 1,28067,151,1.04 [0.71-1.52],0.8474896434724021
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,23430,140,0.94 [0.71-1.24],0.6627637202047123
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLRD1,Natural killer cells antigen CD94,28067,151,1.01 [0.74-1.38],0.948729822766438
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLRF1,Killer cell lectin-like receptor subfamily F member 1,23526,136,1.13 [0.80-1.61],0.479850478260407
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLRK1,NKG2-D type II integral membrane protein,24158,142,0.96 [0.68-1.36],0.8336377549059738
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KRT14,"Keratin, type I cytoskeletal 14",26221,145,0.96 [0.57-1.62],0.875873727833801
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KRT17,"Keratin, type I cytoskeletal 17",23445,136,1.45 [1.01-2.09],0.0463594909661274
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KRT18,"Keratin, type I cytoskeletal 18",27657,152,0.98 [0.82-1.18],0.8697469573874466
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KRT19,"Keratin, type I cytoskeletal 19",27692,152,0.96 [0.77-1.19],0.6867593836474024
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KRT5,"Keratin, type II cytoskeletal 5",27099,148,0.79 [0.58-1.08],0.1450049736504406
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KRT6C,"Keratin, type II cytoskeletal 6C",23445,136,1.14 [0.79-1.65],0.4924124363689304
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KRT8,"Keratin, type II cytoskeletal 8",23430,140,1.06 [0.84-1.33],0.6208020815743349
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KYAT1,Kynurenine--oxoglutarate transaminase 1,27733,151,0.80 [0.62-1.03],0.0847847723873045
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KYNU,Kynureninase,28067,151,0.84 [0.61-1.16],0.2837193761046002
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,L1CAM,Neural cell adhesion molecule L1,27877,155,0.75 [0.46-1.24],0.2644441340729117
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,24214,140,0.88 [0.73-1.05],0.1488324977493195
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LACRT,Extracellular glycoprotein lacritin,24032,140,1.07 [0.80-1.43],0.6554780992237544
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LACTB2,Endoribonuclease LACTB2,27780,151,0.89 [0.71-1.11],0.2910973453871696
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAG3,Lymphocyte activation gene 3 protein,27657,152,1.07 [0.76-1.52],0.7022121487424189
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,27782,151,0.71 [0.46-1.07],0.1017445975212871
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,27586,152,1.00 [0.87-1.15],0.9956887336852694
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAMA1,Laminin subunit alpha-1,23445,136,0.98 [0.72-1.33],0.904437476968462
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAMA4,Laminin subunit alpha-4,27917,151,0.67 [0.43-1.04],0.0759497736526017
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAMB1,Laminin subunit beta-1,23591,137,1.28 [0.73-2.23],0.3910630841030799
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAMP1,Lysosome-associated membrane glycoprotein 1,23532,137,0.42 [0.19-0.91],0.028854224665943
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAMP2,Lysosome-associated membrane glycoprotein 2,26935,146,0.72 [0.32-1.58],0.4101196719517243
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAMP3,Lysosome-associated membrane glycoprotein 3,28021,150,0.90 [0.68-1.19],0.4645244834551011
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAMTOR5,Ragulator complex protein LAMTOR5,24077,140,0.78 [0.51-1.19],0.2417087807734218
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAP3,Cytosol aminopeptidase,27224,148,0.99 [0.73-1.34],0.9404421213034648
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LARP1,La-related protein 1,24077,140,1.12 [0.89-1.41],0.3409158111725816
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAT,Linker for activation of T-cells family member 1,28067,151,0.93 [0.77-1.11],0.4111713539515876
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAT2,Linker for activation of T-cells family member 2,27657,152,0.96 [0.85-1.07],0.4513610869002386
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LATS1,Serine/threonine-protein kinase LATS1,23526,136,0.89 [0.73-1.08],0.2352718454448992
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAYN,Layilin,27534,152,1.06 [0.70-1.62],0.7690155874912307
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LBP,Lipopolysaccharide-binding protein,27874,155,0.95 [0.75-1.21],0.6944883630337919
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LBR,Delta(14)-sterol reductase LBR,28018,153,0.81 [0.64-1.02],0.0683071951793505
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LCAT,Phosphatidylcholine-sterol acyltransferase,24226,140,0.95 [0.46-1.97],0.8965833243613598
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LCN15,Lipocalin-15,24175,141,0.95 [0.72-1.24],0.6921289237362053
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LCN2,Neutrophil gelatinase-associated lipocalin,26933,151,1.18 [0.82-1.70],0.3822872339593778
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LCP1,Plastin-2,24212,142,0.48 [0.33-0.71],0.0002077158907179
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LDLR,Low-density lipoprotein receptor,27847,152,0.92 [0.70-1.21],0.5648282126609303
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LDLRAP1,Low density lipoprotein receptor adapter protein 1,24175,141,0.91 [0.77-1.07],0.2611467177808663
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LECT2,Leukocyte cell-derived chemotaxin-2,24214,140,0.80 [0.62-1.03],0.0866945941140278
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LEFTY2,Left-right determination factor 2,27963,153,0.76 [0.57-1.01],0.0543960708999254
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LEG1,Protein LEG1 homolog,22872,130,0.68 [0.52-0.88],0.0036178196268547
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LELP1,Late cornified envelope-like proline-rich protein 1,23430,140,0.94 [0.75-1.18],0.6170502832280748
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LEO1,RNA polymerase-associated protein LEO1,24175,141,0.87 [0.50-1.51],0.6180866854247651
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LEP,Leptin,27780,151,0.88 [0.70-1.10],0.2673891916181127
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LEPR,Leptin receptor,27780,151,0.63 [0.38-1.03],0.066184879362441
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LETM1,Mitochondrial proton/calcium exchanger protein,24175,141,0.86 [0.62-1.18],0.3495307483628737
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LGALS1,Galectin-1,27780,151,0.79 [0.51-1.22],0.2913617165414046
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LGALS3,Galectin-3,27840,154,0.74 [0.46-1.18],0.2073808652756866
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LGALS3BP,Galectin-3-binding protein,24261,142,0.41 [0.23-0.76],0.0043542759778756
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LGALS4,Galectin-4,27782,151,0.86 [0.65-1.13],0.283325515325419
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LGALS7_LGALS7B,Galectin-7,27695,151,1.15 [0.82-1.62],0.4146749756606404
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LGALS8,Galectin-8,28018,153,0.80 [0.62-1.02],0.071644573876211
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LGALS9,Galectin-9,27779,151,0.77 [0.49-1.22],0.2625457836548955
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LGMN,Legumain,27917,151,0.96 [0.64-1.43],0.8302535270237401
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LHB,Lutropin subunit beta,27127,147,1.13 [0.97-1.32],0.1091997331823501
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,27830,151,0.90 [0.70-1.15],0.3858111051296433
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LIF,Leukemia inhibitory factor,27099,148,1.02 [0.77-1.35],0.9029331684853854
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LIFR,Leukemia inhibitory factor receptor,27734,152,1.01 [0.56-1.83],0.9762967778972592
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,27784,153,0.69 [0.48-1.00],0.0508232162360585
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,24212,142,1.01 [0.90-1.13],0.8867623809608549
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,23445,136,0.85 [0.60-1.21],0.3746484717818015
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,27735,151,0.48 [0.31-0.76],0.0015662401606176
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,24214,140,0.94 [0.75-1.17],0.562151502043021
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,28118,155,0.75 [0.45-1.25],0.2624916316600658
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,27981,154,0.98 [0.65-1.48],0.9326697360917394
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,27224,148,0.91 [0.65-1.28],0.5958164271871276
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,28118,155,0.98 [0.80-1.19],0.8243669917073789
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LIPF,Gastric triacylglycerol lipase,23591,137,1.09 [0.83-1.42],0.541117483167582
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LMNB1,Lamin-B1,24041,141,1.04 [0.81-1.35],0.7419258425199714
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LMNB2,Lamin-B2,24158,142,0.76 [0.42-1.38],0.3643094079484869
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LMOD1,Leiomodin-1,24175,141,1.04 [0.67-1.62],0.8627399562911937
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LMOD2,Leiomodin-2,23430,140,0.69 [0.51-0.94],0.0177434809137502
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LONP1,"Lon protease homolog, mitochondrial",23591,137,0.93 [0.77-1.13],0.4619178134912882
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LPA,Apolipoprotein(a),23661,140,0.91 [0.83-0.99],0.034145818151613
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LPCAT2,Lysophosphatidylcholine acyltransferase 2,27657,152,0.77 [0.50-1.18],0.2272689388644993
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LPL,Lipoprotein lipase,27780,151,0.87 [0.64-1.18],0.3759370590487615
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LPO,Lactoperoxidase,26917,149,0.86 [0.67-1.11],0.2432447634618834
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LPP,Lipoma-preferred partner,23445,136,0.95 [0.74-1.22],0.701053864604152
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,23445,136,0.87 [0.67-1.11],0.2630392284516566
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,23536,141,0.61 [0.40-0.95],0.0286895175807641
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRG1,Leucine-rich alpha-2-glycoprotein,24261,142,0.78 [0.43-1.44],0.4347926118711326
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,27925,152,0.77 [0.51-1.18],0.2306039951927727
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,23435,136,1.15 [0.67-1.97],0.6057870551789799
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRP1,Prolow-density lipoprotein receptor-related protein 1,27657,152,0.86 [0.50-1.49],0.5950049023761649
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRP11,Low-density lipoprotein receptor-related protein 11,27780,151,0.84 [0.56-1.27],0.4140959859806132
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRP2,Low-density lipoprotein receptor-related protein 2,23536,141,0.99 [0.64-1.53],0.9675233504166784
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRP2BP,LRP2-binding protein,23536,141,1.09 [0.93-1.29],0.2746155240741632
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,28018,153,0.84 [0.63-1.10],0.2060746194919748
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRRC25,Leucine-rich repeat-containing protein 25,27657,152,1.02 [0.71-1.48],0.9085254067238792
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRRC37A2,Leucine-rich repeat-containing protein 37A2,24088,141,0.91 [0.62-1.33],0.6344445575950415
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRRC38,Leucine-rich repeat-containing protein 38,23536,141,0.92 [0.66-1.29],0.627740262695437
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRRC59,Leucine-rich repeat-containing protein 59,24214,140,0.76 [0.53-1.09],0.1394918494391917
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,24077,140,1.01 [0.72-1.41],0.95073969480368
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRRN1,Leucine-rich repeat neuronal protein 1,27224,148,0.90 [0.62-1.32],0.594456556605879
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,23536,141,1.10 [0.76-1.59],0.6151177151070892
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,24175,141,0.49 [0.25-0.94],0.0315633477554458
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LSM1,U6 snRNA-associated Sm-like protein LSm1,27127,147,1.04 [0.81-1.33],0.7615406477831668
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LSM8,U6 snRNA-associated Sm-like protein LSm8,23760,138,1.08 [0.92-1.27],0.3242236757289342
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LSP1,Lymphocyte-specific protein 1,27734,152,1.00 [0.70-1.42],0.9835657509158112
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LTA,Lymphotoxin-alpha,27734,152,1.37 [0.98-1.90],0.0640326621715862
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LTA4H,Leukotriene A-4 hydrolase,28012,153,0.97 [0.76-1.24],0.838295976637929
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LTB,Lymphotoxin-beta,24077,140,1.43 [1.04-1.98],0.029108864007129
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LTBP2,Latent-transforming growth factor beta-binding protein 2,28118,155,0.89 [0.56-1.39],0.5988240184655171
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LTBP3,Latent-transforming growth factor beta-binding protein 3,27127,147,1.13 [0.88-1.45],0.3486052669445811
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LTBR,Tumor necrosis factor receptor superfamily member 3,27653,151,0.77 [0.45-1.32],0.3490017582670771
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LTO1,Protein LTO1 homolog,27224,148,1.11 [0.80-1.53],0.5458616001187486
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LUZP2,Leucine zipper protein 2,24077,140,0.85 [0.58-1.24],0.3927070622116376
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LXN,Latexin,27460,152,1.02 [0.82-1.26],0.8715728451108908
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LY6D,Lymphocyte antigen 6D,27648,151,1.06 [0.72-1.55],0.7634544218425723
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LY75,Lymphocyte antigen 75,27734,152,1.07 [0.74-1.55],0.7243997801713569
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LY9,T-lymphocyte surface antigen Ly-9,27481,147,0.73 [0.44-1.22],0.2309042759243588
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LY96,Lymphocyte antigen 96,27586,152,0.74 [0.48-1.13],0.1636440596633182
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LYAR,Cell growth-regulating nucleolar protein,27127,147,0.80 [0.58-1.11],0.179026717649756
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LYN,Tyrosine-protein kinase Lyn,27657,152,0.94 [0.79-1.11],0.4464750092234749
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LYPD1,Ly6/PLAUR domain-containing protein 1,27099,148,0.88 [0.68-1.15],0.3463902716159147
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LYPD3,Ly6/PLAUR domain-containing protein 3,27649,155,1.05 [0.69-1.59],0.8348018838948982
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LYPD8,Ly6/PLAUR domain-containing protein 8,27127,147,1.23 [0.94-1.59],0.1269685050590016
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LYPLA2,Acyl-protein thioesterase 2,23430,140,1.06 [0.92-1.22],0.4003329954717952
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,23536,141,1.08 [0.94-1.25],0.268090999247374
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,24261,142,0.68 [0.30-1.54],0.3575491397948571
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LYZL2,Lysozyme-like protein 2,23335,137,0.60 [0.35-1.02],0.0583633726942696
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LZTFL1,Leucine zipper transcription factor-like protein 1,23702,141,0.80 [0.64-1.01],0.0644629779104444
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,M6PR,Cation-dependent mannose-6-phosphate receptor,23591,137,1.09 [0.75-1.58],0.6469739280897407
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,27490,152,0.71 [0.50-1.01],0.059443951572032
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAEA,E3 ubiquitin-protein transferase MAEA,27127,147,1.06 [0.74-1.50],0.7533863800166565
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAG,Myelin-associated glycoprotein,23536,141,1.20 [0.85-1.69],0.2982085925729567
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAGEA3,Melanoma-associated antigen 3,23760,138,0.99 [0.82-1.19],0.8780700305812976
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAGED1,Melanoma-associated antigen D1,27127,147,0.73 [0.53-1.01],0.0602649220877765
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAMDC2,MAM domain-containing protein 2,24214,140,0.97 [0.61-1.55],0.8975568156025534
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAMDC4,Apical endosomal glycoprotein,24077,140,0.89 [0.66-1.20],0.4411221455680583
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",23591,137,0.98 [0.52-1.87],0.9581413250037832
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAN2B2,Epididymis-specific alpha-mannosidase,24214,140,0.79 [0.60-1.03],0.0818350591163511
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",23335,137,0.90 [0.64-1.25],0.5120902783347919
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MANF,Mesencephalic astrocyte-derived neurotrophic factor,27917,151,0.94 [0.84-1.06],0.3291266699497523
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MANSC1,MANSC domain-containing protein 1,27877,155,0.68 [0.41-1.14],0.1463925641726289
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MANSC4,MANSC domain-containing protein 4,23445,136,1.02 [0.80-1.31],0.8480706316019544
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,23430,140,1.24 [0.75-2.05],0.4047738232258131
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,23445,136,0.82 [0.60-1.12],0.2059437157575887
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAP2,Microtubule-associated protein 2,24158,142,0.83 [0.57-1.21],0.3315901306246421
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,24088,141,0.85 [0.66-1.10],0.20886449157621
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,27734,152,0.92 [0.80-1.06],0.2374157894187945
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,27127,147,0.90 [0.77-1.05],0.1973807031346552
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,27534,152,0.95 [0.83-1.08],0.4205979195363324
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAPK13,Mitogen-activated protein kinase 13,23335,137,0.74 [0.49-1.11],0.1464117640121342
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAPK9,Mitogen-activated protein kinase 9,27734,152,0.73 [0.52-1.02],0.0617185725504601
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAPKAPK2,MAP kinase-activated protein kinase 2,23760,138,0.90 [0.72-1.13],0.3744922370129144
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAPRE3,Microtubule-associated protein RP/EB family member 3,23335,137,0.96 [0.85-1.08],0.5127500869952042
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAPT,Microtubule-associated protein tau,27099,148,1.19 [0.90-1.58],0.2165934757265626
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MARCO,Macrophage receptor MARCO,27780,151,0.90 [0.52-1.55],0.7139097699113598
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MARS1,"Methionine--tRNA ligase, cytoplasmic",23654,141,0.88 [0.73-1.07],0.2029637914055877
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MASP1,Mannan-binding lectin serine protease 1,27534,152,1.39 [0.75-2.57],0.2903913893949234
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MATN2,Matrilin-2,27831,151,1.05 [0.65-1.70],0.8483552930796134
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MATN3,Matrilin-3,27544,152,0.63 [0.40-1.00],0.048794545754658
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAVS,Mitochondrial antiviral-signaling protein,27127,147,0.97 [0.83-1.14],0.711071228222909
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAX,Protein max,27099,148,1.00 [0.87-1.15],0.9877871980057186
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MB,Myoglobin,28118,155,1.40 [1.09-1.80],0.0082794197454255
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MBL2,Mannose-binding protein C,23904,141,1.00 [0.86-1.16],0.9833015853807112
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MCAM,Cell surface glycoprotein MUC18,27874,155,0.88 [0.58-1.34],0.557811110594138
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",24175,141,1.08 [0.76-1.53],0.6728848901482305
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MCEMP1,Mast cell-expressed membrane protein 1,23526,136,0.91 [0.75-1.09],0.2909436003572205
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MCFD2,Multiple coagulation factor deficiency protein 2,27663,151,0.76 [0.54-1.07],0.1131941045405257
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MCTS1,Malignant T-cell-amplified sequence 1,24088,141,0.82 [0.42-1.58],0.5467050284272655
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,27586,152,1.16 [0.94-1.43],0.1570890328903233
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MDH1,"Malate dehydrogenase, cytoplasmic",24082,139,0.94 [0.63-1.40],0.7536955329565558
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MDK,Midkine,27798,155,0.99 [0.75-1.30],0.9231417869134064
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MDM1,Nuclear protein MDM1,23536,141,0.87 [0.51-1.47],0.596167643800009
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",23591,137,0.90 [0.75-1.09],0.2809751626123482
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MED18,Mediator of RNA polymerase II transcription subunit 18,27127,147,0.96 [0.79-1.17],0.6896083966307144
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MED21,Mediator of RNA polymerase II transcription subunit 21,23445,136,1.12 [0.83-1.50],0.4595534143823536
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MEGF10,Multiple epidermal growth factor-like domains protein 10,27782,151,1.76 [1.21-2.57],0.0032634929444197
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MEGF11,Multiple epidermal growth factor-like domains protein 11,23445,136,1.06 [0.67-1.70],0.7965385095699122
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MEGF9,Multiple epidermal growth factor-like domains protein 9,28028,155,0.41 [0.20-0.83],0.0138917744749065
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MELTF,Melanotransferrin,24214,140,0.85 [0.49-1.49],0.5734789096278288
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MENT,Protein MENT,23702,141,0.64 [0.31-1.32],0.2250615769750434
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MEP1A,Meprin A subunit alpha,24088,141,0.87 [0.68-1.11],0.254803135824626
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MEP1B,Meprin A subunit beta,27780,151,1.03 [0.91-1.16],0.6224782863107422
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MEPE,Matrix extracellular phosphoglycoprotein,27782,151,0.76 [0.46-1.28],0.3061483425190993
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MERTK,Tyrosine-protein kinase Mer,28067,151,0.65 [0.37-1.13],0.1272439146679306
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MESD,LRP chaperone MESD,27784,153,0.95 [0.84-1.06],0.3522079889087215
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MET,Hepatocyte growth factor receptor,27853,152,0.67 [0.33-1.36],0.269156370357376
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,METAP1,Methionine aminopeptidase 1,27099,148,1.06 [0.66-1.71],0.8063831078030254
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",27734,152,0.93 [0.78-1.11],0.4370323170159842
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,METAP2,Methionine aminopeptidase 2,27963,153,0.87 [0.69-1.11],0.2576565684622482
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MFAP3,Microfibril-associated glycoprotein 3,27269,150,0.74 [0.53-1.03],0.076062781342407
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MFAP3L,Microfibrillar-associated protein 3-like,23536,141,1.05 [0.84-1.32],0.6580396444287689
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MFAP4,Microfibril-associated glycoprotein 4,23702,141,0.93 [0.56-1.55],0.7814031644546706
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MFAP5,Microfibrillar-associated protein 5,28118,155,0.87 [0.62-1.22],0.4177959739235648
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MFGE8,Lactadherin,27784,153,0.73 [0.52-1.03],0.0722366182737849
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MGLL,Monoglyceride lipase,27869,151,0.92 [0.78-1.08],0.3304727414848693
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MGMT,Methylated-DNA--protein-cysteine methyltransferase,27734,152,1.00 [0.89-1.13],0.9695430270148332
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MIA,Melanoma-derived growth regulatory protein,27877,155,1.15 [0.79-1.68],0.4739428072284629
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MICALL2,MICAL-like protein 2,23536,141,0.85 [0.65-1.09],0.2027667285042854
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,27734,152,1.08 [0.97-1.20],0.1845224775666744
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MIF,Macrophage migration inhibitory factor,27745,153,0.91 [0.74-1.11],0.3455202759341657
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MILR1,Allergin-1,27224,148,0.96 [0.71-1.28],0.7615425099819436
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,24077,140,0.90 [0.77-1.04],0.1455917074453535
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MINK1,Misshapen-like kinase 1,24158,142,0.90 [0.76-1.07],0.2354306640712647
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MITD1,MIT domain-containing protein 1,27586,152,0.94 [0.81-1.08],0.3851164569985
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MKI67,Proliferation marker protein Ki-67,23526,136,0.57 [0.34-0.98],0.040121055983249
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MLLT1,Protein ENL,23335,137,1.00 [0.79-1.27],0.9889559503555108
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MLN,Promotilin,27734,152,0.99 [0.84-1.16],0.8541384808959196
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MME,Neprilysin,27657,152,0.89 [0.75-1.07],0.2240262166277183
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MMP1,Interstitial collagenase,26708,145,1.06 [0.90-1.25],0.4743366143055013
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MMP10,Stromelysin-2,27741,151,0.88 [0.68-1.12],0.2970481216360731
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MMP12,Macrophage metalloelastase,27788,151,0.82 [0.62-1.08],0.1542442716634952
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MMP13,Collagenase 3,27099,148,1.35 [0.87-2.09],0.1840652121107158
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MMP15,Matrix metalloproteinase-15,24214,140,0.91 [0.64-1.30],0.6110368063095875
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MMP3,Stromelysin-1,27784,153,0.92 [0.68-1.24],0.5809269708667949
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MMP7,Matrilysin,27222,149,0.80 [0.59-1.07],0.1244799065942679
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MMP8,Neutrophil collagenase,27971,153,1.02 [0.84-1.24],0.8454553689192716
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MMP9,Matrix metalloproteinase-9,27735,153,1.13 [0.89-1.43],0.3030048979048554
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",23445,136,0.70 [0.48-1.01],0.0552659316513899
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MN1,Transcriptional activator MN1,23536,141,1.22 [0.97-1.53],0.0875918901234928
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MNAT1,CDK-activating kinase assembly factor MAT1,23760,138,0.76 [0.50-1.14],0.1818900105548202
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MNDA,Myeloid cell nuclear differentiation antigen,27739,151,0.97 [0.84-1.12],0.7048561187461806
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MOCS2,Molybdopterin synthase catalytic subunit,23702,141,0.86 [0.67-1.10],0.2235365125250191
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MOG,Myelin-oligodendrocyte glycoprotein,28012,153,0.80 [0.52-1.24],0.3170441466938115
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MORC3,MORC family CW-type zinc finger protein 3,24158,142,1.03 [0.59-1.80],0.9109970979023518
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MORF4L1,Mortality factor 4-like protein 1,23760,138,0.88 [0.57-1.35],0.553063860518642
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MORF4L2,Mortality factor 4-like protein 2,23335,137,0.86 [0.54-1.37],0.5151774802721512
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MORN4,MORN repeat-containing protein 4,23335,137,1.16 [0.97-1.37],0.1010020898748738
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MPHOSPH8,M-phase phosphoprotein 8,27269,150,0.87 [0.71-1.06],0.1781244173654662
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MPI,Mannose-6-phosphate isomerase,27657,152,0.96 [0.81-1.14],0.6628834532730477
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,27869,151,0.93 [0.78-1.12],0.4696255740359397
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MPO,Myeloperoxidase,27784,153,1.21 [0.92-1.61],0.1783893030649461
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MPRIP,Myosin phosphatase Rho-interacting protein,24027,140,0.68 [0.46-0.99],0.0439649540549137
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MRC1,Macrophage mannose receptor 1,24226,140,0.80 [0.46-1.41],0.440132082456945
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MRI1,Methylthioribose-1-phosphate isomerase,23536,141,0.96 [0.76-1.22],0.7650863148090005
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MRPL24,"39S ribosomal protein L24, mitochondrial",23445,136,0.76 [0.47-1.23],0.2622395634783978
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MRPL28,"39S ribosomal protein L28, mitochondrial",24175,141,0.64 [0.35-1.18],0.1545590296974937
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MRPL46,"39S ribosomal protein L46, mitochondrial",27099,148,0.92 [0.54-1.58],0.766142732757236
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MRPL52,"39S ribosomal protein L52, mitochondrial",23295,137,0.77 [0.39-1.49],0.4308197482356546
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",24175,141,0.96 [0.76-1.20],0.7033492492100468
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MRPS16,"28S ribosomal protein S16, mitochondrial",23526,136,0.78 [0.42-1.47],0.4463469336379969
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MSLN,Mesothelin,27613,152,0.96 [0.74-1.24],0.7377937180281908
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MSLNL,Mesothelin-like protein,23536,141,1.07 [0.71-1.62],0.749033675938641
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MSMB,Beta-microseminoprotein,27684,152,0.85 [0.70-1.04],0.1162757403411831
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MSR1,Macrophage scavenger receptor types I and II,28018,153,1.13 [0.82-1.57],0.4465568339595145
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MSRA,Mitochondrial peptide methionine sulfoxide reductase,27877,155,0.86 [0.71-1.05],0.1387487376982031
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MST1,Hepatocyte growth factor-like protein,23849,137,0.95 [0.74-1.20],0.6521920565512302
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MSTN,Growth/differentiation factor 8,27269,150,0.72 [0.54-0.96],0.0250983169175639
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MTDH,Protein LYRIC,23526,136,0.90 [0.75-1.08],0.2781978901436565
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",24158,142,1.54 [1.04-2.27],0.0306344233078357
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,23760,138,0.93 [0.80-1.08],0.3412568202501227
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MTIF3,"Translation initiation factor IF-3, mitochondrial",24088,141,0.88 [0.73-1.06],0.1794742620896841
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MTPN,Myotrophin,27269,150,0.84 [0.53-1.36],0.4874257338293233
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MTR,Methionine synthase,23445,136,0.76 [0.55-1.03],0.0756278468480208
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MTSS1,Protein MTSS 1,24088,141,0.98 [0.84-1.13],0.7475545663595327
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MTSS2,Protein MTSS 2,24077,140,0.91 [0.77-1.07],0.2594895091107893
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MTUS1,Microtubule-associated tumor suppressor 1,23760,138,0.97 [0.72-1.30],0.845016302108708
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MUC13,Mucin-13,27099,148,0.83 [0.61-1.11],0.2095528583409312
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MUC16,Mucin-16,27657,152,0.96 [0.89-1.03],0.2348721122405245
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MUC2,Mucin-2,24212,142,0.92 [0.77-1.09],0.3259281565414995
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MUCL3,Mucin-like protein 3,23335,137,0.71 [0.45-1.12],0.1434170020951016
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MVK,Mevalonate kinase,27224,148,0.92 [0.76-1.11],0.3938070096212469
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MXRA8,Matrix remodeling-associated protein 8,23702,141,0.66 [0.39-1.11],0.1170398798074777
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYBPC1,"Myosin-binding protein C, slow-type",24214,140,1.57 [1.28-1.93],1.193540705708971e-05
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYBPC2,"Myosin-binding protein C, fast-type",23591,137,1.02 [0.84-1.24],0.8304035643238447
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,24175,141,0.96 [0.76-1.23],0.760147853734447
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYDGF,Myeloid-derived growth factor,24214,140,0.89 [0.75-1.04],0.1508613522422189
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYH4,Myosin-4,23445,136,0.92 [0.63-1.35],0.6807628019483036
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYH7B,Myosin-7B,23335,137,0.90 [0.61-1.32],0.5873058366038681
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYH9,Myosin-9,24212,142,0.83 [0.72-0.96],0.0131387381366283
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",23445,136,1.18 [0.85-1.64],0.3278102415211944
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYL3,Myosin light chain 3,23591,137,1.57 [1.26-1.95],4.66489331832556e-05
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYL4,Myosin light chain 4,23591,137,1.25 [0.96-1.64],0.1012722726190347
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYL6B,Myosin light chain 6B,23536,141,0.89 [0.73-1.08],0.2318664575912744
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",23536,141,1.19 [0.86-1.65],0.2886915708129399
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYO6,Unconventional myosin-VI,24175,141,0.60 [0.35-1.01],0.0568231666774819
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYO9B,Unconventional myosin-IXb,27224,148,0.95 [0.76-1.19],0.6679069352926632
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYOC,Myocilin,27784,153,0.87 [0.64-1.19],0.3743661598108023
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYOM1,Myomesin-1,23430,140,1.16 [0.86-1.57],0.3166975567235389
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYOM2,Myomesin-2,23445,136,1.40 [1.04-1.87],0.0269513245977822
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYOM3,Myomesin-3,23702,141,1.54 [1.30-1.81],4.234093168692753e-07
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MZB1,Marginal zone B- and B1-cell-specific protein,27879,151,0.74 [0.55-0.98],0.0372076724231139
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MZT1,Mitotic-spindle organizing protein 1,27127,147,0.82 [0.60-1.11],0.1914597947961909
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NAA10,N-alpha-acetyltransferase 10,23445,136,0.84 [0.61-1.16],0.2797648631579003
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NAA80,N-alpha-acetyltransferase 80,23536,141,0.89 [0.78-1.02],0.0955097967690079
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NAAA,N-acylethanolamine-hydrolyzing acid amidase,27455,152,0.90 [0.70-1.15],0.3867676253375132
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NACC1,Nucleus accumbens-associated protein 1,24077,140,0.76 [0.55-1.05],0.0939608720032111
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NADK,NAD kinase,27780,151,0.99 [0.77-1.28],0.956038613727504
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NAGA,Alpha-N-acetylgalactosaminidase,23476,136,0.75 [0.52-1.06],0.1013730000379255
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NAGK,N-acetyl-D-glucosamine kinase,23545,137,0.88 [0.66-1.19],0.4132090154125911
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,23702,141,0.78 [0.37-1.66],0.5164556094199572
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NAMPT,Nicotinamide phosphoribosyltransferase,27127,147,0.96 [0.73-1.26],0.7679874622707913
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NAP1L4,Nucleosome assembly protein 1-like 4,24047,141,0.88 [0.60-1.29],0.5116716639751071
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NAPRT,Nicotinate phosphoribosyltransferase,24158,142,0.86 [0.52-1.42],0.5637937704394497
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NARS1,"Asparagine--tRNA ligase, cytoplasmic",24175,141,0.96 [0.69-1.34],0.8210482185279175
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NBL1,Neuroblastoma suppressor of tumorigenicity 1,27877,155,0.72 [0.42-1.24],0.2341997448132608
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NBN,Nibrin,27224,148,1.02 [0.78-1.34],0.8758941267127229
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NCAM1,Neural cell adhesion molecule 1,27874,155,1.17 [0.71-1.94],0.5387016153580546
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NCAM2,Neural cell adhesion molecule 2,27784,153,1.00 [0.59-1.69],0.9899098735649808
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NCAN,Neurocan core protein,28018,153,0.56 [0.39-0.81],0.002229940870947
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NCF2,Neutrophil cytosol factor 2,27696,152,0.98 [0.83-1.16],0.811553462676785
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NCK2,Cytoplasmic protein NCK2,27917,151,0.96 [0.84-1.10],0.5873403864425752
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NCLN,Nicalin,27224,148,0.86 [0.63-1.19],0.3717237424550388
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NCR1,Natural cytotoxicity triggering receptor 1,27693,152,0.89 [0.60-1.32],0.5623049671150813
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,24088,141,1.08 [0.66-1.75],0.763401024791643
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NCS1,Neuronal calcium sensor 1,28012,153,0.80 [0.49-1.32],0.3831463503142405
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NDRG1,Protein NDRG1,27099,148,1.00 [0.81-1.23],0.977393969969808
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,24077,140,1.00 [0.78-1.28],0.997476776604422
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,23485,135,1.10 [0.69-1.75],0.6819172905613498
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,24088,141,0.82 [0.69-0.99],0.040145955730664
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",27127,147,1.10 [0.93-1.30],0.2466843060121362
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NEB,Nebulin,23445,136,1.18 [0.79-1.74],0.4167246521367469
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NECAP2,Adaptin ear-binding coat-associated protein 2,23445,136,0.80 [0.61-1.04],0.100051822121354
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NECTIN1,Nectin-1,23526,136,1.10 [0.67-1.81],0.6967259677078962
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NECTIN2,Nectin-2,27735,151,0.65 [0.39-1.08],0.0951202792578444
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NECTIN4,Nectin-4,27877,155,0.87 [0.54-1.41],0.5808031968020579
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,23526,136,0.92 [0.66-1.28],0.631624715157902
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NEDD9,Enhancer of filamentation 1,23526,136,0.88 [0.53-1.48],0.6307507370217236
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NEFL,Neurofilament light polypeptide,27010,147,3.41 [2.83-4.10],4.630984271305675e-38
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NEK7,Serine/threonine-protein kinase Nek7,23760,138,0.93 [0.74-1.17],0.5590030711352739
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NELL1,Protein kinase C-binding protein NELL1,27877,155,0.83 [0.60-1.15],0.2649961246568539
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NELL2,Protein kinase C-binding protein NELL2,27917,151,0.59 [0.35-0.99],0.0448556755431449
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NENF,Neudesin,24077,140,1.01 [0.87-1.16],0.9204046416543584
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NEO1,Neogenin,24175,141,1.02 [0.49-2.12],0.9545135883564894
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NEXN,Nexilin,24226,140,0.84 [0.66-1.07],0.1553761203934272
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFASC,Neurofascin,28067,151,0.59 [0.34-1.00],0.0519031079624415
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFAT5,Nuclear factor of activated T-cells 5,23526,136,0.87 [0.71-1.06],0.1713246452507803
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",27734,152,1.01 [0.87-1.18],0.8721604666021069
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",27224,148,0.82 [0.63-1.07],0.1516559565328397
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFE2,Transcription factor NF-E2 45 kDa subunit,23591,137,0.94 [0.75-1.18],0.5912342068843666
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFIC,Nuclear factor 1 C-type,24175,141,0.92 [0.62-1.37],0.6797949273774049
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFKB1,Nuclear factor NF-kappa-B p105 subunit,23445,136,0.88 [0.70-1.10],0.2699076132979173
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFKB2,Nuclear factor NF-kappa-B p100 subunit,23760,138,1.11 [0.87-1.43],0.3863803746458549
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFKBIE,NF-kappa-B inhibitor epsilon,27127,147,0.86 [0.63-1.17],0.3331306841083939
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",24088,141,0.90 [0.77-1.06],0.2151582857300816
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFX1,Transcriptional repressor NF-X1,23445,136,1.08 [0.85-1.38],0.5127373219097785
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFYA,Nuclear transcription factor Y subunit alpha,23445,136,0.69 [0.42-1.15],0.1534553210315795
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NGF,Beta-nerve growth factor,27586,152,1.78 [0.60-5.32],0.3020957478345285
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NGFR,Tumor necrosis factor receptor superfamily member 16,24214,140,0.70 [0.38-1.28],0.247472986359116
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NGRN,Neugrin,24158,142,1.03 [0.51-2.11],0.9311010549422888
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NHLRC3,NHL repeat-containing protein 3,23119,137,0.96 [0.57-1.62],0.8732260098086675
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NID1,Nidogen-1,27779,155,0.88 [0.62-1.26],0.4848138498519356
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NID2,Nidogen-2,27784,153,0.92 [0.76-1.11],0.372500598764399
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NINJ1,Ninjurin-1,27127,147,0.72 [0.51-1.01],0.0578480897021422
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NIT1,Deaminated glutathione amidase,23591,137,1.00 [0.71-1.39],0.9833068831761514
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NIT2,Omega-amidase NIT2,24128,140,0.90 [0.72-1.11],0.3154695340966422
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NLGN1,Neuroligin-1,23536,141,0.88 [0.67-1.15],0.337468213626294
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NLGN2,Neuroligin-2,23430,140,0.73 [0.49-1.09],0.1258547164160007
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NME1,Nucleoside diphosphate kinase A,23526,136,0.63 [0.28-1.37],0.2423715895680362
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NME3,Nucleoside diphosphate kinase 3,27831,151,0.76 [0.40-1.45],0.4103180815683549
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NMI,N-myc-interactor,23992,140,0.96 [0.76-1.20],0.7058108621930654
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,27586,152,1.01 [0.83-1.22],0.9415610719616628
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NMRK2,Nicotinamide riboside kinase 2,23335,137,0.89 [0.58-1.36],0.5785601989592761
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,24175,141,0.95 [0.74-1.22],0.6934486118671247
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NOMO1,Nodal modulator 1,27784,153,0.67 [0.36-1.23],0.1961812975909507
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NOP56,Nucleolar protein 56,23445,136,1.00 [0.86-1.16],0.9704279316296304
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NOS1,"Nitric oxide synthase, brain",27099,148,1.11 [0.83-1.49],0.4767995055583403
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NOS2,"Nitric oxide synthase, inducible",23445,136,0.87 [0.56-1.34],0.5144779072223187
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NOS3,"Nitric oxide synthase, endothelial",27099,148,1.04 [0.80-1.35],0.7893806597570181
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NOTCH1,Neurogenic locus notch homolog protein 1,28118,155,0.69 [0.27-1.72],0.4244579692926011
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NOTCH2,Neurogenic locus notch homolog protein 2,24212,142,1.20 [0.56-2.57],0.6362029508770108
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NOTCH3,Neurogenic locus notch homolog protein 3,28118,155,0.96 [0.64-1.45],0.8423180265839328
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPC2,NPC intracellular cholesterol transporter 2,23804,139,0.97 [0.58-1.63],0.9048410177217496
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPDC1,Neural proliferation differentiation and control protein 1,27780,151,0.82 [0.51-1.33],0.4296706048575296
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPHS1,Nephrin,23526,136,0.86 [0.52-1.41],0.5418530214603906
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPHS2,Podocin,23526,136,0.97 [0.83-1.14],0.7453816983250365
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPL,N-acetylneuraminate lyase,24214,140,0.78 [0.54-1.12],0.1791418771747371
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPPB,Natriuretic peptides B,27269,150,0.89 [0.80-0.98],0.0190105505999681
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPPC,C-type natriuretic peptide,27734,152,0.75 [0.53-1.06],0.1081400483583423
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPR1,Atrial natriuretic peptide receptor 1,23445,136,0.65 [0.39-1.07],0.0916277360048736
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPTN,Neuroplastin,27127,147,1.01 [0.85-1.20],0.9088429323085532
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPTX1,Neuronal pentraxin-1,27784,153,1.08 [0.75-1.55],0.6877705992960442
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPTX2,Neuronal pentraxin-2,24212,142,0.57 [0.35-0.94],0.0275231103418448
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPTXR,Neuronal pentraxin receptor,27780,151,0.49 [0.31-0.78],0.002671435356946
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPY,Pro-neuropeptide Y,28012,153,0.96 [0.77-1.19],0.6848455219336653
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NRCAM,Neuronal cell adhesion molecule,27780,151,1.30 [0.79-2.15],0.3003095677103236
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NRGN,Neurogranin,24226,140,0.92 [0.77-1.10],0.3717076153402159
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NRN1,Neuritin,24175,141,1.16 [0.80-1.68],0.4456774165892038
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NRP1,Neuropilin-1,27921,155,1.46 [0.89-2.39],0.1372843290079977
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NRP2,Neuropilin-2,27784,153,0.54 [0.32-0.90],0.0176857368979052
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NRTN,Neurturin,27224,148,0.87 [0.64-1.18],0.3640684983476957
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NRXN3,Neurexin-3,23536,141,1.06 [0.68-1.65],0.7907857127942479
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NSFL1C,NSFL1 cofactor p47,28018,153,0.88 [0.71-1.09],0.2353638438836068
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",24214,140,0.89 [0.72-1.10],0.2845649210732648
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NT5C1A,Cytosolic 5'-nucleotidase 1A,24158,142,0.82 [0.48-1.40],0.4680135049438716
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NT5C3A,Cytosolic 5'-nucleotidase 3A,27696,152,0.93 [0.79-1.09],0.3642547314314939
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NT5E,5'-nucleotidase,27877,155,1.00 [0.78-1.27],0.9851937553672948
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NTF3,Neurotrophin-3,27734,152,0.63 [0.42-0.96],0.0307384397443975
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NTF4,Neurotrophin-4,27127,147,1.04 [0.73-1.48],0.8139806179700617
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NTRK2,BDNF/NT-3 growth factors receptor,27780,151,0.76 [0.43-1.33],0.3348696823503491
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NTRK3,NT-3 growth factor receptor,28018,153,1.12 [0.58-2.16],0.7325994360761343
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NTproBNP,N-terminal prohormone of brain natriuretic peptide,27780,151,0.82 [0.71-0.96],0.011191224247059
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUB1,NEDD8 ultimate buster 1,27734,152,0.92 [0.77-1.10],0.348613113758531
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,24077,140,1.12 [0.96-1.30],0.1417373192936997
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUCB2,Nucleobindin-2,27962,153,0.80 [0.54-1.18],0.260955879388299
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUDC,Nuclear migration protein nudC,28067,151,0.90 [0.72-1.12],0.3500584849822575
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,23591,137,1.16 [0.66-2.03],0.6089451870832334
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,23445,136,0.74 [0.51-1.09],0.1291026193718024
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUDT16,U8 snoRNA-decapping enzyme,24046,140,0.89 [0.74-1.07],0.2272749400240953
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],27657,152,0.89 [0.69-1.15],0.3844441131569073
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUDT5,ADP-sugar pyrophosphatase,27784,153,0.97 [0.73-1.27],0.8087205128003947
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUMB,Protein numb homolog,23526,136,0.90 [0.74-1.09],0.2838064022470214
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUP50,Nuclear pore complex protein Nup50,23445,136,0.65 [0.36-1.18],0.1585724748064419
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NXPE4,NXPE family member 4,23445,136,1.20 [0.81-1.79],0.3699571751507797
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NXPH1,Neurexophilin-1,27099,148,1.03 [0.70-1.53],0.8685103468557311
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NXPH3,Neurexophilin-3,23526,136,0.63 [0.37-1.08],0.0921388598865332
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OBP2B,Odorant-binding protein 2b,27500,152,0.88 [0.71-1.09],0.2373008184507556
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OCLN,Occludin,24175,141,0.81 [0.55-1.19],0.2857526836093456
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ODAM,Odontogenic ameloblast-associated protein,27057,147,1.09 [0.85-1.39],0.5017191550732204
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OFD1,Oral-facial-digital syndrome 1 protein,23760,138,0.99 [0.78-1.27],0.9495338320003948
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OGA,Protein O-GlcNAcase,24088,141,0.92 [0.73-1.16],0.4995977192583342
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OGFR,Opioid growth factor receptor,27657,152,0.77 [0.50-1.20],0.2540497702251079
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OGN,Mimecan,27784,153,1.19 [0.84-1.68],0.3211565821113776
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,23760,138,1.07 [0.84-1.36],0.5673159415664418
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OLFM4,Olfactomedin-4,22815,133,1.04 [0.90-1.19],0.6245184595317836
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OLR1,Oxidized low-density lipoprotein receptor 1,27513,150,1.16 [0.93-1.46],0.1903526532990891
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OMD,Osteomodulin,27917,151,0.82 [0.60-1.12],0.2100106838644065
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OMG,Oligodendrocyte-myelin glycoprotein,27657,152,0.89 [0.71-1.12],0.3202012987578466
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OMP,Olfactory marker protein,23430,140,1.17 [0.88-1.56],0.2733979126681921
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OPHN1,Oligophrenin-1,24158,142,0.92 [0.79-1.06],0.2447441853885155
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OPLAH,5-oxoprolinase,23591,137,0.92 [0.72-1.17],0.4988098450884972
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OPTC,Opticin,27657,152,0.71 [0.50-1.00],0.0521922312111604
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ORM1,Alpha-1-acid glycoprotein 1,24178,142,1.38 [0.62-3.04],0.4311807922661003
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OSBPL2,Oxysterol-binding protein-related protein 2,24158,142,0.89 [0.58-1.36],0.591031023784861
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OSCAR,Osteoclast-associated immunoglobulin-like receptor,27831,151,0.79 [0.52-1.20],0.2705220943881946
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OSM,Oncostatin-M,27605,152,1.00 [0.82-1.22],0.9981032933214666
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OSMR,Oncostatin-M-specific receptor subunit beta,27921,155,1.15 [0.58-2.26],0.694054528455961
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OSTN,Osteocrin,23536,141,1.22 [0.88-1.68],0.2274977263338454
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OTOA,Otoancorin,23430,140,1.00 [0.74-1.35],0.9863298343013028
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OTUD6B,Deubiquitinase OTUD6B,24088,141,0.83 [0.63-1.09],0.1877403609574292
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OTUD7B,OTU domain-containing protein 7B,24175,141,0.92 [0.71-1.19],0.5175725525069703
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",23591,137,0.96 [0.75-1.23],0.763786130122496
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OXT,Oxytocin-neurophysin 1,28018,153,0.90 [0.81-1.01],0.0696616674868126
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,P4HB,Protein disulfide-isomerase,27655,155,0.65 [0.45-0.95],0.0252048094273617
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PACS2,Phosphofurin acidic cluster sorting protein 2,23445,136,0.95 [0.73-1.25],0.7150742067193576
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PADI2,Protein-arginine deiminase type-2,27224,148,1.00 [0.77-1.30],0.9898219043040994
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PADI4,Protein-arginine deiminase type-4,27057,147,1.03 [0.86-1.25],0.7324600734437093
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAEP,Glycodelin,27586,152,0.95 [0.84-1.08],0.4253890931922373
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,24175,141,1.01 [0.89-1.16],0.8271804443943562
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",23760,138,0.79 [0.56-1.12],0.1792639661493298
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,27269,150,0.83 [0.63-1.09],0.1731629700737769
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAGR1,PAXIP1-associated glutamate-rich protein 1,23591,137,0.84 [0.57-1.24],0.3933035694004532
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,23293,137,0.96 [0.70-1.33],0.8252000848122487
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAK4,Serine/threonine-protein kinase PAK 4,27099,148,0.86 [0.67-1.11],0.2518191368107051
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PALLD,Palladin,23526,136,0.90 [0.58-1.39],0.6349085181779048
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PALM,Paralemmin-1,23963,141,0.70 [0.41-1.19],0.1884749220710479
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PALM2,Paralemmin-2,24158,142,0.93 [0.60-1.45],0.760753209086733
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PALM3,Paralemmin-3,23445,136,0.97 [0.77-1.22],0.8035386395772435
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAM,Peptidyl-glycine alpha-amidating monooxygenase,27966,154,0.77 [0.48-1.25],0.2945569742645507
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAMR1,Inactive serine protease PAMR1,27784,153,0.78 [0.47-1.31],0.3549285149634599
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAPPA,Pappalysin-1,27224,148,0.85 [0.62-1.17],0.3231701094410419
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PARD3,Partitioning defective 3 homolog,23760,138,0.92 [0.73-1.16],0.4996986039621237
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PARK7,Parkinson disease protein 7,27784,153,0.94 [0.72-1.22],0.6242203450002406
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PARP1,Poly [ADP-ribose] polymerase 1,27734,152,0.78 [0.57-1.06],0.1143923803406016
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAXX,Protein PAXX,23702,141,0.58 [0.41-0.82],0.0022629758280586
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PBK,Lymphokine-activated killer T-cell-originated protein kinase,23335,137,0.88 [0.51-1.51],0.644440693819905
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PBLD,Phenazine biosynthesis-like domain-containing protein,27099,148,1.02 [0.76-1.35],0.919278776341362
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,24088,141,0.38 [0.20-0.71],0.0023249448334566
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCARE,Photoreceptor cilium actin regulator,23430,140,1.06 [0.90-1.26],0.4894113795523518
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,23658,140,0.85 [0.59-1.22],0.3723453014129448
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCBP2,Poly(rC)-binding protein 2,24175,141,0.88 [0.70-1.10],0.2598571849131847
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCDH1,Protocadherin-1,27978,150,1.00 [0.52-1.93],0.9940070875258868
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCDH12,Protocadherin-12,24175,141,1.17 [0.63-2.18],0.6218558691516539
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCDH17,Protocadherin-17,27780,151,1.08 [0.72-1.63],0.7084528177724969
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCDH7,Protocadherin-7,24088,141,0.84 [0.51-1.38],0.488795805032266
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCDH9,Protocadherin-9,24088,141,1.08 [0.67-1.73],0.7636742410794315
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCDHB15,Protocadherin beta-15,24077,140,0.88 [0.58-1.33],0.5482775041964703
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCNA,Proliferating cell nuclear antigen,23335,137,0.74 [0.53-1.04],0.0842902145057076
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCSK7,Proprotein convertase subtilisin/kexin type 7,24077,140,0.97 [0.67-1.38],0.8470044598376721
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCSK9,Proprotein convertase subtilisin/kexin type 9,28118,155,0.77 [0.54-1.11],0.1671398758820805
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCYT2,Ethanolamine-phosphate cytidylyltransferase,24088,141,0.83 [0.67-1.02],0.0777879226943937
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDAP1,28 kDa heat- and acid-stable phosphoprotein,24214,140,0.91 [0.77-1.07],0.241003859049841
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDCD1,Programmed cell death protein 1,27971,153,0.98 [0.70-1.36],0.8912717517383264
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDCD1LG2,Programmed cell death 1 ligand 2,27657,152,1.18 [0.75-1.86],0.4693038691068075
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDCD5,Programmed cell death protein 5,28018,153,0.87 [0.68-1.11],0.2675014348288843
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDCD6,Programmed cell death protein 6,27780,151,0.96 [0.79-1.17],0.6870111757771079
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDCL2,Phosducin-like protein 2,23335,137,1.06 [0.80-1.41],0.6630750417482671
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",23335,137,1.16 [0.92-1.48],0.2142375106829444
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",23445,136,0.88 [0.65-1.19],0.4036659920650134
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",23702,141,0.95 [0.81-1.10],0.4716492815662959
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDGFA,Platelet-derived growth factor subunit A,28118,155,0.82 [0.68-1.00],0.0453892966686774
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDGFB,Platelet-derived growth factor subunit B,27917,151,0.89 [0.76-1.05],0.1777989397499784
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDGFC,Platelet-derived growth factor C,27127,147,1.00 [0.61-1.64],0.9876141350219796
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDGFRA,Platelet-derived growth factor receptor alpha,27780,151,0.74 [0.44-1.23],0.2394199056412291
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDGFRB,Platelet-derived growth factor receptor beta,28118,155,0.88 [0.59-1.32],0.5383867539607574
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDIA2,Protein disulfide-isomerase A2,23335,137,1.16 [0.81-1.67],0.4259708993350516
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDIA3,Protein disulfide-isomerase A3,23702,141,0.51 [0.26-1.03],0.0607175020441309
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDIA4,Protein disulfide-isomerase A4,24212,142,0.73 [0.55-0.96],0.0250513754690458
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDIA5,Protein disulfide-isomerase A5,23335,137,0.84 [0.62-1.13],0.2477432923879643
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDLIM5,PDZ and LIM domain protein 5,24175,141,0.96 [0.84-1.10],0.5835736723500461
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDLIM7,PDZ and LIM domain protein 7,27917,151,0.94 [0.84-1.06],0.3265228063402656
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",27127,147,0.94 [0.69-1.27],0.6754969372068224
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDRG1,p53 and DNA damage-regulated protein 1,23536,141,0.90 [0.65-1.25],0.5363609261251849
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,23335,137,0.54 [0.33-0.88],0.0134299904165644
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDZD2,PDZ domain-containing protein 2,23445,136,0.89 [0.67-1.19],0.4511895956349396
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,23526,136,0.63 [0.41-0.98],0.0400921712712104
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PEAR1,Platelet endothelial aggregation receptor 1,28118,155,0.74 [0.40-1.38],0.3477590968321866
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PEBP1,Phosphatidylethanolamine-binding protein 1,27784,153,0.89 [0.70-1.14],0.3702862187080147
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PECAM1,Platelet endothelial cell adhesion molecule,27784,153,0.57 [0.35-0.92],0.0227112701620123
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PECR,Peroxisomal trans-2-enoyl-CoA reductase,23591,137,0.65 [0.35-1.23],0.1877537636903511
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PENK,Proenkephalin-A,23702,141,0.71 [0.41-1.23],0.2213310390757441
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PEPD,Xaa-Pro dipeptidase,24226,140,0.86 [0.46-1.60],0.6293487296452278
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PER3,Period circadian protein homolog 3,23526,136,1.02 [0.89-1.17],0.7714199113112671
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PF4,Platelet factor 4,24084,142,0.84 [0.71-0.99],0.0392741028071911
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PFDN2,Prefoldin subunit 2,27099,148,0.91 [0.70-1.19],0.4923741231975199
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PFDN4,Prefoldin subunit 4,23335,137,0.86 [0.62-1.20],0.3781224307001972
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PFDN6,Prefoldin subunit 6,23536,141,1.11 [0.89-1.37],0.3566409059776049
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",27609,151,0.94 [0.78-1.14],0.5385296972815863
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PGA4,Pepsin A-4,24226,140,1.01 [0.81-1.26],0.942694657282381
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",24214,140,1.00 [0.75-1.35],0.977130534847177
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PGF,Placenta growth factor,28067,151,0.66 [0.36-1.22],0.1862373181931911
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PGLYRP1,Peptidoglycan recognition protein 1,27981,154,0.89 [0.63-1.25],0.4994970093255054
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,23949,140,0.78 [0.47-1.31],0.3526683603233047
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PGLYRP4,Peptidoglycan recognition protein 4,23445,136,1.11 [0.88-1.40],0.3818175806077084
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PGM2,Phosphoglucomutase-2,23536,141,1.03 [0.79-1.34],0.8256498915151995
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PGR,Progesterone receptor,23526,136,0.98 [0.83-1.15],0.7702307887706791
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PHACTR2,Phosphatase and actin regulator 2,24175,141,0.98 [0.85-1.13],0.7572355296548086
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PHLDB1,Pleckstrin homology-like domain family B member 1,24088,141,0.89 [0.65-1.22],0.4684992037672008
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PHLDB2,Pleckstrin homology-like domain family B member 2,23335,137,0.92 [0.77-1.12],0.41144664053578
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,27586,152,1.50 [0.94-2.40],0.0867910602377176
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,23702,141,0.69 [0.47-1.01],0.058114702425086
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PI16,Peptidase inhibitor 16,24226,140,0.66 [0.35-1.25],0.2047495277063354
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PI3,Elafin,27407,152,1.05 [0.80-1.36],0.744048016631953
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",24175,141,0.91 [0.73-1.12],0.3508655430963106
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PIGR,Polymeric immunoglobulin receptor,27424,150,0.85 [0.56-1.28],0.4358831871542595
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,27734,152,1.01 [0.80-1.27],0.9397320545214208
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,27784,153,0.90 [0.52-1.56],0.7105877443571609
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,23526,136,0.81 [0.58-1.12],0.1973346762492116
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PILRA,Paired immunoglobulin-like type 2 receptor alpha,27784,153,0.90 [0.64-1.26],0.5250018505845986
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PILRB,Paired immunoglobulin-like type 2 receptor beta,27780,151,0.96 [0.75-1.23],0.737936393553179
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,23702,141,0.88 [0.70-1.11],0.2760918911233886
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PITHD1,PITH domain-containing protein 1,23293,137,1.07 [0.89-1.29],0.4589865088459477
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PKD1,Polycystin-1,24214,140,0.87 [0.47-1.61],0.6501920353341936
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PKD2,Polycystin-2,23445,136,0.79 [0.58-1.07],0.1322362730757368
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PKLR,Pyruvate kinase PKLR,27830,151,1.08 [0.88-1.32],0.4826472584100352
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PKN3,Serine/threonine-protein kinase N3,23760,138,1.04 [0.84-1.28],0.7047132819367834
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLA2G10,Group 10 secretory phospholipase A2,27586,152,1.04 [0.82-1.32],0.7517454990307821
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLA2G15,Phospholipase A2 group XV,27877,155,0.95 [0.55-1.64],0.8516671024898363
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLA2G1B,Phospholipase A2,28068,155,0.75 [0.54-1.03],0.0776968200083465
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLA2G2A,"Phospholipase A2, membrane associated",27697,153,0.91 [0.70-1.18],0.4659356694794457
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLA2G4A,Cytosolic phospholipase A2,27917,151,0.91 [0.77-1.07],0.2539400061430661
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLA2G7,Platelet-activating factor acetylhydrolase,27784,153,0.94 [0.60-1.47],0.7891679447804569
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLAT,Tissue-type plasminogen activator,28028,155,0.77 [0.58-1.01],0.0628939760027099
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLAU,Urokinase-type plasminogen activator,27784,153,0.86 [0.52-1.41],0.5404849389386404
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLAUR,Urokinase plasminogen activator surface receptor,27604,151,1.03 [0.60-1.76],0.9179848645411914
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLB1,"Phospholipase B1, membrane-associated",24158,142,0.98 [0.75-1.28],0.8727455749682786
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",23526,136,1.01 [0.71-1.44],0.9636193811085768
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",24158,142,0.85 [0.72-1.00],0.0549641157412758
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLEKHO1,Pleckstrin homology domain-containing family O member 1,24158,142,0.83 [0.65-1.05],0.1279119933793056
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLG,Plasminogen,23627,139,0.48 [0.24-0.98],0.0445588604267964
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLIN1,Perilipin-1,27099,148,0.72 [0.46-1.13],0.1554788783351074
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLIN3,Perilipin-3,27780,151,0.77 [0.54-1.09],0.1387788205267217
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLPBP,Pyridoxal phosphate homeostasis protein,27780,151,0.87 [0.71-1.08],0.2106010484454347
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLSCR3,Phospholipid scramblase 3,24118,142,0.85 [0.64-1.12],0.2392668701952306
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLTP,Phospholipid transfer protein,28019,154,0.91 [0.61-1.37],0.6573775784625482
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLXDC1,Plexin domain-containing protein 1,27127,147,0.57 [0.34-0.98],0.0402031622413768
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLXDC2,Plexin domain-containing protein 2,24158,142,0.91 [0.50-1.65],0.7477548937661329
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLXNA4,Plexin-A4,27734,152,0.85 [0.72-1.01],0.0651351508720808
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLXNB2,Plexin-B2,27984,155,1.03 [0.56-1.88],0.9261976310067987
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLXNB3,Plexin-B3,27690,151,0.75 [0.55-1.03],0.0797554823205458
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,27639,151,1.03 [0.95-1.12],0.4808606813456193
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PMCH,Pro-MCH,23445,136,1.02 [0.84-1.23],0.8743188415371994
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PMM2,Phosphomannomutase 2,23445,136,0.99 [0.75-1.30],0.9299077073331832
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PMS1,PMS1 protein homolog 1,23536,141,0.86 [0.61-1.20],0.3772506993910379
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PMVK,Phosphomevalonate kinase,27054,148,0.97 [0.85-1.10],0.6280317403934998
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PNLIP,Pancreatic triacylglycerol lipase,24226,140,0.79 [0.60-1.03],0.0763646349041903
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PNLIPRP1,Inactive pancreatic lipase-related protein 1,24158,142,0.76 [0.62-0.94],0.0116410505365234
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PNLIPRP2,Pancreatic lipase-related protein 2,27782,151,0.98 [0.94-1.03],0.4542389368532077
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PNMA1,Paraneoplastic antigen Ma1,23591,137,0.87 [0.64-1.18],0.3718163984076917
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PNMA2,Paraneoplastic antigen Ma2,23430,140,1.25 [0.90-1.74],0.1780949652544828
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",27224,148,0.95 [0.84-1.08],0.4504298574559771
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PODXL,Podocalyxin,27657,152,0.42 [0.16-1.05],0.062928377178474
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PODXL2,Podocalyxin-like protein 2,27877,155,0.54 [0.33-0.91],0.0203898769480899
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,POF1B,Protein POF1B,23526,136,1.03 [0.72-1.45],0.8893460847992706
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,POLR2A,DNA-directed RNA polymerase II subunit RPB1,23526,136,0.92 [0.52-1.61],0.7588363295899632
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",27657,152,0.68 [0.41-1.11],0.1231568160339928
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,POMC,Pro-opiomelanocortin,23591,137,1.10 [0.87-1.41],0.4220129983544474
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PON1,Serum paraoxonase/arylesterase 1,24226,140,0.69 [0.39-1.22],0.2040128930057837
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PON2,Serum paraoxonase/arylesterase 2,27269,150,0.95 [0.62-1.44],0.7952535918612826
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PON3,Serum paraoxonase/lactonase 3,27917,151,0.85 [0.53-1.34],0.478722987149947
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,POSTN,Periostin,24212,142,0.62 [0.40-0.96],0.0323143430486919
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPBP,Platelet basic protein,24084,142,0.79 [0.66-0.95],0.0127903943048824
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPCDC,Phosphopantothenoylcysteine decarboxylase,28018,153,0.84 [0.62-1.13],0.2515691738626385
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPIB,Peptidyl-prolyl cis-trans isomerase B,27795,151,0.90 [0.77-1.04],0.1554990921935693
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPIE,Peptidyl-prolyl cis-trans isomerase E,23760,138,0.98 [0.76-1.27],0.8859157194957652
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",24212,142,0.73 [0.55-0.98],0.034634696906079
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPL,Periplakin,23526,136,0.91 [0.55-1.51],0.7053593908824808
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPM1A,Protein phosphatase 1A,27127,147,0.84 [0.51-1.38],0.4851602125617534
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPM1B,Protein phosphatase 1B,23526,136,1.01 [0.78-1.31],0.9336931658996632
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPM1F,Protein phosphatase 1F,24214,140,0.80 [0.59-1.10],0.1654019961513836
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPME1,Protein phosphatase methylesterase 1,27657,152,0.97 [0.77-1.22],0.782199209329938
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,24077,140,0.94 [0.77-1.14],0.5122256425340534
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,27877,155,0.86 [0.74-1.00],0.0558469722245596
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,23760,138,0.84 [0.65-1.09],0.1987821796342197
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,24175,141,0.89 [0.72-1.10],0.2710530534140222
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,24175,141,1.02 [0.67-1.54],0.9423024637979844
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPP1R2,Protein phosphatase inhibitor 2,27780,151,0.93 [0.77-1.11],0.4245782883402
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPP1R9B,Neurabin-2,28067,151,0.92 [0.79-1.07],0.2636858474764403
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,24088,141,0.92 [0.80-1.06],0.249592491672906
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPP3R1,Calcineurin subunit B type 1,27586,152,0.83 [0.58-1.17],0.2834533020143361
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPT1,Palmitoyl-protein thioesterase 1,23536,141,0.95 [0.76-1.18],0.6233803197104819
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPY,Pancreatic prohormone,27769,155,0.99 [0.86-1.14],0.8700153273515768
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PQBP1,Polyglutamine-binding protein 1,27127,147,0.71 [0.52-0.96],0.0284705538352024
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRAME,Melanoma antigen preferentially expressed in tumors,23335,137,0.52 [0.27-1.00],0.0502082679648589
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRAP1,Proline-rich acidic protein 1,24212,142,1.07 [0.73-1.57],0.732641836544748
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRC1,Protein regulator of cytokinesis 1,24077,140,1.02 [0.73-1.42],0.9244227140130488
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRCP,Lysosomal Pro-X carboxypeptidase,27946,155,0.82 [0.52-1.31],0.4083597456357136
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRDX1,Peroxiredoxin-1,27022,149,0.91 [0.77-1.08],0.299577781454157
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRDX2,Peroxiredoxin-2,23817,134,0.99 [0.77-1.28],0.967510803522884
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",27224,148,0.86 [0.70-1.06],0.1591159487607727
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRDX5,"Peroxiredoxin-5, mitochondrial",28067,151,0.93 [0.76-1.14],0.499583279383503
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRDX6,Peroxiredoxin-6,28012,153,0.98 [0.77-1.24],0.8576845248098576
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PREB,Prolactin regulatory element-binding protein,27224,148,1.00 [0.62-1.63],0.9961020091263104
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRELP,Prolargin,27782,151,0.88 [0.48-1.59],0.6615043159792904
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRG2,Bone marrow proteoglycan,24212,142,1.15 [0.85-1.55],0.3711730611526096
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRG3,Proteoglycan 3,24212,142,0.89 [0.64-1.22],0.4647362548559438
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,27224,148,0.93 [0.70-1.22],0.5847606050956653
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,23536,141,1.44 [0.95-2.16],0.0832648402965524
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,27780,151,0.88 [0.74-1.05],0.1486247636571191
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,24117,142,0.92 [0.76-1.11],0.3974557222019255
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRKCQ,Protein kinase C theta type,27224,148,0.99 [0.71-1.38],0.9452462860631604
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRKD2,Serine/threonine-protein kinase D2,23445,136,0.86 [0.58-1.27],0.4354394693390597
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRKG1,cGMP-dependent protein kinase 1,23702,141,0.92 [0.81-1.04],0.1917500768933035
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,27127,147,0.96 [0.77-1.19],0.6888231630845378
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRL,Prolactin,28018,153,1.05 [0.87-1.27],0.585678286571591
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRND,Prion-like protein doppel,24158,142,1.05 [0.78-1.41],0.7649317733707549
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PROC,Vitamin K-dependent protein C,27826,155,1.30 [0.73-2.31],0.3669729507106253
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PROCR,Endothelial protein C receptor,23445,136,0.92 [0.57-1.49],0.7345033875142792
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PROK1,Prokineticin-1,27734,152,0.93 [0.75-1.17],0.5477265376107542
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PROS1,Vitamin K-dependent protein S,24261,142,0.66 [0.34-1.28],0.2175919981422291
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRR4,Proline-rich protein 4,23532,141,0.76 [0.59-0.97],0.028550915737632
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRR5,Proline-rich protein 5,23526,136,0.92 [0.64-1.33],0.6713584653751474
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRRT3,Proline-rich transmembrane protein 3,23591,137,0.77 [0.50-1.20],0.2519919586146887
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRSS2,Trypsin-2,27874,155,0.71 [0.53-0.95],0.019718411803824
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRSS22,Brain-specific serine protease 4,23526,136,0.90 [0.55-1.46],0.6571706057357606
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRSS27,Serine protease 27,27691,151,0.85 [0.59-1.21],0.3612325805556918
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRSS53,Serine protease 53,24158,142,1.04 [0.67-1.60],0.8638121837326309
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRSS8,Prostasin,27691,151,0.84 [0.59-1.20],0.333813284271877
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,27099,148,0.98 [0.86-1.11],0.709976632349977
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRTG,Protogenin,28012,153,1.06 [0.60-1.87],0.8416213466230935
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRTN3,Myeloblastin,27060,148,1.01 [0.75-1.37],0.9408619836786996
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRUNE2,Protein prune homolog 2,23760,138,0.98 [0.56-1.72],0.9530053733271058
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSAP,Prosaposin,23981,140,0.61 [0.33-1.12],0.1074783086571159
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSAPL1,Proactivator polypeptide-like 1,24088,141,0.88 [0.64-1.21],0.4161800118253783
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSCA,Prostate stem cell antigen,24088,141,1.00 [0.94-1.07],0.8872267026895256
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSG1,Pregnancy-specific beta-1-glycoprotein 1,27586,152,1.12 [0.98-1.28],0.0833722091258124
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSIP1,PC4 and SFRS1-interacting protein,27734,152,0.83 [0.65-1.07],0.1524255864592708
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSMA1,Proteasome subunit alpha type-1,27127,147,1.01 [0.74-1.39],0.9372121161237555
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSMC3,26S proteasome regulatory subunit 6A,23335,137,0.83 [0.48-1.43],0.4999510864600298
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSMD1,26S proteasome non-ATPase regulatory subunit 1,24175,141,0.85 [0.61-1.18],0.329650955550934
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSMD5,26S proteasome non-ATPase regulatory subunit 5,23536,141,1.02 [0.77-1.35],0.8896861404626646
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSMD9,26S proteasome non-ATPase regulatory subunit 9,27657,152,1.01 [0.78-1.30],0.9431651753803572
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSME1,Proteasome activator complex subunit 1,27547,151,0.90 [0.62-1.32],0.5868560539652594
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSME2,Proteasome activator complex subunit 2,27454,152,0.85 [0.57-1.25],0.3944985963863379
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSMG3,Proteasome assembly chaperone 3,27734,152,0.92 [0.70-1.21],0.5601392745848576
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSMG4,Proteasome assembly chaperone 4,23526,136,0.95 [0.71-1.26],0.7248599262940225
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSPN,Persephin,27734,152,0.89 [0.77-1.03],0.1329974151854684
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSRC1,Proline/serine-rich coiled-coil protein 1,27127,147,0.80 [0.61-1.05],0.1141916702546073
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,22839,138,0.89 [0.77-1.03],0.1123862860961365
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",27099,148,1.14 [0.70-1.84],0.5991714092328633
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTGDS,Prostaglandin-H2 D-isomerase,27553,155,1.11 [0.69-1.80],0.6563547202745699
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTGES2,Prostaglandin E synthase 2,23333,136,1.03 [0.76-1.39],0.8539267607470677
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTGR1,Prostaglandin reductase 1,24214,140,0.82 [0.67-1.01],0.0578980721075612
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTH,Parathyroid hormone,23536,141,1.05 [0.86-1.29],0.6224103452186309
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,27734,152,0.93 [0.63-1.38],0.7272270452758904
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTK7,Inactive tyrosine-protein kinase 7,27099,148,0.83 [0.57-1.23],0.3595193263163601
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTN,Pleiotrophin,27269,150,0.86 [0.64-1.15],0.3119280333803931
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTP4A3,Protein tyrosine phosphatase type IVA 3,23526,136,0.68 [0.48-0.98],0.0405166231705088
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,27586,152,0.90 [0.74-1.08],0.2484757026841405
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,27869,151,0.95 [0.81-1.11],0.5338815515514084
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,23480,136,1.13 [0.75-1.70],0.5553163443757012
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPRB,Receptor-type tyrosine-protein phosphatase beta,24214,140,0.61 [0.34-1.07],0.0822261466250565
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPRC,Receptor-type tyrosine-protein phosphatase C,24212,142,0.58 [0.28-1.20],0.1440403774315591
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPRF,Receptor-type tyrosine-protein phosphatase F,28118,155,0.53 [0.33-0.86],0.0100643784486688
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPRH,Receptor-type tyrosine-protein phosphatase H,24088,141,1.37 [0.99-1.88],0.0558827693149714
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,24088,141,0.41 [0.17-0.97],0.0434375755781935
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPRM,Receptor-type tyrosine-protein phosphatase mu,27690,152,0.72 [0.40-1.30],0.2779559026775522
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,27493,152,0.64 [0.41-1.01],0.0559031833776487
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPRR,Receptor-type tyrosine-protein phosphatase R,24158,142,0.77 [0.49-1.21],0.2582256972923266
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPRS,Receptor-type tyrosine-protein phosphatase S,28118,155,0.75 [0.42-1.34],0.3261569434304483
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,24214,140,0.77 [0.47-1.26],0.2903916488411601
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,23702,141,0.83 [0.64-1.08],0.1707049993633705
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTS,6-pyruvoyl tetrahydrobiopterin synthase,26978,147,0.98 [0.75-1.28],0.8855783270553887
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTTG1,Securin,23760,138,1.13 [0.78-1.63],0.5220673630731915
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTX3,Pentraxin-related protein PTX3,27734,152,1.09 [0.81-1.47],0.5760003945956
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PVALB,Parvalbumin alpha,27877,152,1.01 [0.89-1.15],0.848899244596293
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PVR,Poliovirus receptor,28018,153,1.23 [0.84-1.79],0.2890887768878291
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PXDNL,Peroxidasin-like protein,24077,140,0.93 [0.69-1.26],0.6500245780675723
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PXN,Paxillin,27099,148,0.98 [0.74-1.30],0.9139424065497772
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PYDC1,Pyrin domain-containing protein 1,23591,137,0.82 [0.54-1.25],0.3580861310392637
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PYY,Peptide YY,23445,136,1.07 [0.90-1.26],0.4536016594851459
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PZP,Pregnancy zone protein,24261,142,0.91 [0.71-1.18],0.4924581177362616
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,QDPR,Dihydropteridine reductase,27648,151,0.78 [0.56-1.09],0.1410972371664003
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,QPCT,Glutaminyl-peptide cyclotransferase,27818,155,0.61 [0.37-1.03],0.0665156272150631
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,QSOX1,Sulfhydryl oxidase 1,23764,139,0.65 [0.37-1.14],0.1324908660118635
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB10,Ras-related protein Rab-10,24214,140,0.80 [0.59-1.09],0.1553901435783526
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB11FIP3,Rab11 family-interacting protein 3,24214,140,0.91 [0.78-1.05],0.2082349609073333
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB27B,Ras-related protein Rab-27B,24214,140,0.86 [0.71-1.03],0.1053656274957773
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB2B,Ras-related protein Rab-2B,24077,140,0.85 [0.65-1.11],0.2231674847218841
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB33A,Ras-related protein Rab-33A,23445,136,0.81 [0.63-1.05],0.1113720390896818
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB37,Ras-related protein Rab-37,27224,148,0.78 [0.63-0.96],0.0181991571234961
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB39B,Ras-related protein Rab-39B,23445,136,0.90 [0.73-1.12],0.3625876376159813
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,23430,140,0.87 [0.63-1.20],0.3825474264489451
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB44,Ras-related protein Rab-44,24077,140,1.05 [0.75-1.47],0.7904743790698715
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB6A,Ras-related protein Rab-6A,27734,152,0.86 [0.63-1.17],0.3314859920491333
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB6B,Ras-related protein Rab-6B,27099,148,1.18 [0.90-1.54],0.233309082882306
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RABEP1,Rab GTPase-binding effector protein 1,23702,141,0.86 [0.69-1.06],0.1464898980490841
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RABEPK,Rab9 effector protein with kelch motifs,27127,147,0.85 [0.65-1.12],0.2405663683932656
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RABGAP1L,Rab GTPase-activating protein 1-like,27224,148,0.97 [0.76-1.24],0.815107879184388
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAC3,Ras-related C3 botulinum toxin substrate 3,23536,141,1.05 [0.85-1.30],0.6503937997778082
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAD23B,UV excision repair protein RAD23 homolog B,27127,147,1.05 [0.77-1.43],0.7468961921561281
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAD51,DNA repair protein RAD51 homolog 1,23760,138,0.86 [0.61-1.21],0.3817763008307584
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RALB,Ras-related protein Ral-B,23526,136,0.70 [0.40-1.21],0.2003160769809799
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RALY,RNA-binding protein Raly,24077,140,1.17 [0.88-1.55],0.2848609748709247
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RANBP1,Ran-specific GTPase-activating protein,23591,137,0.88 [0.65-1.20],0.4358811179249984
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RANBP2,E3 SUMO-protein ligase RanBP2,23430,140,0.86 [0.52-1.42],0.5500467771311089
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RANGAP1,Ran GTPase-activating protein 1,27127,147,1.06 [0.79-1.41],0.7164553206408109
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAP1A,Ras-related protein Rap-1A,23526,136,1.02 [0.81-1.28],0.8757277100448312
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAPGEF2,Rap guanine nucleotide exchange factor 2,23760,138,0.81 [0.58-1.12],0.198804191384258
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RARRES1,Retinoic acid receptor responder protein 1,27127,147,1.09 [0.72-1.63],0.684950800443442
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RARRES2,Retinoic acid receptor responder protein 2,27921,155,0.85 [0.63-1.17],0.320343248500594
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RASA1,Ras GTPase-activating protein 1,27099,148,0.91 [0.58-1.42],0.6644746506210797
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,23335,137,0.80 [0.55-1.18],0.2669757899609739
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RASSF2,Ras association domain-containing protein 2,27127,147,0.96 [0.74-1.24],0.7421401804774772
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBFOX3,RNA binding protein fox-1 homolog 3,24175,141,1.37 [0.95-1.96],0.0899334160158889
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBKS,Ribokinase,27131,152,0.97 [0.73-1.28],0.8250310221174947
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBM17,Splicing factor 45,24175,141,0.87 [0.70-1.08],0.2090892814178228
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBM19,Probable RNA-binding protein 19,23445,136,1.03 [0.74-1.44],0.8573770901382041
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBM25,RNA-binding protein 25,23335,137,0.93 [0.65-1.34],0.6960017888686785
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBP1,Retinol-binding protein 1,23536,141,1.04 [0.83-1.29],0.7446619437134085
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBP2,Retinol-binding protein 2,27657,152,0.82 [0.67-0.99],0.044192955840471
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBP5,Retinol-binding protein 5,27657,152,1.11 [0.86-1.42],0.4133671703795547
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBP7,Retinoid-binding protein 7,24088,141,0.84 [0.63-1.12],0.2266116176464647
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBPMS,RNA-binding protein with multiple splicing,23526,136,0.76 [0.55-1.04],0.089198932573451
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBPMS2,RNA-binding protein with multiple splicing 2,23591,137,0.90 [0.77-1.06],0.2253016397455737
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RCC1,Regulator of chromosome condensation,24077,140,0.90 [0.65-1.26],0.5513466082813392
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RCOR1,REST corepressor 1,27269,150,1.15 [0.88-1.50],0.3097664145417855
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,23591,137,1.18 [0.52-2.66],0.6956988563479927
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,REEP4,Receptor expression-enhancing protein 4,24175,141,0.84 [0.64-1.10],0.2081088514402527
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,REG1A,Lithostathine-1-alpha,27603,154,0.94 [0.70-1.26],0.6904844273783084
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,REG1B,Lithostathine-1-beta,28118,155,0.95 [0.74-1.23],0.710120507386673
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,REG3A,Regenerating islet-derived protein 3-alpha,28118,155,0.97 [0.77-1.22],0.8183117815910967
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,REG3G,Regenerating islet-derived protein 3-gamma,24077,140,1.39 [0.97-1.99],0.0692786659852111
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,REG4,Regenerating islet-derived protein 4,27831,151,0.77 [0.57-1.04],0.0842048822544274
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RELB,Transcription factor RelB,23526,136,1.08 [0.81-1.45],0.5996254259927285
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RELT,Tumor necrosis factor receptor superfamily member 19L,27784,153,0.75 [0.44-1.29],0.3007094499416817
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,REN,Renin,27780,151,0.92 [0.76-1.13],0.4319115017621778
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,REPS1,RalBP1-associated Eps domain-containing protein 1,23526,136,0.78 [0.49-1.22],0.2746511515039592
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,REST,RE1-silencing transcription factor,23335,137,0.72 [0.44-1.21],0.215171453429604
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,27657,152,0.92 [0.65-1.31],0.646550054006485
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RETN,Resistin,27710,154,0.92 [0.65-1.30],0.6271757699272008
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,REXO2,"Oligoribonuclease, mitochondrial",23445,136,0.90 [0.63-1.29],0.5730521932147341
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RFC4,Replication factor C subunit 4,24077,140,0.35 [0.15-0.81],0.014726148999355
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RGCC,Regulator of cell cycle RGCC,24175,141,0.95 [0.77-1.18],0.6695553141048618
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,23760,138,0.95 [0.73-1.24],0.7109859653468833
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RGMA,Repulsive guidance molecule A,28018,153,0.78 [0.49-1.24],0.3016647560028605
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RGMB,RGM domain family member B,28018,153,0.77 [0.44-1.34],0.3492310733968953
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RGS10,Regulator of G-protein signaling 10,24175,141,0.81 [0.61-1.07],0.132201665522024
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RGS8,Regulator of G-protein signaling 8,27224,148,1.17 [0.98-1.41],0.0897807890319643
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RHOC,Rho-related GTP-binding protein RhoC,27405,152,0.98 [0.87-1.11],0.7321787069687413
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RICTOR,Rapamycin-insensitive companion of mTOR,23526,136,0.99 [0.71-1.38],0.9341400079626948
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,23702,141,0.84 [0.60-1.18],0.3250280023926878
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RILP,Rab-interacting lysosomal protein,27925,152,0.93 [0.73-1.18],0.5420931049151625
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RILPL2,RILP-like protein 2,24214,140,0.92 [0.78-1.08],0.3268150731845244
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,23445,136,0.84 [0.63-1.10],0.20346152505415
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RLN1,Prorelaxin H1,24175,141,0.90 [0.69-1.17],0.4414783832428479
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RLN2,Prorelaxin H2,23658,141,0.91 [0.76-1.08],0.2748936189672752
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNASE1,Ribonuclease pancreatic,24226,140,0.94 [0.48-1.81],0.8446738553740962
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNASE10,Inactive ribonuclease-like protein 10,23591,137,0.93 [0.66-1.31],0.6666416205478003
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNASE3,Eosinophil cationic protein,27650,151,0.96 [0.84-1.10],0.5460224180274895
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNASE4,Ribonuclease 4,23409,136,0.69 [0.40-1.17],0.1674961155745699
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNASE6,Ribonuclease K6,24042,139,1.19 [0.73-1.96],0.48100797279018
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNASEH2A,Ribonuclease H2 subunit A,24175,141,0.81 [0.57-1.16],0.2541970701428098
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNASET2,Ribonuclease T2,27985,155,1.06 [0.62-1.79],0.8422727379995136
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNF149,E3 ubiquitin-protein ligase RNF149,23591,137,1.22 [0.72-2.05],0.4598781721719303
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNF168,E3 ubiquitin-protein ligase RNF168,23526,136,0.77 [0.49-1.20],0.247832077085117
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNF31,E3 ubiquitin-protein ligase RNF31,23526,136,0.58 [0.33-1.01],0.0549245824613907
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNF4,E3 ubiquitin-protein ligase RNF4,23760,138,1.12 [0.90-1.39],0.3302712853193121
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNF41,E3 ubiquitin-protein ligase NRDP1,27127,147,0.88 [0.71-1.10],0.2714465304176343
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNF43,E3 ubiquitin-protein ligase RNF43,23760,138,1.07 [0.83-1.39],0.583562160465544
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNF5,E3 ubiquitin-protein ligase RNF5,23591,137,1.02 [0.81-1.27],0.8969006229694
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ROBO1,Roundabout homolog 1,27831,151,0.65 [0.35-1.19],0.1598875513532158
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ROBO2,Roundabout homolog 2,28018,153,0.96 [0.52-1.76],0.8900295385772355
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ROBO4,Roundabout homolog 4,23591,137,1.21 [0.48-3.07],0.6814309109060881
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,27780,151,1.04 [0.66-1.63],0.8757720862646394
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RP2,Protein XRP2,27657,152,0.63 [0.43-0.90],0.012705267155332
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RPA2,Replication protein A 32 kDa subunit,23526,136,0.79 [0.45-1.39],0.4128552689027298
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RPE,Ribulose-phosphate 3-epimerase,23760,138,0.96 [0.76-1.21],0.7077700692846084
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RPGR,X-linked retinitis pigmentosa GTPase regulator,23536,141,0.80 [0.52-1.23],0.3070087418878178
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RPL14,60S ribosomal protein L14,23591,137,1.03 [0.70-1.53],0.876128045125504
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RPS10,40S ribosomal protein S10,23445,136,0.68 [0.43-1.09],0.1125892927855617
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RRAS,Ras-related protein R-Ras,23536,141,0.92 [0.81-1.04],0.179892090505175
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RRM2,Ribonucleoside-diphosphate reductase subunit M2,27127,147,0.89 [0.65-1.21],0.4629641407819935
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,27127,147,0.96 [0.77-1.19],0.7107616575652398
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RRP15,RRP15-like protein,23430,140,0.98 [0.82-1.16],0.7788264678010425
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RSPO1,R-spondin-1,27586,152,0.74 [0.49-1.13],0.1607955167722655
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RSPO3,R-spondin-3,28012,153,0.62 [0.37-1.04],0.0681134143080299
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RTBDN,Retbindin,27657,152,0.51 [0.31-0.85],0.0093590903940038
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RTKN2,Rhotekin-2,23445,136,0.84 [0.59-1.19],0.3258090341671419
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",24175,141,0.91 [0.76-1.09],0.2952773859198224
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RTN4R,Reticulon-4 receptor,28012,153,1.01 [0.67-1.53],0.95247224799315
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RUVBL1,RuvB-like 1,27127,147,1.01 [0.88-1.16],0.8667760809850046
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RWDD1,RWD domain-containing protein 1,28018,153,0.86 [0.69-1.07],0.1811213564562398
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RYR1,Ryanodine receptor 1,23445,136,1.31 [0.90-1.91],0.1631188298844401
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,S100A11,Protein S100-A11,27554,151,0.79 [0.56-1.12],0.1939965046141724
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,S100A12,Protein S100-A12,27408,152,0.97 [0.80-1.17],0.7216268807118322
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,S100A13,Protein S100-A13,23526,136,1.22 [0.79-1.88],0.3734367736994611
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,S100A14,Protein S100-A14,24175,141,1.04 [0.78-1.40],0.7699286172806763
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,S100A16,Protein S100-A16,27057,147,0.90 [0.71-1.15],0.3916562225405673
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,S100A3,Protein S100-A3,24077,140,0.77 [0.49-1.21],0.2578488825533626
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,S100A4,Protein S100-A4,27877,155,0.92 [0.72-1.18],0.5129402965616998
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,S100G,Protein S100-G,24175,141,0.94 [0.65-1.35],0.7295855669879444
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,S100P,Protein S100-P,27269,150,1.10 [0.86-1.41],0.4352060089560778
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SAA4,Serum amyloid A-4 protein,24261,142,0.45 [0.16-1.26],0.1299239693716719
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SAFB2,Scaffold attachment factor B2,24175,141,0.91 [0.51-1.63],0.7484836236084398
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SAG,S-arrestin,23430,140,1.04 [0.77-1.40],0.8214631266767419
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SAMD9L,Sterile alpha motif domain-containing protein 9-like,27734,152,0.89 [0.73-1.09],0.2760210195251078
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SAP18,Histone deacetylase complex subunit SAP18,23760,138,0.82 [0.64-1.06],0.1335257034160495
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SARG,Specifically androgen-regulated gene protein,24117,140,0.93 [0.80-1.07],0.3193673063567357
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SART1,U4/U6.U5 tri-snRNP-associated protein 1,23445,136,1.17 [0.80-1.71],0.4202891788325811
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SAT1,Diamine acetyltransferase 1,23445,136,0.77 [0.53-1.12],0.1769924228425058
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SAT2,Thialysine N-epsilon-acetyltransferase,23760,138,0.94 [0.73-1.21],0.6231712915543823
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SATB1,DNA-binding protein SATB1,24175,141,0.75 [0.42-1.36],0.3496867570621664
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SBSN,Suprabasin,24165,142,0.67 [0.42-1.09],0.1094229046477031
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCAMP3,Secretory carrier-associated membrane protein 3,27657,152,0.86 [0.72-1.02],0.0777033835137642
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCARA5,Scavenger receptor class A member 5,28018,153,0.89 [0.55-1.45],0.6464978708907753
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCARB1,Scavenger receptor class B member 1,27099,148,0.91 [0.69-1.19],0.4844534764488339
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCARB2,Lysosome membrane protein 2,27076,150,0.91 [0.56-1.47],0.6923724499025744
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCARF1,Scavenger receptor class F member 1,28118,155,0.82 [0.59-1.16],0.2598995824964768
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCARF2,Scavenger receptor class F member 2,28018,153,1.03 [0.63-1.67],0.9164948597169976
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCG2,Secretogranin-2,27875,152,0.70 [0.44-1.09],0.1165872743650528
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCG3,Secretogranin-3,27831,151,0.58 [0.38-0.88],0.0099171526941521
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCGB1A1,Uteroglobin,27827,151,0.91 [0.71-1.17],0.4631526129414051
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCGB2A2,Mammaglobin-A,23445,136,1.04 [0.63-1.73],0.8734929476479512
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCGB3A1,Secretoglobin family 3A member 1,23702,141,0.61 [0.32-1.16],0.1299358739495819
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCGB3A2,Secretoglobin family 3A member 2,27869,151,0.76 [0.63-0.93],0.0065224447351575
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCGN,Secretagogin,27224,148,0.63 [0.45-0.89],0.0094298023830247
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCIN,Adseverin,23430,140,0.80 [0.63-1.03],0.0867052303388735
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCLY,Selenocysteine lyase,27925,152,0.90 [0.67-1.22],0.5035649793583434
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCN2A,Sodium channel protein type 2 subunit alpha,23430,140,1.00 [0.71-1.39],0.9908317355691628
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCN2B,Sodium channel subunit beta-2,23536,141,0.99 [0.58-1.71],0.9809212990283508
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCN3A,Sodium channel protein type 3 subunit alpha,23536,141,0.82 [0.51-1.31],0.3966978100799684
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCN3B,Sodium channel subunit beta-3,23430,140,0.94 [0.66-1.35],0.7472934698176164
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCN4B,Sodium channel subunit beta-4,23591,137,0.75 [0.50-1.11],0.1510044020461759
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCP2,Non-specific lipid-transfer protein,27127,147,0.88 [0.71-1.09],0.240229993843791
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCPEP1,Retinoid-inducible serine carboxypeptidase,23495,137,0.86 [0.61-1.21],0.3743830353528489
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCRG1,Scrapie-responsive protein 1,24214,140,0.74 [0.41-1.35],0.322853727874694
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCRIB,Protein scribble homolog,23591,137,1.01 [0.84-1.20],0.9526250613480376
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCRN1,Secernin-1,27734,152,0.88 [0.68-1.15],0.3608270723031618
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCT,Secretin,23536,141,1.09 [0.77-1.54],0.6175154290848561
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SDC1,Syndecan-1,27780,151,0.63 [0.43-0.94],0.0236529194075011
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SDC4,Syndecan-4,27780,151,0.71 [0.53-0.97],0.0296670862275132
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SDCCAG8,Serologically defined colon cancer antigen 8,24077,140,0.95 [0.82-1.09],0.437159163223926
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SDHB,Succinate dehydrogenase,24088,141,0.96 [0.76-1.21],0.7170616077412533
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SDK2,Protein sidekick-2,23702,141,0.75 [0.48-1.16],0.1961165881995452
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEC31A,Protein transport protein Sec31A,23591,137,0.90 [0.73-1.12],0.3463510739649024
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEL1L,Protein sel-1 homolog 1,23591,137,1.08 [0.67-1.74],0.7585183866551994
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SELE,E-selectin,28118,155,0.74 [0.56-0.98],0.0334643832058118
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SELENOP,Selenoprotein P,24261,142,0.64 [0.31-1.33],0.2350970379515279
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SELL,L-selectin,24261,142,0.62 [0.31-1.22],0.1679476925376193
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SELP,P-selectin,27874,155,0.76 [0.59-0.97],0.0305268537117749
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SELPLG,P-selectin glycoprotein ligand 1,27734,152,0.67 [0.41-1.08],0.1003080771410173
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEMA3F,Semaphorin-3F,27780,151,1.15 [0.66-2.01],0.6120049072338339
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEMA3G,Semaphorin-3G,23702,141,0.96 [0.66-1.39],0.82292740328449
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEMA4C,Semaphorin-4C,27657,152,1.15 [0.70-1.87],0.5863258598895671
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEMA4D,Semaphorin-4D,28018,153,0.79 [0.49-1.27],0.3250465559893839
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEMA6C,Semaphorin-6C,23526,136,0.50 [0.25-1.03],0.0605275049101076
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEMA7A,Semaphorin-7A,28028,155,0.91 [0.54-1.55],0.7361685021537163
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEPTIN3,Neuronal-specific septin-3,24175,141,0.75 [0.59-0.95],0.0178131420858979
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEPTIN7,Septin-7,23760,138,0.87 [0.62-1.23],0.4270102439779328
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEPTIN8,Septin-8,24111,142,0.89 [0.53-1.48],0.6446766508170627
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEPTIN9,Septin-9,27657,152,0.70 [0.41-1.20],0.1890670834763292
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINA1,Alpha-1-antitrypsin,23794,138,0.72 [0.09-5.67],0.752242125607671
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINA11,Serpin A11,28118,155,1.03 [0.73-1.47],0.8484339778619535
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINA12,Serpin A12,26973,148,1.00 [0.87-1.14],0.9504877278777708
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINA3,Alpha-1-antichymotrypsin,24161,141,1.51 [0.52-4.34],0.4447485048801797
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINA4,Kallistatin,23804,140,0.79 [0.40-1.56],0.5047918825086676
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINA5,Plasma serine protease inhibitor,23903,141,0.64 [0.37-1.09],0.099514994301748
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINA6,Corticosteroid-binding globulin,24261,142,0.53 [0.28-1.03],0.0630971454852543
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINA7,Thyroxine-binding globulin,24261,142,0.54 [0.23-1.28],0.1629435088906457
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINA9,Serpin A9,27512,150,1.02 [0.83-1.25],0.8422373800369807
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINB1,Leukocyte elastase inhibitor,27696,153,0.93 [0.79-1.09],0.388026866040403
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINB5,Serpin B5,27269,150,1.16 [0.86-1.57],0.3302284663427778
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINB6,Serpin B6,27930,152,0.97 [0.76-1.23],0.792901487625536
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINB8,Serpin B8,28067,151,0.79 [0.60-1.05],0.1053089946724308
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINB9,Serpin B9,27586,152,0.88 [0.58-1.35],0.5603137033844336
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINC1,Antithrombin-III,24209,142,0.63 [0.21-1.85],0.3998086105383273
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPIND1,Heparin cofactor 2,24209,142,0.69 [0.38-1.24],0.2114263070361162
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINE1,Plasminogen activator inhibitor 1,28118,155,0.80 [0.65-0.98],0.029629297250712
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINE2,Glia-derived nexin,24214,140,0.66 [0.51-0.86],0.0017637985011976
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINF1,Pigment epithelium-derived factor,23895,136,0.76 [0.40-1.42],0.3870889616868361
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINF2,Alpha-2-antiplasmin,23802,139,0.46 [0.14-1.50],0.1961671024753056
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPING1,Plasma protease C1 inhibitor,24209,142,0.56 [0.23-1.32],0.181894373818621
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINH1,Serpin H1,23760,138,0.89 [0.78-1.01],0.0693295113435387
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINI1,Neuroserpin,23654,141,0.75 [0.44-1.28],0.2845699370127941
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINI2,Serpin I2,24088,141,0.77 [0.57-1.05],0.0977826159839736
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,27099,148,0.85 [0.67-1.08],0.1906705747877368
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SETMAR,Histone-lysine N-methyltransferase SETMAR,27504,151,0.62 [0.38-1.01],0.0550158982327411
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEZ6,Seizure protein 6 homolog,23536,141,0.90 [0.53-1.54],0.7051604679856109
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEZ6L,Seizure 6-like protein,27877,155,0.56 [0.34-0.94],0.0274350608221361
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEZ6L2,Seizure 6-like protein 2,27657,152,0.73 [0.39-1.35],0.3142920465692753
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SF3B4,Splicing factor 3B subunit 4,27657,152,0.87 [0.71-1.06],0.1562576127438323
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SFRP1,Secreted frizzled-related protein 1,27503,152,0.81 [0.58-1.14],0.2310768565655969
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SFRP4,Secreted frizzled-related protein 4,23702,141,1.22 [0.82-1.80],0.3252284548862059
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SFTPA1,Pulmonary surfactant-associated protein A1,27127,147,0.77 [0.57-1.05],0.0986166410505403
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SFTPA2,Pulmonary surfactant-associated protein A2,27127,147,1.00 [0.75-1.33],0.9953619572695208
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SFTPD,Pulmonary surfactant-associated protein D,27780,151,0.88 [0.71-1.10],0.2568701259484038
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SGSH,N-sulphoglucosamine sulphohydrolase,23794,138,0.84 [0.62-1.14],0.2717934520437768
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SH2B3,SH2B adapter protein 3,27127,147,0.97 [0.83-1.12],0.6519054560751185
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SH2D1A,SH2 domain-containing protein 1A,27734,152,0.85 [0.64-1.12],0.2480230307689779
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,23430,140,1.22 [0.99-1.51],0.0633621698275836
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SH3BP1,SH3 domain-binding protein 1,24088,141,1.01 [0.73-1.40],0.9327665439506454
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SH3GL3,Endophilin-A3,23631,138,0.95 [0.79-1.16],0.6254406786528601
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SH3GLB2,Endophilin-B2,24158,142,1.00 [0.79-1.27],0.9703046736498712
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SHBG,Sex hormone-binding globulin,24226,140,0.79 [0.59-1.06],0.1190976694955764
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SHC1,SHC-transforming protein 1,23335,137,1.02 [0.88-1.17],0.8178424426805332
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SHD,SH2 domain-containing adapter protein D,23395,136,0.87 [0.69-1.08],0.2113512661101291
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SHH,Sonic hedgehog protein,23526,136,0.73 [0.48-1.10],0.1369307969742622
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SHISA5,Protein shisa-5,24212,142,0.93 [0.49-1.76],0.8263411627503738
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SHMT1,"Serine hydroxymethyltransferase, cytosolic",27869,151,0.93 [0.79-1.09],0.3665919068349054
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SHPK,Sedoheptulokinase,23760,138,0.99 [0.67-1.47],0.965685145718704
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIAE,Sialate O-acetylesterase,27834,155,0.73 [0.54-1.00],0.0478407392406953
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIGLEC1,Sialoadhesin,27917,151,1.07 [0.77-1.49],0.6999298017454214
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIGLEC10,Sialic acid-binding Ig-like lectin 10,27734,152,1.26 [0.83-1.92],0.2807150344345533
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIGLEC15,Sialic acid-binding Ig-like lectin 15,27099,148,1.12 [0.95-1.31],0.1666413393741839
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIGLEC5,Sialic acid-binding Ig-like lectin 5,27784,153,1.03 [0.91-1.16],0.6845892816336419
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIGLEC6,Sialic acid-binding Ig-like lectin 6,28012,153,1.21 [0.79-1.84],0.3778191076561563
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIGLEC7,Sialic acid-binding Ig-like lectin 7,27780,151,0.90 [0.54-1.51],0.6946423888340256
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIGLEC8,Sialic acid-binding Ig-like lectin 8,23591,137,1.39 [0.97-1.99],0.0740615463418887
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIGLEC9,Sialic acid-binding Ig-like lectin 9,27974,152,1.05 [0.65-1.71],0.8391071456430546
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIL1,Nucleotide exchange factor SIL1,23591,137,1.24 [0.82-1.88],0.2973423030426201
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,27846,153,0.96 [0.75-1.23],0.7648373152955105
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIRPB1,Signal-regulatory protein beta-1,27743,151,0.95 [0.69-1.31],0.7619618532043537
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIRT1,NAD-dependent protein deacetylase sirtuin-1,23526,136,0.89 [0.71-1.11],0.3020132967922285
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIRT2,NAD-dependent protein deacetylase sirtuin-2,27657,152,0.93 [0.80-1.09],0.3955888218041049
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",27099,148,1.03 [0.80-1.33],0.8071559446977326
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIT1,Signaling threshold-regulating transmembrane adapter 1,27224,148,0.94 [0.72-1.22],0.6546259010292022
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SKAP1,Src kinase-associated phosphoprotein 1,27534,152,0.91 [0.75-1.10],0.3326154879588715
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SKAP2,Src kinase-associated phosphoprotein 2,27917,151,0.88 [0.77-1.01],0.0633517183566912
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SKIV2L,Helicase SKI2W,23445,136,0.85 [0.55-1.31],0.4662279257798764
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLA2,Src-like-adapter 2,24175,141,0.94 [0.80-1.09],0.3967151721116267
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLAMF1,Signaling lymphocytic activation molecule,27224,148,0.91 [0.72-1.16],0.4515051032045051
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLAMF6,SLAM family member 6,27127,147,1.05 [0.71-1.54],0.8249552311423918
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLAMF7,SLAM family member 7,27734,152,0.81 [0.63-1.04],0.0964139325394434
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLAMF8,SLAM family member 8,27127,147,0.96 [0.73-1.26],0.7747726170527739
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC12A2,Solute carrier family 12 member 2,23445,136,0.89 [0.48-1.64],0.7154668600751999
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC13A1,Solute carrier family 13 member 1,24077,140,0.75 [0.52-1.07],0.1094161938892401
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC16A1,Monocarboxylate transporter 1,27099,148,0.94 [0.73-1.21],0.6256487018779558
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC1A4,Neutral amino acid transporter A,23536,141,1.00 [0.74-1.37],0.9797682276342377
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC27A4,Long-chain fatty acid transport protein 4,27099,148,0.98 [0.78-1.23],0.8494430908428846
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC28A1,Sodium/nucleoside cotransporter 1,23335,137,1.08 [0.84-1.39],0.5448593052215931
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC34A3,Sodium-dependent phosphate transport protein 2C,23335,137,0.82 [0.56-1.20],0.2996118966213282
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC39A14,Zinc transporter ZIP14,27099,148,1.11 [0.73-1.70],0.6157153866682451
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC39A5,Zinc transporter ZIP5,27734,152,1.00 [0.76-1.30],0.9716417155328424
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC44A4,Choline transporter-like protein 4,23536,141,1.11 [0.91-1.35],0.3176291485417172
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC4A1,Band 3 anion transport protein,24212,142,1.07 [0.76-1.50],0.6995062150023044
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC51B,Organic solute transporter subunit beta,23445,136,0.98 [0.79-1.20],0.8149262034567475
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,23702,141,0.84 [0.69-1.02],0.0842906874452704
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,24088,141,0.90 [0.64-1.27],0.5501316632861635
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",23335,137,1.05 [0.80-1.38],0.7225935501572608
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLIT2,Slit homolog 2 protein,27099,148,0.78 [0.57-1.05],0.1041115261622607
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLITRK1,SLIT and NTRK-like protein 1,23526,136,0.46 [0.27-0.77],0.0032609437070324
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLITRK2,SLIT and NTRK-like protein 2,28012,153,1.12 [0.77-1.62],0.5609732921315538
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLITRK6,SLIT and NTRK-like protein 6,27269,150,0.83 [0.54-1.27],0.3949755001790211
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLK,STE20-like serine/threonine-protein kinase,23760,138,1.29 [1.13-1.48],0.0002399971051179
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLMAP,Sarcolemmal membrane-associated protein,24088,141,0.91 [0.74-1.10],0.3246770908453373
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLURP1,Secreted Ly-6/uPAR-related protein 1,24026,142,0.76 [0.47-1.22],0.2553169590991756
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMAD1,Mothers against decapentaplegic homolog 1,27127,147,0.93 [0.77-1.11],0.4049989643101007
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMAD2,Mothers against decapentaplegic homolog 2,24077,140,0.92 [0.72-1.16],0.4714955464024272
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMAD3,Mothers against decapentaplegic homolog 3,24077,140,0.94 [0.68-1.29],0.6921402670388879
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMAD5,Mothers against decapentaplegic homolog 5,27657,152,1.07 [0.53-2.17],0.8514288378123753
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMARCA2,Probable global transcription activator SNF2L2,27099,148,1.03 [0.84-1.26],0.766241324321632
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMC3,Structural maintenance of chromosomes protein 3,23335,137,1.08 [0.83-1.42],0.5566607830931046
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMNDC1,Survival of motor neuron-related-splicing factor 30,24088,141,0.83 [0.61-1.11],0.2090386702823385
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMOC1,SPARC-related modular calcium-binding protein 1,28012,153,1.05 [0.68-1.61],0.8326050578445948
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMOC2,SPARC-related modular calcium-binding protein 2,27917,151,1.07 [0.74-1.56],0.7120419660619506
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMPD1,Sphingomyelin phosphodiesterase,27882,151,0.88 [0.65-1.20],0.4305473082011278
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMPD3,Sphingomyelin phosphodiesterase 3,23526,136,0.87 [0.62-1.20],0.3919347283860225
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,27878,151,0.84 [0.67-1.04],0.1061596895692253
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,24077,140,1.12 [0.94-1.34],0.2166725421301059
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMS,Spermine synthase,23430,140,0.79 [0.59-1.05],0.1078609985334917
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMTN,Smoothelin,24115,142,0.93 [0.78-1.11],0.4212233045958045
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNAP23,Synaptosomal-associated protein 23,27780,151,0.92 [0.78-1.08],0.31725031437965
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNAP25,Synaptosomal-associated protein 25,23430,140,0.79 [0.55-1.12],0.1887467592123546
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNAP29,Synaptosomal-associated protein 29,27877,155,0.89 [0.76-1.04],0.1331448263251712
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNAPIN,SNARE-associated protein Snapin,24175,141,0.91 [0.68-1.21],0.5013762041532297
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNCA,Alpha-synuclein,23702,141,0.90 [0.78-1.04],0.1599950669222493
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNCG,Gamma-synuclein,27586,152,0.93 [0.76-1.15],0.5268588477334526
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",23591,137,0.88 [0.54-1.46],0.6296211555815072
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNRPB2,U2 small nuclear ribonucleoprotein B'',24158,142,0.75 [0.47-1.19],0.2227896784086261
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNU13,NHP2-like protein 1,23445,136,0.78 [0.57-1.06],0.1110325370266555
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNX15,Sorting nexin-15,23702,141,0.88 [0.65-1.18],0.3833468443371719
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNX18,Sorting nexin-18,24088,141,0.91 [0.63-1.33],0.6270506979045862
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNX2,Sorting nexin-2,24077,140,1.06 [0.87-1.29],0.5669071068086367
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNX5,Sorting nexin-5,23591,137,0.68 [0.38-1.22],0.1989990767038197
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNX9,Sorting nexin-9,27780,151,0.91 [0.73-1.12],0.3641235763784372
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SOD1,Superoxide dismutase [Cu-Zn],27201,153,1.03 [0.77-1.38],0.8269668312357499
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SOD2,"Superoxide dismutase [Mn], mitochondrial",27784,153,0.81 [0.55-1.20],0.3041327542342412
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SOD3,Extracellular superoxide dismutase,24226,140,0.87 [0.63-1.20],0.3997521165301225
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SORBS1,Sorbin and SH3 domain-containing protein 1,24175,141,1.38 [1.04-1.85],0.0269414038017758
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SORCS2,VPS10 domain-containing receptor SorCS2,27127,147,0.87 [0.58-1.32],0.5250078295197028
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SORD,Sorbitol dehydrogenase,27881,152,1.05 [0.85-1.30],0.6513178264552817
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SORT1,Sortilin,27735,151,0.83 [0.56-1.23],0.3511186907648537
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SOST,Sclerostin,27735,151,0.71 [0.49-1.03],0.0688584692748529
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,23536,141,0.87 [0.61-1.23],0.4242063858063978
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SOX2,Transcription factor SOX-2,24135,141,0.90 [0.45-1.81],0.7613127251581493
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SOX9,Transcription factor SOX-9,23536,141,0.78 [0.43-1.42],0.4209032636763374
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,24175,141,0.98 [0.56-1.71],0.9368497570873012
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPAG1,Sperm-associated antigen 1,24175,141,1.16 [0.91-1.49],0.231271398341591
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPARC,SPARC,27877,155,0.88 [0.72-1.06],0.1803832284187285
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPARCL1,SPARC-like protein 1,27786,154,0.83 [0.49-1.40],0.4862700228638155
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPART,Spartin,23702,141,0.87 [0.71-1.08],0.2189790800829331
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPESP1,Sperm equatorial segment protein 1,24214,140,0.80 [0.45-1.43],0.4518905798373247
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPINK1,Serine protease inhibitor Kazal-type 1,27784,153,0.76 [0.53-1.07],0.1183474529897155
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPINK2,Serine protease inhibitor Kazal-type 2,23702,141,1.02 [0.67-1.56],0.929418114666825
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPINK4,Serine protease inhibitor Kazal-type 4,27734,152,0.96 [0.77-1.20],0.7139010027661967
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPINK5,Serine protease inhibitor Kazal-type 5,27784,153,0.95 [0.61-1.48],0.8169675128698525
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPINK6,Serine protease inhibitor Kazal-type 6,28012,153,1.00 [0.77-1.30],0.9966741462985904
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPINK8,Serine protease inhibitor Kazal-type 8,23445,136,1.16 [0.80-1.68],0.4461591123162096
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPINT1,Kunitz-type protease inhibitor 1,27703,153,0.96 [0.53-1.72],0.8871052226146157
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPINT2,Kunitz-type protease inhibitor 2,27917,151,0.79 [0.57-1.09],0.1533793924388051
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPINT3,Kunitz-type protease inhibitor 3,24088,141,0.93 [0.83-1.05],0.24415008045111
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPOCK1,Testican-1,27586,152,0.70 [0.39-1.23],0.2134777749164154
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPON1,Spondin-1,27831,151,0.69 [0.43-1.08],0.1027542871573077
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPON2,Spondin-2,27649,151,0.90 [0.59-1.36],0.6092561343996383
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPP1,Osteopontin,28071,154,0.79 [0.59-1.05],0.1069306903729311
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",23526,136,0.71 [0.47-1.08],0.1117713862090152
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPRING1,SREBP regulating gene protein,23335,137,0.87 [0.64-1.19],0.3881366753796148
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPRR1B,Cornifin-B,23760,138,1.11 [0.94-1.32],0.2276561921743993
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPRR3,Small proline-rich protein 3,24158,142,1.11 [0.89-1.38],0.3493093592456241
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPRY2,Protein sprouty homolog 2,27224,148,0.92 [0.78-1.08],0.3021991583398022
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",23430,140,0.67 [0.39-1.16],0.1535812352834883
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPTLC1,Serine palmitoyltransferase 1,24158,142,0.47 [0.27-0.84],0.0105914538807228
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SRC,Proto-oncogene tyrosine-protein kinase Src,27830,155,0.94 [0.83-1.05],0.2585503710912693
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SRP14,Signal recognition particle 14 kDa protein,27657,152,0.92 [0.72-1.16],0.4689211693964301
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SRPK2,SRSF protein kinase 2,27734,152,0.92 [0.77-1.10],0.3389589977761336
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SRPX,Sushi repeat-containing protein SRPX,24214,140,1.05 [0.64-1.71],0.8479633989202465
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SSB,Lupus La protein,27099,148,0.86 [0.65-1.14],0.2869470767152314
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",23526,136,0.75 [0.45-1.26],0.2775652780023087
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,27735,151,1.01 [0.88-1.16],0.8861948544142522
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,27874,155,1.13 [0.81-1.59],0.4720051603910747
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SSH3,Protein phosphatase Slingshot homolog 3,23335,137,0.66 [0.36-1.20],0.1738185448292666
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SSNA1,Sjoegren syndrome nuclear autoantigen 1,24088,141,0.80 [0.58-1.10],0.1733248361498031
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ST13,Hsc70-interacting protein,23702,141,0.83 [0.63-1.10],0.1976914050020178
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",27657,152,1.00 [0.71-1.42],0.9824622476283844
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",28118,155,0.60 [0.36-0.99],0.0463699075146063
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",23526,136,0.76 [0.49-1.17],0.2124756375796113
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STAB2,Stabilin-2,24212,142,0.86 [0.49-1.51],0.5994235906040595
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STAM,Signal transducing adapter molecule 1,24077,140,0.81 [0.51-1.27],0.3577031734294029
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STAMBP,STAM-binding protein,27534,152,0.95 [0.76-1.18],0.6337333660170255
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STAT2,Signal transducer and activator of transcription 2,23526,136,0.85 [0.68-1.06],0.1400764770534536
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STAT5B,Signal transducer and activator of transcription 5B,27657,152,0.96 [0.86-1.06],0.406896532439436
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,23335,137,0.73 [0.54-0.98],0.0385612719316907
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STC1,Stanniocalcin-1,28018,153,0.87 [0.61-1.24],0.4364178374526946
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STC2,Stanniocalcin-2,27745,153,1.10 [0.63-1.92],0.7315524043038
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STEAP4,Metalloreductase STEAP4,23430,140,0.91 [0.72-1.16],0.4483710420076148
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STIP1,Stress-induced-phosphoprotein 1,27745,153,0.94 [0.75-1.16],0.5494926610266838
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STK11,Serine/threonine-protein kinase STK11,27269,150,0.91 [0.75-1.12],0.3792449387631162
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STK24,Serine/threonine-protein kinase 24,27099,148,0.91 [0.72-1.16],0.4412320860803026
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STK4,Serine/threonine-protein kinase 4,27780,151,0.93 [0.79-1.10],0.428041645530702
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STOML2,"Stomatin-like protein 2, mitochondrial",23335,137,0.95 [0.79-1.14],0.5585651674800978
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STX16,Syntaxin-16,27127,147,1.09 [0.86-1.38],0.4761681371721935
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STX1B,Syntaxin-1B,23536,141,0.62 [0.38-1.02],0.0621484574166604
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STX3,Syntaxin-3,24158,142,0.84 [0.54-1.32],0.4503776821909492
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STX4,Syntaxin-4,27657,152,0.80 [0.61-1.06],0.1159420694841261
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STX5,Syntaxin-5,23526,136,0.90 [0.59-1.38],0.6394163394881593
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STX6,Syntaxin-6,27127,147,0.85 [0.67-1.08],0.1749884136339268
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STX7,Syntaxin-7,23526,136,0.95 [0.68-1.32],0.7636336087010246
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STX8,Syntaxin-8,27734,152,0.79 [0.58-1.08],0.1406636807516464
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STXBP1,Syntaxin-binding protein 1,24175,141,0.92 [0.75-1.14],0.4540852097444616
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STXBP3,Syntaxin-binding protein 3,27127,147,0.97 [0.69-1.36],0.8567214108109715
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SUGP1,SURP and G-patch domain-containing protein 1,24088,141,0.78 [0.51-1.19],0.2526472983879666
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SUGT1,Protein SGT1 homolog,27127,147,0.94 [0.79-1.13],0.5325978088010394
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SULT1A1,Sulfotransferase 1A1,28018,153,0.96 [0.86-1.07],0.5063124109769521
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SULT2A1,Bile salt sulfotransferase,27734,152,0.78 [0.58-1.05],0.1028677841475649
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SUMF1,Formylglycine-generating enzyme,23526,136,0.88 [0.66-1.17],0.3732404953366445
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,28018,153,0.70 [0.54-0.90],0.0055304316459692
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SUOX,"Sulfite oxidase, mitochondrial",24175,141,0.80 [0.61-1.06],0.1224262311955413
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SUSD1,Sushi domain-containing protein 1,27269,150,0.84 [0.63-1.12],0.241338764944014
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SUSD2,Sushi domain-containing protein 2,27784,153,1.00 [0.61-1.63],0.99910236653109
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SUSD4,Sushi domain-containing protein 4,24077,140,0.93 [0.64-1.35],0.7133504872197418
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SUSD5,Sushi domain-containing protein 5,23559,140,1.14 [0.71-1.83],0.5911023870150127
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SV2A,Synaptic vesicle glycoprotein 2A,23536,141,0.76 [0.56-1.02],0.0631567942680204
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SWAP70,Switch-associated protein 70,24088,141,0.55 [0.33-0.92],0.0236256933224508
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SYAP1,Synapse-associated protein 1,23702,141,0.83 [0.62-1.12],0.2240314492596914
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,23430,140,0.97 [0.72-1.29],0.8096116989371166
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SYT1,Synaptotagmin-1,24158,142,0.99 [0.65-1.51],0.9652430117771172
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SYTL4,Synaptotagmin-like protein 4,24214,140,0.89 [0.71-1.12],0.3085567995171043
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,23760,138,0.96 [0.82-1.12],0.6025354556523845
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TACC3,Transforming acidic coiled-coil-containing protein 3,27657,152,0.95 [0.84-1.07],0.4100458056316824
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TACSTD2,Tumor-associated calcium signal transducer 2,24623,130,0.69 [0.40-1.19],0.1791545917776984
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TADA3,Transcriptional adapter 3,24077,140,0.67 [0.44-1.03],0.0653080572602135
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TAFA5,Chemokine-like protein TAFA-5,27657,152,0.92 [0.61-1.38],0.6790727748777292
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TAGLN3,Transgelin-3,23335,137,0.69 [0.52-0.92],0.0126112556418745
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TALDO1,Transaldolase,24115,142,0.80 [0.55-1.15],0.2264478312513693
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TANK,TRAF family member-associated NF-kappa-B activator,27224,148,1.01 [0.82-1.25],0.9408771253453349
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TAP1,Antigen peptide transporter 1,23760,138,0.90 [0.67-1.22],0.4987176751269826
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TARBP2,RISC-loading complex subunit TARBP2,27099,148,0.94 [0.78-1.14],0.5391255636641452
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",23536,141,1.14 [0.96-1.36],0.1433186737215094
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",24077,140,0.63 [0.40-0.99],0.0442977324943729
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TAX1BP1,Tax1-binding protein 1,24158,142,0.87 [0.67-1.13],0.3027365147476268
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TBC1D17,TBC1 domain family member 17,27099,148,1.03 [0.76-1.40],0.8399902884791057
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TBC1D23,TBC1 domain family member 23,27657,152,0.90 [0.77-1.06],0.2197082542404515
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TBC1D5,TBC1 domain family member 5,27734,152,0.86 [0.71-1.05],0.1330807842278319
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TBCA,Tubulin-specific chaperone A,23702,141,0.87 [0.72-1.05],0.1340094554469699
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TBCB,Tubulin-folding cofactor B,27586,152,0.98 [0.85-1.13],0.7778302542338078
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TBCC,Tubulin-specific chaperone C,27586,152,0.97 [0.81-1.15],0.7137861716671949
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TBL1X,F-box-like/WD repeat-containing protein TBL1X,27127,147,0.93 [0.78-1.10],0.4010046452465555
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TBR1,T-box brain protein 1,23536,141,0.89 [0.61-1.29],0.5368750384509672
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TCL1A,T-cell leukemia/lymphoma protein 1A,27540,152,0.96 [0.83-1.12],0.6244585178809102
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TCL1B,T-cell leukemia/lymphoma protein 1B,27269,150,1.18 [1.03-1.35],0.0159898844777238
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TCN1,Transcobalamin-1,23722,138,0.75 [0.46-1.24],0.2671839960289275
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TCN2,Transcobalamin-2,28071,154,0.66 [0.41-1.08],0.1008688812544944
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TCOF1,Treacle protein,24214,140,0.82 [0.47-1.42],0.4735613788419661
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TCP11,T-complex protein 11 homolog,23760,138,0.86 [0.63-1.20],0.3783025017706383
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TCTN3,Tectonic-3,24214,140,0.54 [0.32-0.93],0.0264576963584705
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TDGF1,Teratocarcinoma-derived growth factor 1,27099,148,1.08 [0.97-1.19],0.1507830964305395
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TDO2,"Tryptophan 2,3-dioxygenase",23536,141,0.88 [0.57-1.38],0.5798744597464814
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TDP1,Tyrosyl-DNA phosphodiesterase 1,24077,140,1.06 [0.85-1.31],0.6179576024938309
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TDRKH,Tudor and KH domain-containing protein,27099,148,0.92 [0.77-1.10],0.3425063083799146
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TEF,Thyrotroph embryonic factor,23445,136,0.96 [0.65-1.41],0.8265178968768341
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TEK,Angiopoietin-1 receptor,27877,155,0.82 [0.42-1.57],0.5415531838308361
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TERF1,Telomeric repeat-binding factor 1,23526,136,0.60 [0.33-1.09],0.0932384525594395
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TET2,Methylcytosine dioxygenase TET2,23714,138,1.02 [0.87-1.19],0.8244784912041878
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TEX101,Testis-expressed protein 101,23536,141,0.95 [0.62-1.43],0.7911414531843765
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TEX33,Testis-expressed protein 33,23760,138,0.77 [0.47-1.25],0.2851021397483437
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TF,Serotransferrin,24261,142,0.91 [0.44-1.91],0.8107253164490336
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TFAP2A,Transcription factor AP-2-alpha,23430,140,0.84 [0.62-1.14],0.2633081940326983
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TFF1,Trefoil factor 1,27644,152,0.90 [0.74-1.09],0.2818596168277087
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TFF2,Trefoil factor 2,27869,151,0.91 [0.71-1.18],0.4940091868638977
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TFF3,Trefoil factor 3,27738,153,0.93 [0.68-1.27],0.6425448181303652
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TFPI,Tissue factor pathway inhibitor,27689,155,0.96 [0.61-1.53],0.871273588379424
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TFPI2,Tissue factor pathway inhibitor 2,27786,155,0.67 [0.44-1.02],0.0635259078531485
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TFRC,Transferrin receptor protein 1,27881,155,1.10 [0.76-1.58],0.6156798253599378
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TG,Thyroglobulin,24077,140,1.01 [0.89-1.16],0.8517670344091606
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TGFA,Protransforming growth factor alpha,27734,152,0.92 [0.67-1.25],0.5731231239419421
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TGFB1,Transforming growth factor beta-1 proprotein,28021,150,0.73 [0.49-1.07],0.1102010581431436
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TGFB2,Transforming growth factor beta-2 proprotein,24077,140,1.09 [0.81-1.46],0.5675382125287471
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TGFBI,Transforming growth factor-beta-induced protein ig-h3,27599,155,0.64 [0.38-1.09],0.1015317398685578
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TGFBR1,TGF-beta receptor type-1,23526,136,1.02 [0.48-2.16],0.9575350347762198
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TGFBR2,TGF-beta receptor type-2,27877,155,0.92 [0.59-1.46],0.7352961824660834
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TGFBR3,Transforming growth factor beta receptor type 3,28118,155,0.78 [0.52-1.17],0.2386422789711245
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TGM2,Protein-glutamine gamma-glutamyltransferase 2,27737,151,1.00 [0.83-1.20],0.9713744888433856
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TGOLN2,Trans-Golgi network integral membrane protein 2,24226,140,1.15 [0.62-2.13],0.6506475159955467
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,THAP12,52 kDa repressor of the inhibitor of the protein kinase,23293,137,0.82 [0.65-1.02],0.0749635358875828
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,THBD,Thrombomodulin,27780,151,0.73 [0.43-1.23],0.2347658672464348
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,THBS2,Thrombospondin-2,27784,153,0.80 [0.53-1.21],0.29662290429225
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,THBS4,Thrombospondin-4,27779,155,1.23 [0.90-1.68],0.2007987693520282
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,THOP1,Thimet oligopeptidase,27647,150,0.97 [0.60-1.55],0.8890470022396295
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,THPO,Thrombopoietin,27269,150,0.58 [0.39-0.85],0.0055850029982699
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,THRAP3,Thyroid hormone receptor-associated protein 3,23445,136,1.09 [0.97-1.23],0.1556862858630849
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,THSD1,Thrombospondin type-1 domain-containing protein 1,23338,136,0.71 [0.42-1.18],0.1857194005487919
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,THTPA,Thiamine-triphosphatase,24040,140,0.91 [0.76-1.10],0.3366924982184353
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,THY1,Thy-1 membrane glycoprotein,28018,153,1.24 [0.75-2.06],0.3930386745453563
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIA1,Nucleolysin TIA-1 isoform p40,26961,146,0.95 [0.84-1.08],0.4486050476374521
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIE1,Tyrosine-protein kinase receptor Tie-1,28118,155,1.10 [0.77-1.56],0.6038352312435971
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",27047,148,0.91 [0.66-1.24],0.5453344918648266
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,23760,138,1.04 [0.67-1.63],0.8524326204812218
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,27874,155,1.38 [1.01-1.89],0.0439199382027267
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,24214,140,0.73 [0.48-1.12],0.1519513141298632
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,24158,142,0.91 [0.75-1.10],0.3185170483450559
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIMP1,Metalloproteinase inhibitor 1,27457,153,1.06 [0.64-1.76],0.8131073973880156
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIMP2,Metalloproteinase inhibitor 2,24214,140,0.52 [0.24-1.13],0.0982133949552124
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIMP3,Metalloproteinase inhibitor 3,27917,151,0.92 [0.82-1.02],0.1159811374154358
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIMP4,Metalloproteinase inhibitor 4,27784,153,0.73 [0.51-1.06],0.0962021049071801
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TINAGL1,Tubulointerstitial nephritis antigen-like,27686,150,1.15 [0.60-2.20],0.6789145234565139
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TJAP1,Tight junction-associated protein 1,27877,155,0.91 [0.76-1.08],0.2623694132327074
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TJP3,Tight junction protein ZO-3,23430,140,0.85 [0.56-1.28],0.4294382534727313
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TK1,"Thymidine kinase, cytosolic",23760,138,0.79 [0.53-1.19],0.2630066662828417
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TLR1,Toll-like receptor 1,23526,136,1.00 [0.54-1.86],0.9982393891059006
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TLR2,Toll-like receptor 2,23760,138,0.81 [0.40-1.64],0.5606162230659172
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TLR3,Toll-like receptor 3,28067,151,0.86 [0.69-1.08],0.1949789579227773
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TLR4,Toll-like receptor 4,23526,136,0.89 [0.50-1.61],0.7063360215490027
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,23536,141,1.02 [0.76-1.37],0.9101589257460246
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMED1,Transmembrane emp24 domain-containing protein 1,23760,138,0.90 [0.66-1.24],0.5220766837861034
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMED10,Transmembrane emp24 domain-containing protein 10,23445,136,1.10 [0.83-1.45],0.5071525883403735
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMED4,Transmembrane emp24 domain-containing protein 4,23445,136,0.98 [0.73-1.31],0.8681272771742047
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMED8,Protein TMED8,24088,141,0.90 [0.77-1.05],0.1878067069423604
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMEM106A,Transmembrane protein 106A,24077,140,0.82 [0.64-1.04],0.101721754760144
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMEM132A,Transmembrane protein 132A,23591,137,1.04 [0.80-1.35],0.7506279559338
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMEM25,Transmembrane protein 25,24175,141,1.13 [0.81-1.58],0.4648137774020748
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMOD4,Tropomodulin-4,23335,137,0.67 [0.43-1.02],0.0618722505035143
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMPRSS11B,Transmembrane protease serine 11B,23430,140,0.86 [0.67-1.09],0.2054464747453281
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMPRSS11D,Transmembrane protease serine 11D,24111,142,0.91 [0.60-1.38],0.6503658382743944
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMPRSS15,Enteropeptidase,27657,152,0.94 [0.80-1.10],0.4482578859470626
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMPRSS5,Transmembrane protease serine 5,27456,151,0.78 [0.54-1.13],0.1855255613078237
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMSB10,Thymosin beta-10,27784,153,0.92 [0.76-1.11],0.375797868778492
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNC,Tenascin,27874,155,0.94 [0.70-1.27],0.6886174097106406
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNF,Tumor necrosis factor,27223,150,0.91 [0.62-1.34],0.631043650228899
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,24088,141,0.74 [0.51-1.07],0.104389242833508
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,27224,148,0.78 [0.52-1.18],0.2446282219795996
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,23702,141,0.77 [0.59-1.01],0.0596551838426823
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,27586,152,0.96 [0.61-1.50],0.8467232748633141
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,27586,152,1.08 [0.78-1.49],0.6318137856004271
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,27835,153,0.72 [0.55-0.95],0.0193017548010634
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,28067,151,0.83 [0.56-1.21],0.3267468288938817
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,27782,151,0.89 [0.54-1.47],0.6584022725450374
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,27877,155,1.13 [0.75-1.71],0.5467057123434405
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,27831,151,0.81 [0.51-1.27],0.3544451091273242
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,27224,148,0.99 [0.69-1.40],0.9366469091931856
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,27831,151,0.72 [0.44-1.18],0.1944092018735796
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,23702,141,0.67 [0.45-1.00],0.0519778726937973
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,28012,153,0.87 [0.54-1.39],0.553692124569014
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,27784,153,0.95 [0.58-1.57],0.8437899402917662
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,27784,153,0.92 [0.61-1.38],0.6833484779380453
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,28018,153,0.85 [0.50-1.44],0.5513326109000944
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,28021,150,0.86 [0.58-1.27],0.449518014666364
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,27586,152,0.88 [0.67-1.15],0.3515712155751861
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,28018,153,0.97 [0.71-1.33],0.8452679168515377
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,27586,152,0.90 [0.63-1.30],0.5785283094119611
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFSF10,Tumor necrosis factor ligand superfamily member 10,28067,151,0.93 [0.53-1.61],0.7837797368335065
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFSF11,Tumor necrosis factor ligand superfamily member 11,27734,152,0.88 [0.70-1.12],0.299071472464639
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFSF12,Tumor necrosis factor ligand superfamily member 12,28067,151,0.80 [0.49-1.31],0.3761786035042123
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFSF13,Tumor necrosis factor ligand superfamily member 13,27917,151,0.94 [0.55-1.62],0.8317887006923131
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,28071,155,0.75 [0.44-1.28],0.2925003819260376
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFSF14,Tumor necrosis factor ligand superfamily member 14,27586,152,0.92 [0.71-1.18],0.4896874621198909
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFSF8,Tumor necrosis factor ligand superfamily member 8,24212,142,0.99 [0.64-1.55],0.9751890953594878
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNIP1,TNFAIP3-interacting protein 1,24158,142,0.90 [0.75-1.08],0.2738761849350664
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNN,Tenascin-N,24212,142,1.12 [0.78-1.60],0.5466860123158284
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNNI3,"Troponin I, cardiac muscle",27269,150,0.95 [0.80-1.12],0.5122963118497257
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNPO1,Transportin-1,23760,138,0.68 [0.42-1.11],0.1244383559565714
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNR,Tenascin-R,27586,152,0.71 [0.51-1.00],0.0495160517985785
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNXB,Tenascin-X,27784,153,0.77 [0.44-1.35],0.3636968372269354
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,24214,140,0.86 [0.69-1.06],0.1552964737463696
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TOP1,DNA topoisomerase 1,24088,141,1.10 [0.94-1.28],0.226713277223581
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TOP1MT,"DNA topoisomerase I, mitochondrial",23335,137,0.89 [0.63-1.27],0.5267644002650678
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TOP2B,DNA topoisomerase 2-beta,23526,136,0.83 [0.67-1.03],0.0988656756184628
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TOR1AIP1,Torsin-1A-interacting protein 1,23591,137,0.81 [0.57-1.13],0.2130613606917952
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TP53,Cellular tumor antigen p53,27127,147,0.76 [0.53-1.07],0.1172036357794053
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TP53BP1,TP53-binding protein 1,23526,136,0.88 [0.72-1.06],0.182159927627382
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TP53I3,Quinone oxidoreductase PIG3,23184,137,0.84 [0.62-1.16],0.2954262080144558
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TP53INP1,Tumor protein p53-inducible nuclear protein 1,27269,150,0.65 [0.37-1.14],0.1341848283029902
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TP73,Tumor protein p73,23536,141,0.90 [0.56-1.45],0.6711199132941265
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPBGL,Trophoblast glycoprotein-like,23536,141,0.74 [0.48-1.15],0.1832592841220948
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPD52L2,Tumor protein D54,23702,141,0.88 [0.76-1.02],0.0901918998319726
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPK1,Thiamin pyrophosphokinase 1,24214,140,0.43 [0.24-0.77],0.0042769427745874
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPM3,Tropomyosin alpha-3 chain,23445,136,1.06 [0.72-1.55],0.7764446042317239
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPMT,Thiopurine S-methyltransferase,27127,147,1.00 [0.82-1.22],0.985729903303336
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPP1,Tripeptidyl-peptidase 1,27599,150,0.88 [0.63-1.24],0.4663205371088144
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPPP2,Tubulin polymerization-promoting protein family member 2,23760,138,1.06 [0.88-1.28],0.5093272817897357
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPPP3,Tubulin polymerization-promoting protein family member 3,27099,148,1.04 [0.73-1.48],0.8324100207500675
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPR,Nucleoprotein TPR,23445,136,0.80 [0.54-1.17],0.2487143880375767
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPRKB,EKC/KEOPS complex subunit TPRKB,23335,137,0.99 [0.76-1.28],0.9335274148968522
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPSAB1,Tryptase alpha/beta-1,28020,151,0.77 [0.59-1.00],0.0533825256477809
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPSD1,Tryptase delta,24175,141,0.81 [0.51-1.30],0.3855231234118846
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPSG1,Tryptase gamma,23526,136,0.78 [0.41-1.48],0.4488520039114224
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPT1,Translationally-controlled tumor protein,27224,148,1.00 [0.80-1.25],0.9897690307756256
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRAF2,TNF receptor-associated factor 2,27734,152,0.95 [0.77-1.16],0.6087430882969396
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRAF3,"TNF receptor-associated factor 3, Isoform 2",23526,136,0.86 [0.54-1.38],0.5331169899082395
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,23445,136,1.05 [0.75-1.46],0.7726657886032281
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,23760,138,0.90 [0.73-1.09],0.28047865481725
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TREH,Trehalase,24212,142,0.79 [0.64-0.97],0.0225063866122089
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TREM2,Triggering receptor expressed on myeloid cells 2,27782,151,0.84 [0.63-1.11],0.2235415150926672
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TREML1,Trem-like transcript 1 protein,24226,140,0.69 [0.50-0.95],0.0212332194427227
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TREML2,Trem-like transcript 2 protein,27784,153,0.96 [0.62-1.47],0.8415025332033412
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRIAP1,TP53-regulated inhibitor of apoptosis 1,28012,153,0.85 [0.68-1.08],0.1824311173045579
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRIM21,E3 ubiquitin-protein ligase TRIM21,27734,152,0.95 [0.80-1.14],0.6017149231607314
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRIM24,Transcription intermediary factor 1-alpha,23713,138,1.11 [0.87-1.40],0.4135890825841707
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,24088,141,0.90 [0.77-1.04],0.1468040661886183
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRIM26,Tripartite motif-containing protein 26,23335,137,0.73 [0.52-1.02],0.0652070518651533
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRIM40,E3 ubiquitin ligase TRIM40,23536,141,0.97 [0.77-1.22],0.7809139461508345
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRIM5,Tripartite motif-containing protein 5,27734,152,0.92 [0.78-1.09],0.3186406857675539
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRIM58,E3 ubiquitin-protein ligase TRIM58,24077,140,0.97 [0.80-1.16],0.7288044629473709
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRPV3,Transient receptor potential cation channel subfamily V member 3,23445,136,0.64 [0.42-0.96],0.0300225184424002
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TSC1,Hamartin,23526,136,0.84 [0.64-1.09],0.1865594395256577
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TSC22D1,TSC22 domain family protein 1,24175,141,0.97 [0.76-1.23],0.7921047584104787
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TSHB,Thyrotropin subunit beta,27780,151,0.98 [0.83-1.16],0.8157540447131986
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TSLP,Thymic stromal lymphopoietin,27269,150,0.95 [0.74-1.22],0.6864227645801173
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TSNAX,Translin-associated protein X,23445,136,0.90 [0.59-1.37],0.6324288582210208
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TSPAN1,Tetraspanin-1,27269,150,0.74 [0.42-1.30],0.294321510565307
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TSPAN15,Tetraspanin-15,23445,136,1.36 [1.07-1.72],0.0116119573963911
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TSPAN7,Tetraspanin-7,23430,140,0.92 [0.76-1.12],0.4083995740570972
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TSPAN8,Tetraspanin-8,24088,141,0.94 [0.81-1.10],0.4502819186294238
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TSPYL1,Testis-specific Y-encoded-like protein 1,23526,136,0.68 [0.44-1.06],0.0873583494516939
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TST,Thiosulfate sulfurtransferase,27052,148,0.93 [0.76-1.13],0.4388698859333595
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TTF2,Transcription termination factor 2,23536,141,0.95 [0.68-1.32],0.7453132866198355
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TTN,Titin,23445,136,1.18 [0.96-1.45],0.1211591877254559
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TTR,Transthyretin,23991,142,1.03 [0.54-1.94],0.932488545246358
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TUBB3,Tubulin beta-3 chain,23430,140,0.63 [0.34-1.14],0.1230263088165436
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TWF2,Twinfilin-2,24212,142,0.82 [0.68-1.00],0.0492428844717557
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TXK,Tyrosine-protein kinase TXK,23760,138,1.09 [0.90-1.31],0.3885319751060694
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TXLNA,Alpha-taxilin,27586,152,0.95 [0.81-1.12],0.555516486004357
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TXN,Thioredoxin,23818,139,0.85 [0.58-1.25],0.4001572621632276
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TXNDC15,Thioredoxin domain-containing protein 15,27877,155,0.59 [0.35-1.00],0.0500878203937788
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TXNDC5,Thioredoxin domain-containing protein 5,28018,153,0.83 [0.67-1.04],0.1013493694015441
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TXNDC9,Thioredoxin domain-containing protein 9,24158,142,0.75 [0.54-1.05],0.090174825596102
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TXNL1,Thioredoxin-like protein 1,23381,139,1.01 [0.86-1.19],0.9171655935052352
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",27784,153,0.87 [0.64-1.20],0.402651711722547
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TYMP,Thymidine phosphorylase,27598,150,0.86 [0.69-1.07],0.184947402392628
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TYRO3,Tyrosine-protein kinase receptor TYRO3,27780,151,0.57 [0.35-0.95],0.0311791902706876
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",23526,136,1.03 [0.79-1.35],0.8010136109956377
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UBAC1,Ubiquitin-associated domain-containing protein 1,27657,152,0.88 [0.59-1.31],0.5166382946061456
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UBE2B,Ubiquitin-conjugating enzyme E2 B,24077,140,1.08 [0.63-1.84],0.781983471262727
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,24214,140,0.79 [0.61-1.04],0.0941747977192801
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,23526,136,0.74 [0.54-1.03],0.0739197620620834
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UBQLN3,Ubiquilin-3,23445,136,1.02 [0.71-1.46],0.9145203558588164
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UBXN1,UBX domain-containing protein 1,23702,141,0.84 [0.66-1.07],0.1583399324047664
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,24088,141,0.92 [0.82-1.03],0.1652077529133168
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UGDH,UDP-glucose 6-dehydrogenase,23445,136,1.04 [0.89-1.22],0.6026252115970594
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UHRF2,E3 ubiquitin-protein ligase UHRF2,23445,136,0.72 [0.42-1.25],0.2413504337260015
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ULBP2,UL16-binding protein 2,27586,152,1.22 [0.83-1.78],0.3096911583047666
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UMOD,Uromodulin,28037,155,1.00 [0.77-1.30],0.9944650453053336
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UNC5D,Netrin receptor UNC5D,23526,136,0.56 [0.29-1.09],0.085978321858088
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UNC79,Protein unc-79 homolog,23335,137,0.87 [0.64-1.18],0.3682188703556713
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UNG,Uracil-DNA glycosylase,24077,140,0.37 [0.22-0.61],0.0001183950038135
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UPB1,Beta-ureidopropionase,24214,140,0.99 [0.83-1.18],0.8965815116139225
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UPK3A,Uroplakin-3a,23430,140,1.17 [0.87-1.58],0.3013737089210563
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UPK3BL1,Uroplakin-3b-like protein 1,23719,138,0.94 [0.68-1.29],0.7011736377284192
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UROD,Uroporphyrinogen decarboxylase,23702,141,0.97 [0.77-1.22],0.7995718357449764
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UROS,Uroporphyrinogen-III synthase,23536,141,1.07 [0.86-1.33],0.5439075877288218
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,USO1,General vesicular transport factor p115,27657,152,0.92 [0.79-1.08],0.305269518182065
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,USP25,Ubiquitin carboxyl-terminal hydrolase 25,24077,140,0.90 [0.72-1.13],0.3589150274079536
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,USP28,Ubiquitin carboxyl-terminal hydrolase 28,24158,142,0.92 [0.59-1.43],0.7033983585210379
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,USP47,Ubiquitin carboxyl-terminal hydrolase 47,23445,136,0.81 [0.65-1.02],0.0719786511612936
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,USP8,Ubiquitin carboxyl-terminal hydrolase 8,27269,150,0.92 [0.78-1.07],0.2620288056483164
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UXS1,UDP-glucuronic acid decarboxylase 1,27127,147,1.14 [0.88-1.47],0.3305467370293046
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VAMP5,Vesicle-associated membrane protein 5,27269,150,0.89 [0.68-1.18],0.4285961995369791
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VAMP8,Vesicle-associated membrane protein 8,23526,136,0.91 [0.75-1.09],0.3083063504600887
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VASH1,Tubulinyl-Tyr carboxypeptidase 1,27734,152,0.90 [0.75-1.08],0.2461818356073749
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VASN,Vasorin,27331,154,1.16 [0.68-1.95],0.5898876789158981
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VASP,Vasodilator-stimulated phosphoprotein,24226,140,0.87 [0.70-1.09],0.2313410747691097
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,27657,152,0.66 [0.32-1.36],0.2578132471770406
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VAV3,Guanine nucleotide exchange factor VAV3,23430,140,0.91 [0.77-1.08],0.273819204678648
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VCAM1,Vascular cell adhesion protein 1,27826,155,1.42 [0.85-2.37],0.1746297385873572
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VCAN,Versican core protein,28018,153,0.55 [0.34-0.89],0.0141200218927671
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VCPKMT,Protein-lysine methyltransferase METTL21D,23335,137,0.66 [0.51-0.87],0.0027984962203244
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VEGFA,Vascular endothelial growth factor A,27973,151,0.80 [0.62-1.03],0.0893166378827894
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VEGFB,Vascular endothelial growth factor B,23526,136,0.50 [0.28-0.91],0.0224555360655252
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VEGFC,Vascular endothelial growth factor C,27877,155,0.80 [0.62-1.02],0.0729422201771557
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VEGFD,Vascular endothelial growth factor D,28016,151,0.91 [0.60-1.40],0.682468432325104
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VGF,Neurosecretory protein VGF,24175,141,0.58 [0.34-0.99],0.0442640833274221
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VIM,Vimentin,27269,150,0.98 [0.87-1.11],0.8057647561800554
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VIPR1,Vasoactive intestinal polypeptide receptor 1,23591,137,0.96 [0.50-1.85],0.8978354616756662
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VIT,Vitrin,24214,140,0.67 [0.43-1.03],0.0675032202372168
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VMO1,Vitelline membrane outer layer protein 1 homolog,27657,152,0.91 [0.75-1.11],0.3691573697146791
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VNN1,Pantetheinase,24226,140,0.92 [0.74-1.14],0.4557999456112629
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VNN2,Vascular non-inflammatory molecule 2,27657,152,0.98 [0.72-1.34],0.903495031265726
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VPS28,Vacuolar protein sorting-associated protein 28 homolog,23760,138,0.91 [0.71-1.17],0.464007116535276
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VPS37A,Vacuolar protein sorting-associated protein 37A,27657,152,0.95 [0.79-1.13],0.5561640801020351
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VPS4B,Vacuolar protein sorting-associated protein 4B,24077,140,0.90 [0.76-1.07],0.233311177380336
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VPS53,Vacuolar protein sorting-associated protein 53 homolog,27657,152,0.91 [0.75-1.10],0.3184125611087039
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VSIG10,V-set and immunoglobulin domain-containing protein 10,24077,140,0.58 [0.34-0.99],0.0471523982893083
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,23445,136,1.08 [0.66-1.75],0.7699446953192257
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VSIG2,V-set and immunoglobulin domain-containing protein 2,24077,140,0.98 [0.75-1.28],0.8837990303973049
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VSIG4,V-set and immunoglobulin domain-containing protein 4,27745,153,0.96 [0.66-1.38],0.8203959062653006
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,27739,151,0.78 [0.61-1.00],0.0480972966974557
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VSNL1,Visinin-like protein 1,24158,142,0.99 [0.64-1.51],0.9470191434955888
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VSTM1,V-set and transmembrane domain-containing protein 1,27099,148,1.06 [0.79-1.42],0.7017501446244702
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VSTM2B,V-set and transmembrane domain-containing protein 2B,23760,138,0.77 [0.49-1.21],0.252797602432977
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,27269,150,1.03 [0.80-1.32],0.8213854082209269
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,28018,153,0.84 [0.69-1.03],0.0868222793050038
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VTCN1,V-set domain-containing T-cell activation inhibitor 1,27127,147,1.12 [0.71-1.78],0.6237016651345638
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,23702,141,0.77 [0.57-1.03],0.082057837694122
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VWA1,von Willebrand factor A domain-containing protein 1,27963,153,0.68 [0.48-0.96],0.0298129006261659
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VWA5A,von Willebrand factor A domain-containing protein 5A,23335,137,0.58 [0.41-0.81],0.0012994619211123
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VWC2,Brorin,27492,152,0.83 [0.57-1.20],0.3121266958559154
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VWC2L,von Willebrand factor C domain-containing protein 2-like,24175,141,0.92 [0.64-1.33],0.6497555132951898
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VWF,von Willebrand factor,28118,155,0.94 [0.77-1.14],0.5391122111357749
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WARS,"Tryptophan--tRNA ligase, cytoplasmic",27784,153,1.02 [0.70-1.49],0.9118175241275775
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WAS,Wiskott-Aldrich syndrome protein,27224,148,0.95 [0.76-1.18],0.6436328352278775
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WASF1,Wiskott-Aldrich syndrome protein family member 1,27269,150,0.95 [0.81-1.12],0.5651934564443089
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WASF3,Wiskott-Aldrich syndrome protein family member 3,27099,148,0.87 [0.73-1.03],0.0964174977285317
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WASHC3,WASH complex subunit 3,24158,142,0.84 [0.67-1.05],0.1345650792894687
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WASL,Neural Wiskott-Aldrich syndrome protein,23526,136,0.84 [0.62-1.13],0.2492508307780936
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WDR46,WD repeat-containing protein 46,24077,140,0.57 [0.34-0.95],0.0314535179158575
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WFDC1,WAP four-disulfide core domain protein 1,23601,138,0.87 [0.62-1.23],0.4360532039190007
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WFDC12,WAP four-disulfide core domain protein 12,27975,152,1.15 [0.93-1.43],0.2018050519647847
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WFDC2,WAP four-disulfide core domain protein 2,26355,146,0.88 [0.59-1.32],0.5340452758556593
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",27504,151,1.51 [1.07-2.11],0.0174675799716047
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",27831,151,0.81 [0.53-1.22],0.3071583680101946
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WIF1,Wnt inhibitory factor 1,28012,153,0.62 [0.41-0.95],0.0267027316107076
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WNT9A,Protein Wnt-9a,27224,148,1.01 [0.60-1.69],0.972690376725998
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,27586,152,0.94 [0.72-1.22],0.6356960585460951
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,XCL1,Lymphotactin,28012,153,1.03 [0.80-1.32],0.8113743129514323
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,XG,Glycoprotein Xg,27976,155,1.02 [0.64-1.64],0.92450535566222
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,XIAP,E3 ubiquitin-protein ligase XIAP,23526,136,0.77 [0.57-1.04],0.0879101509809656
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,XPNPEP2,Xaa-Pro aminopeptidase 2,27877,155,0.92 [0.78-1.08],0.2950439571841857
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,XRCC4,DNA repair protein XRCC4,27099,148,0.68 [0.44-1.03],0.0679509634483647
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,YAP1,Transcriptional coactivator YAP1,24158,142,0.96 [0.53-1.75],0.9007831067048186
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",24088,141,0.94 [0.85-1.05],0.2706985135012821
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,YES1,Tyrosine-protein kinase Yes,27657,152,0.98 [0.86-1.11],0.726500441570221
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,YJU2,Splicing factor YJU2,24077,140,0.68 [0.40-1.14],0.1438376932277674
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,YOD1,Ubiquitin thioesterase OTU1,23445,136,0.98 [0.76-1.27],0.8933688159456382
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,YTHDF3,YTH domain-containing family protein 3,27224,148,0.92 [0.78-1.10],0.3800465207871861
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,YWHAQ,14-3-3 protein theta,23702,141,0.86 [0.68-1.07],0.1705152941052864
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,YY1,Transcriptional repressor protein YY1,23526,136,0.48 [0.26-0.90],0.0226763363539111
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZBP1,Z-DNA-binding protein 1,23526,136,0.90 [0.58-1.39],0.6391243729003382
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZBTB16,Zinc finger and BTB domain-containing protein 16,27127,147,0.91 [0.73-1.13],0.4111855710544906
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZBTB17,Zinc finger and BTB domain-containing protein 17,27269,150,0.82 [0.56-1.21],0.3216606535860299
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZCCHC8,Zinc finger CCHC domain-containing protein 8,23445,136,1.07 [0.84-1.38],0.576801066623615
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZFYVE19,Abscission/NoCut checkpoint regulator,24088,141,0.87 [0.73-1.04],0.1258498228683203
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZHX2,Zinc fingers and homeoboxes protein 2,24158,142,1.02 [0.64-1.62],0.9347455694280884
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZNF174,Zinc finger protein 174,23526,136,0.95 [0.61-1.47],0.8140677413268653
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZNF75D,Zinc finger protein 75D,23760,138,1.14 [0.91-1.44],0.2426707621153533
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZNF830,Zinc finger protein 830,24077,140,0.82 [0.65-1.04],0.1028919285728043
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZNRD2,Protein ZNRD2,24088,141,0.77 [0.60-0.99],0.0426316615811775
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,24077,140,0.94 [0.70-1.27],0.6990112317783137
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZP3,Zona pellucida sperm-binding protein 3,23591,137,1.00 [0.94-1.06],0.9606175346331202
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZP4,Zona pellucida sperm-binding protein 4,23335,137,0.73 [0.40-1.31],0.2859565457176555
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZPR1,Zinc finger protein ZPR1,23430,140,1.00 [0.85-1.19],0.9627093706358972
